omeprazole has been researched along with Stomach Ulcer in 747 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Stomach Ulcer: Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Equine gastric ulcer syndrome (EGUS) is the most common disease of the stomach in horses and treatment is based on the oral administration of omeprazole for at least 28 days." | 9.69 | A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial. ( Busechian, S; Conte, G; Conti, MB; Marchesi, MC; Pieramati, C; Rueca, F; Sgorbini, M; Vitale, V; Zappulla, F, 2023) |
| " Anecdotally, many practitioners prescribe omeprazole concurrently with phenylbutazone to reduce development of equine gastric ulcer syndrome (EGUS), but the efficacy and safety of this practice remains unknown." | 9.41 | Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS). ( Andrews, FM; Banse, HE; Chapman, A; Garza, F; Keowen, M; Paul, L; Ricord, M; Yñiguez, FJM, 2021) |
| "To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome." | 9.27 | Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome. ( Bush, J; Franklin, S; van den Boom, R, 2018) |
| "To further investigate the presence of a dose relationship in the treatment of gastric ulceration under conditions that may favour omeprazole efficacy such as administration prior to exercise and after a brief fast, and potential differences between the response of squamous and glandular ulceration to omeprazole therapy." | 9.20 | A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2015) |
| "To compare: 1) the efficacy of 2 doses of omeprazole in the treatment of primary squamous and glandular gastric ulceration; and 2) the healing response of primary squamous and glandular gastric ulceration to acid suppression therapy." | 9.19 | A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2014) |
| " EC-ASA 325 mg in a secondary cardiovascular disease prevention population taking aspirin 325 mg daily for ≥3 months and at risk for ASA-associated gastric ulcers (GUs)." | 9.19 | PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies. ( Cryer, BL; Eisen, GM; Fort, JG; Goldstein, JL; Lanas, A; Miller, AB; O'Connor, C; Scheiman, JM; Whellan, DJ; Zhang, Y, 2014) |
| "Melatonin (MT) and its precursor L-tryptophan (TRP) are implicated in the protection of gastric mucosa against aspirin-induced lesions and in the acceleration of healing of idiopathic gastro-duodenal ulcers, but no information is available whether these agents are also effective in healing of gastroduodenal ulcers accompanied by Helicobacter pylori (H." | 9.15 | Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans. ( Bielanski, W; Brzozowski, T; Celinski, K; Cichoz-Lach, H; Konturek, PC; Konturek, SJ; Slomka, M, 2011) |
| " This study evaluated and compared it with a reference PPI, omeprazole, in the treatment of gastric and duodenal ulcers." | 9.14 | Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers. ( Goh, KL; Ho, KY; Kim, DY; Kuan, A; Mahachai, V; Yoon, HM; Zaño, F, 2009) |
| "A large percentage of performance horses develop gastric ulcers and many of those horses are treated with omeprazole." | 9.12 | Effect of omeprazole on markers of performance in gastric ulcer-free standardbred horses. ( Albeirci, JM; Gordon, ME; Manso Filho, HC; McKeever, JM; McKeever, KH, 2006) |
| "To determine the effects of 8 days of light to heavy exercise on gastric ulcer development in horses and determine the efficacy of omeprazole paste in preventing gastric ulceration." | 9.12 | Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration. ( Cramer, LG; Fleishman, C; Holste, JE; McClure, SR; Murray, MJ; Sifferman, R; White, G, 2007) |
| "To observe the histological changes of gastric mucosa in patients with active gastric ulcer before and after treatment by Qifang Weitong Powder combined with omeprazole (QWP-Op)." | 9.12 | [Morphological observation on gastric mucosa membrane of patients with gastric ulcer treated with combined use of Qifang Weitong Powder and omeprazole]. ( Deng, C; Li, GX; Luo, WS, 2007) |
| "To evaluate the effect of a single dose of rebeprazole (RAB) versus omeprazole (OME) on acid suppression and symptom relief in patients with gastric ulcer." | 9.11 | [The effect of rabeprazole on gastric pH in patients with gastric ulcer]. ( Ke, MY, 2004) |
| "Horses with gastric ulcers were treated with omeprazole at a dosage of 4 mg/kg (1." | 9.11 | Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Fleishman, C; Holste, JE; Hughes, FE; McClure, SR; Sifferman, RL; White, GW, 2005) |
| "To compare effects of a commercially available omeprazole paste and a compounded omeprazole suspension on healing of gastric ulcers in Thoroughbred racehorses in active training." | 9.10 | Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training. ( Aleman, MR; Nieto, JE; Pipers, FS; Smith, DC; Snyder, JR; Spier, S; Stanley, S, 2002) |
| " pylori-positive patients with active gastric ulcer were randomized to receive pantoprazole (40 mg) (P) and two of three antibiotics: clarithromycin (500 mg) (C), metronidazole (500 mg) (M) or amoxicillin (1000 mg) (A)." | 9.10 | Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. ( Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S, 2003) |
| " This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection." | 9.10 | Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. ( Aoyagi, K; Esaki, M; Fujishima, M; Kuwano, Y; Matsumoto, T; Shimizu, M, 2002) |
| "To study the efficacy of omeprazole triple therapy in the eradication of Helicobacter pylori in patients with active gastric ulcer, and to assess healing and relapse of gastric ulcer." | 9.09 | The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. ( Bayerdörffer, E; Diete, U; Gil, J; Lind, T; Malfertheiner, P; Misiuna, P; O'Morain, C; Sipponen, P; Spiller, RC; Stasiewicz, J; Treichel, H; Ujszászy, L; Unge, P; Zanten, SJ; Zeijlon, L, 1999) |
| "A multicentre, blinded, randomised complete-block, field trial was conducted with 140 horses and foals age 4 weeks-28 years to determine if omeprazole paste is effective and safe in promoting healing of spontaneous gastric ulcers under a variety of field conditions and in different breeds and ages of horses." | 9.09 | Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial. ( Cox, JL; Ericcson, GF; Holste, JE; MacAllister, CG; McClure, SR; Sifferman, RL; Vatistas, NJ; White, GW, 1999) |
| "In patients who require continuous treatment with NSAIDs, lansoprazole is superior to ranitidine for healing of NSAID-associated gastric ulcers." | 9.09 | Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. ( Agrawal, NM; Campbell, DR; Haber, MM; Huang, B; Lukasik, NL; Safdi, MA, 2000) |
| "To clarify whether the depth of ulceration evaluated by endoscopic ultrasonography (EUS) influences a modified dual therapy with amoxicillin and lansoprazole for the treatment of Helicobacter pylori-positive patients with gastric ulcer." | 9.09 | Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer? ( Kawashima, A; Motoo, Y; Ohtsubo, K; Okai, T; Sakai, J; Sawabu, N; Watanabe, H, 2000) |
| "Controlled trials were conducted to determine if treatment with the benzimidazole compound, omeprazole, would prevent gastric ulceration associated with feed withdrawal." | 9.09 | The use of omeprazole to alleviate stomach ulcers in swine during periods of feed withdrawal. ( Dewey, CE; Friendship, RM; Melnichouk, SI, 2000) |
| "We examined the effects of lansoprazole and famotidine on gastric basic fibroblast growth factor (bFGF) levels and ulcer healing in patients with gastric ulcer." | 9.08 | Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine. ( Fukuda, M; Higashi, T; Imaizumi, T; Kawano, S; Miura, N; Miyajima, K; Mukuda, T; Noguchi, M; Tatsumi, T; Tsuji, S, 1995) |
| "This study attempted to determine the efficacy of lansoprazole plus clarithromycin therapy in the eradication of Helicobacter pylori in gastric ulcer patients." | 9.08 | Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. ( Aisawa, T; Akagi, T; Fukuda, S; Fukushi, M; Mizuki, I; Munakata, A; Ohkawa, K; Sakata, Y; Shimoyama, T; Yoshida, Y, 1995) |
| "We studied the action on acid secretion of lansoprazole compared with famotidine by 24-h intragastric pH monitoring, evaluated its clinical effects prospectively, and assessed the importance of acid inhibition in gastric ulcer patients." | 9.08 | Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine. ( Ashida, K; Katsu, K; Miyoshi, H; Sakaguchi, M; Umegaki, E, 1995) |
| "To compare the efficacy of lansoprazole and famotidine in the treatment of gastric ulcer, 24 patients with gastric ulcer were treated for 8 weeks." | 9.08 | Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial. ( Motoo, Y; Okai, T; Sawabu, N; Songür, Y; Watanabe, H, 1995) |
| "The effects of lansoprazole (30 mg/day) in 18 patients with gastric ulcers and the quality of ulcer healing were studied using endoscopy (including dye endoscopy) and endoscopic ultrasonography (EUS)." | 9.08 | Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings. ( Ajima, H; Ejiri, Y; Ishihata, R; Kasukawa, R; Kondo, Y; Kuwana, T; Mukai, S; Obara, K; Okubo, Y; Yokogi, K, 1995) |
| "The effect of lansoprazole, a new benzimidazole proton pump inhibitor, on the relationship between ulcer healing and changes in mucin content was studied in gastric ulcer patients." | 9.08 | Effects of lansoprazole on gastric ulcer healing and mucin content. ( Ishii, K; Komuro, Y; Miyake, Y; Oida, M; Saigenji, K; Tanabe, S, 1995) |
| "This study reports preliminary results of a controlled, multicenter trial on the quality of ulcer healing induced by lansoprazole (LPZ) or roxatidine (R) in gastric ulcer (GU) or duodenal ulcer (DU) patients." | 9.08 | Quality of peptic ulcer healing induced by lansoprazole and roxatidine. ( Fujino, MA; Kobayashi, K; Morozumi, A; Ohtsuka, H; Sano, S; Suzuki, Y; Tachikawa, H; Uchida, N; Ueda, F; Yamamoto, Y, 1995) |
| "The clinical usefulness of lansoprazole in the healing of gastric and duodenal ulcers, the S2-stage shift rate (white scarring rate), and endoscopic healing rate with respect to degree of gastric mucosal atrophy were investigated." | 9.08 | Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group. ( Asaki, S; Hongo, M; Sakurada, H; Sato, A; Takeda, T; Toyota, T, 1995) |
| "In the present study, the effects of short-term treatment with lansoprazole on healing and recurrence of peptic ulcer were investigated." | 9.08 | The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody. ( Akimoto, K; Fukujin, H; Katoaka, A; Mashima, H; Mine, T; Nagasawa, J; Tajima, A; Takano, T; Tsuchida, T; Yasuda, H, 1995) |
| "A multicenter, double-blind study was conducted in 268 patients to compare the safety and efficacy of 15, 30, and 60 mg of lansoprazole and placebo in the treatment of gastric ulcer." | 9.08 | Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer. ( Avner, DL; Berry, W; Erfling, W; McFarland, M; Movva, R; Nelson, KJ, 1995) |
| "Pantoprazole appears to be superior to ranitidine in gastric ulcer healing." | 9.08 | Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. ( Hotz, J; Plein, K; Rose, K; Schönekäs, H, 1995) |
| "The proton pump inhibitors pantoprazole and omeprazole were compared in a randomized, double-blind study in 219 patients with benign gastric ulcers." | 9.08 | Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995) |
| "The proton-pump inhibitor, lansoprazole, a more potent gastric acid inhibitor with a longer action than H2-receptor antagonists, should heal refractory gastric ulcers more effectively." | 9.08 | A trial of lansoprazole in refractory gastric ulcer. ( Girdwood, AH; Louw, JA; Marks, IN; Simjee, AE; van Rensburg, CJ, 1996) |
| "The purpose of this multicenter, randomized, double-blind study, conducted in 520 patients, was to compare the efficacy and safety of omeprazole (40 and 20 mg once daily) with placebo in the treatment of benign gastric ulcer." | 9.08 | Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. ( Colón Pagán, JR; Gilde, LR; Kogut, DG; McCullough, AJ; Shah, U; Simon, TJ; Valenzuela, JE; Whipple, J, 1996) |
| "Seventeen Thoroughbred horses with moderate to severe gastric ulceration were purchased from a race track within 10 days of racing and were treated once daily with either omeprazole (9 horses) or vehicle (8 horses) and evaluated gastroscopically for ulcer healing." | 9.08 | Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses. ( Eagleson, J; Eichorn, ES; Haven, ML; Hickey, GJ; Murray, MJ; Zhang, D, 1997) |
| "Our aim was to investigate the efficacy of omeprazole and amoxicillin in curing Helicobacter pylori infection in gastric ulcer patients." | 9.08 | Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany. ( Bayerdörffer, E; Bolle, KH; Fischer, G; Hatz, R; Höchter, W; Huber, F; Klann, H; Lehn, N; Meining, A; Simon, T; Sommer, A; Stolte, M; Weingart, J, 1998) |
| "Our purpose was to compare the safety and efficacy of lansoprazole 15 mg and 30 mg with placebo in preventing recurrence in 49 patients with a history of gastric ulcer." | 9.08 | Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer. ( Campbell, D; Haber, M; Jennings, DE; Kovacs, TO; Richter, J; Rose, P, 1998) |
| "Rabeprazole, a new proton pump inhibitor, was studied in patients with acid-peptic-related diseases (duodenal ulcer, gastric ulcer, GERD) in three placebo-controlled, double-blind, randomized clinical trials." | 9.08 | Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group. ( Bassion, S; Cloud, ML; Enas, N; Humphries, TJ, 1998) |
| " Omeprazole was significantly superior to sucralfate in inducing gastric ulcer healing after both 4 (87 vs." | 9.08 | Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer. ( Bianchi Porro, G; Lazzaroni, M; Manzionna, G; Petrillo, M, 1998) |
| "In this randomized, double-blind, multicentre study, conducted at 25 European sites, rabeprazole and omeprazole were compared in patients with active gastric ulcers." | 9.08 | Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group. ( Beker, JA; Bell, NE; Dekkers, CP; Gabryelewicz, A; Humphries, TJ; Thjodleifsson, B, 1998) |
| " pylori-positive gastric ulcer patients were assigned at random to two groups; in addition to dual therapy (amoxicillin 500 mg thrice daily and lansoprazole 30 mg every morning for two weeks), one group received rebamipide 100 mg thrice daily for eight weeks, while the other group received teprenone 50 mg thrice daily for eight weeks." | 9.08 | Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients. ( Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H, 1998) |
| "The effects of trimebutine maleate (TM), a prokinetic drug, on gastrointestinal motility in patients with gastric ulcer were investigated." | 9.08 | Effects of trimebutine maleate on gastric motility in patients with gastric ulcer. ( Andou, T; Fujinami, T; Hara, M; Hirako, M; Kamiya, T; Kobayashi, Y; Misu, N; Nagao, T, 1998) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 9.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| "We compared the efficacy and short-term safety of lansoprazole against ranitidine in the healing of gastric ulcer." | 9.07 | Rapid healing of gastric ulcers with lansoprazole. ( Ahlberg, J; Bardhan, KD; Hislop, WS; Lindholmer, C; Long, RG; Morgan, AG; Sjostedt, S; Smith, PM; Stig, R; Wormsley, KG, 1994) |
| "To compare the efficacy of two omeprazole/amoxicillin regimens concerning Helicobacter pylori eradication, ulcer healing, pain relief, and safety in patients with gastric ulcer disease." | 9.07 | Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. ( Bertrams, J; Börsch, G; Labenz, J; Rühl, GH, 1994) |
| "Patients (106) with peptic ulceration of the oesophagus, stomach and duodenum, unresponsive to 3 or more months of high-dose treatment with ranitidine, were initially given pantoprazole (40-80 mg, p." | 9.07 | Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. ( Brunner, G; Harke, U, 1994) |
| "We studied the effectiveness of lansoprazole and ranitidine in promoting gastric ulcer healing in a multicentre double-blind trial, by comparing the proportion of healed ulcers after 4 and 8 weeks of treatment." | 9.07 | Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. ( Bigard, MA; Bommelaer, G; Colin, R; Dupas, JL; Lemaire, M; Michel, P; Rambaud, JC; Verwaerd, JC, 1994) |
| "Forty-two patients with peptic ulceration of the duodenum, stomach or oesophagus, who had not responded to 3 or more months of high-dose treatment with ranitidine (450 or 600 mg/day), were treated with oral lansoprazole at 30-60 mg daily." | 9.07 | An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. ( Arnold, R; Brunner, G; Fuchs, W; Hennig, U, 1993) |
| " Altogether 107 patients (duodenal ulcer, n = 88; prepyloric ulcer, n = 14; gastric ulcer, n = 3; mixed sites, n = 2) with refractory peptic ulcer - that is ulcer unhealed after at least two months' treatment with cimetidine 0." | 9.07 | Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. ( Bardhan, KD; Bianchi Porro, G; Carroll, NJ; Daly, MJ; Hinchliffe, RF; Lazzaroni, M; Morris, P; Naesdal, J; Petrillo, M; Thompson, M, 1991) |
| "The primary aim of this double-blind, randomized Italian multicenter trial was to compare the healing rates in patients with benign gastric ulcers after 4-8 weeks treatment with either omeprazole 20 mg uid or ranitidine 150 mg bid." | 9.07 | Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole. ( , 1991) |
| "We studied omeprazole and ranitidine in promoting duodenal ulcer healing in a multicentre trial by comparing the proportion of healed ulcers after two, four, and eight weeks of treatment." | 9.06 | Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group. ( , 1990) |
| "This study was an open evaluation of omeprazole, 20 mg or 40 mg once daily, for the treatment of gastric ulcer." | 9.06 | Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients. ( Domingo, EO; Gloria, VI; Makalinao, AU; Rasco, ET; Sy, CT; Zano, FM, 1989) |
| "Twenty-seven patients with peptic ulcer (19 with duodenal ulcer (DU) and eight with gastric ulcer (GU] refractory to H2-antagonists were treated with 40 mg of omeprazole once daily for 4-8 weeks, depending on the rate of ulcer healing." | 9.06 | Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists. ( Chelvam, P; Wong, EC, 1989) |
| "Two hundred and seventeen gastric ulcer patients whose ulcers had healed during omeprazole (30 mg) or cimetidine (1 g) treatment entered a follow-up study for 6 months." | 9.06 | Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group. ( , 1989) |
| "In a randomised, double blind, parallel group study in patients with symptomatic gastric ulcer (94% greater than or equal to 5 mm diameter), 102 received omeprazole 20 mg om and 87 cimetidine 400 mg bd." | 9.06 | Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. ( Bate, CM; Bateson, MC; Bradby, GV; Crowe, JP; Hislop, WS; Peers, EM; Richardson, PD; Wilkinson, SP; Willoughby, CP, 1989) |
| "We conducted a six week double blind randomised study of 176 patients with prepyloric gastric ulcer to determine whether the proton pump inhibitor, omeprazole 30 mg daily would accelerate healing and pain relief, as compared with cimetidine 1 g daily." | 9.06 | Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. ( Astrup, L; Bendtsen, F; Bytzer, P; Havelund, T; Lauritsen, K; Laursen, LS; Linde, J; Olsen, JH; Rune, SJ; Wulff, HR, 1988) |
| "The effectiveness of omeprazole (20 mg orally each morning) or ranitidine (150 mg orally twice daily) in the treatment of gastric ulcer was compared in 184 out-patient in a randomized, endoscopically controlled multi-centre double-blind ("double dummy") trial." | 9.05 | [Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. ( Berger, J; Classen, M; Dammann, HG; Domschke, W; Hüttemann, W; Londong, W; Rehner, M; Scholten, T; Simon, B; Witzel, L, 1985) |
| "In preventing gastric ulcer occurrence, omeprazole prophylaxis was superior to sham in training horses (7 trials, 566 horses, RR 0." | 9.01 | Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis. ( Mason, LV; Mason, RJ; Moroney, JR, 2019) |
| "This paper is a meta-analysis of 30 published, double-blind clinical trials comparing omeprazole with ranitidine or cimetidine for the treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis." | 8.79 | Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. ( Carlsson, R; Eriksson, S; Långström, G; Naesdal, J; Rikner, L, 1995) |
| "The efficacy and safety of pantoprazole in the treatment of duodenal and gastric ulcers has been compared with that of the first proton pump inhibitor omeprazole in two (previously reported) clinical studies." | 8.79 | A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole. ( Rehner, M; Schepp, W; Witzel, L, 1994) |
| "To observe the effect of lansoprazole and omeprazole combined with antibiotics on gastric juice pH and inflammatory factors in elderly patients with Hp positive gastric ulcer." | 8.31 | Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer. ( Chen, B; Gao, N; Yan, S, 2023) |
| " The well-known drug omeprazole is a proton pump inhibitor used for curing gastric ulcer." | 8.12 | Omeprazole prevents stress induced gastric ulcer by direct inhibition of MMP-2/TIMP-3 interactions. ( Bagchi, A; Chowdhury, N; Maiti, NC; Pal, U; Rudra, DS; Swarnakar, S, 2022) |
| " Patchouli Alcohol (PA), the main extract of Pogostemonis Herba, have demonstrated benefits in treating gastric ulcer (GU) with low toxicity." | 7.96 | A potential drug combination of omeprazole and patchouli alcohol significantly normalizes oxidative stress and inflammatory responses against gastric ulcer in ethanol-induced rat model. ( Chen, YR; Guo, YL; Wang, B; Wang, ZC; Xie, L; Zhang, LY; Zhang, T, 2020) |
| "The aim of this paper was to observe the combination therapy with total triterpenoids of Chaenomeles speciosa and omeprazole on indomethacin-induced gastric ulcer in rats, and explore its possible mechanism." | 7.91 | [Therapeutic effect of total triterpenoids of Chaenomeles speciosa combined with omeprazole on gastric ulcer induced by indomethacin in rats]. ( He, HB; He, YM; Li, XM; Li, XQ; Qin, HL; Wang, JZ; Xiong, XJ; Zhang, YF; Zou, K, 2019) |
| "This research was conducted to evaluate the hypothesis that gastric ulcers caused by the NSAID diclofenac sodium (DCF) can be prevented by the soluble epoxide hydrolase inhibitor TPPU." | 7.85 | Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers. ( Goswami, SK; Hammock, BD; Inceoglu, B; Morisseau, C; Rand, AA; Thomas, M; Wan, D; Yang, GY; Yang, J, 2017) |
| "Mangiferin (MF), a xanthonoid from Mangifera indica, has been proved to have antisecretory and antioxidant gastroprotective effects against different gastric ulcer models; however, its molecular mechanism has not been previously elucidated." | 7.81 | Mangiferin Mitigates Gastric Ulcer in Ischemia/ Reperfused Rats: Involvement of PPAR-γ, NF-κB and Nrf2/HO-1 Signaling Pathways. ( Abd-Ellah, MF; Attia, AS; El-Abhar, HS; Mahmoud-Awny, M, 2015) |
| "The present work is an attempt to elucidate the antiulcer activity of indole-3-carbinol (I3C), which is one of the anticarcinogenic phytochemicals found in the vegetables of Cruciferae family such as broccoli and cauliflower, alone or in combination with omeprazole (OMP), a proton pump inhibitor, to diminish the effects of induced acute gastric ulcer by aspirin (ASA) in male albino rats." | 7.80 | Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats. ( Abd-Elmageid, SA; Alshailabi, EM; El-Shinnawy, NA, 2014) |
| " Chebulinic acid was evaluated against cold restraint (CRU), aspirin (AS), alcohol (AL) and pyloric ligation (PL) induced gastric ulcer models in rats." | 7.79 | Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers. ( Agrawal, M; Madhur, G; Mishra, V; Narender, T; Onasanwo, SA; Palit, G; Pandey, HP; Rastogi, P, 2013) |
| "The aim of this study which was structured with the objective of determination of the optimum protective therapy against the long term NSAID therapy-induced ulcers was to compare the gastro-protective effects of various antiulcer drugs (ranitidine, omeprazole, bismuth and misoprostol) alone or in combination with each other in different doses on indomethacin-induced gastric ulcers in rats." | 7.78 | Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats. ( Apikoglu-Rabus, S; Cevikbas, U; Izzettin, FV; Okuyan, B; Sancar, M, 2012) |
| "The aim of the present study was to determine the anti-ulcer activity of a methanol extract of Bauhinia purpurea leaf (MEBP)." | 7.78 | Methanol extract of Bauhinia purpurea leaf possesses anti-ulcer activity. ( Abdul Hisam, EE; Hasiah, AH; Norhafizah, M; Othman, F; Rofiee, MS; Vasudevan, M; Zakaria, ZA, 2012) |
| " Therefore, we examined the potential of the green tea-derived polyphenol epigallocatechin gallate (EGCG) to treat indomethacin-induced stomach ulcers in mice." | 7.77 | Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice. ( Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK, 2011) |
| "The modulation of the cyclooxygenase-independent pathway by the green tea-derived polyphenol, epigallocatechin gallate (EGCG) during its healing action against indomethacin (IND)-induced stomach ulceration in mice was investigated." | 7.77 | Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate. ( Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK, 2011) |
| "The healing activity of black tea (BT) and BT fermented with Candida parapsilosis and kombucha culture, designated as CT and KT respectively against the indomethacin-induced stomach ulceration has been studied in a mouse model." | 7.76 | Comparative healing property of kombucha tea and black tea against indomethacin-induced gastric ulceration in mice: possible mechanism of action. ( Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Hassarajani, SA; Maity, B; Narayan, G, 2010) |
| "Omeprazole is a valuable alternative in modern treatment of gastric ulcer, being superior to histamine H2-receptor antagonists." | 7.76 | Omeprazole in the acute treatment of gastric ulcer. ( Classen, M; Schepp, W, 1989) |
| "The healing rate of gastrocutaneous fistula in rat (2-mm-diameter stomach defect, 3-mm-diameter skin defect) validates macro/microscopically and biomechanically a direct skin wound/stomach ulcer relation, and identifies a potential therapy consisting of: (i) stable gastric pentadecapeptide BPC 157 [in drinking water (10 microg/kg) (12 ml/rat/day) or intraperitoneally (10 microg/kg, 10 ng/kg, 10 pg/kg)], (ii) atropine (10 mg/kg), ranitidine (50 mg/kg), and omeprazole (50 mg/kg), (iii) 6-alpha-methylprednisolone (1 mg/kg) [intraperitoneally, once daily, first application at 30 min following surgery; last 24 h before sacrifice (at postoperative days 1, 2, 3, 7, 14, and 21)]." | 7.75 | Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. ( Anic, T; Batelja, L; Berkopic, L; Blagaic Boban, A; Brcic, L; Cesarec, V; Coric, M; Dolovski, Z; Drmic, D; Ilic, S; Ivica, M; Klicek, R; Kocman, I; Kolenc, D; Lovric Bencic, M; Mise, S; Radic, B; Seiwerth, S; Sever, M; Sikiric, P; Skorjanec, S; Staresinic, M; Tonkic, A; Zoricic, I, 2009) |
| "The role of the arginine-metabolism in the healing action of the Myristica malabarica phenol malabaricone B (mal B) and omeprazole against indomethacin-induced stomach ulceration in mouse was investigated." | 7.75 | Regulation of arginase/nitric oxide synthesis axis via cytokine balance contributes to the healing action of malabaricone B against indomethacin-induced gastric ulceration in mice. ( Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Maity, B, 2009) |
| "The healing activity of malabaricone B and malabaricone C, the major antioxidant constituents of the spice Myristica malabarica against the indomethacin-induced gastric ulceration in mice has been studied." | 7.74 | Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. ( Bandyopadhyay, SK; Banerjee, D; Bauri, AK; Chattopadhyay, S; Guha, RK, 2008) |
| "The drugs, mal B and mal C could effectively heal indomethacin-induced stomach ulceration in mice by promoting angiogenesis." | 7.74 | Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration. ( Bandivdeker, AH; Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Maity, B, 2008) |
| "Indomethacin caused maximum stomach ulceration in mice on the 3rd day, which was associated with reduction of plasma total antioxidant status (TAS), COX-1, COX-2, mucosal PGE(2), VEGF, and vWF, along with an increase in endostatin levels." | 7.74 | Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice. ( Bandyopadhyay, SK; Banerjee, D; Bhattacharya, S; Chattopadhyay, S, 2008) |
| "Subcutaneous administration of leptin, two PPIs lansoprazole and omeprazole or H(2)-receptor antagonist ranitidine 30 min before AE or Indo produced a dose-dependent and reproducible inhibition of gastric ulcers (GUs)." | 7.73 | Mechanisms of action of leptin in preventing gastric ulcer. ( Adem, A; Adeyemi, EO; Bastaki, SA; Chandranath, IS; Fahim, M; Hasan, MY, 2005) |
| "The efficacy of a paste formulation of the H+, K+, -ATPase inhibitor omeprazole was evaluated in standardbred racehorses for the treatment and prevention of gastric ulcers." | 7.72 | Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada. ( Alva, R; Dionne, R; Doucet, MY; Ericsson, G; Vrins, AA, 2003) |
| "Following induction of gastric ulcers by intermittent feed deprivation, horses underwent sucrose permeability testing (administration of sucrose by nasogastric intubation followed by collection of urine at 2 and 4 hours after intubation) and gastric endoscopy." | 7.72 | Evaluation of urine sucrose concentration for detection of gastric ulcers in horses. ( Cohen, ND; Meddings, JB; O'Conner, MS; Pipers, F; Roussel, AJ; Steiner, JM; Williams, DA, 2004) |
| "To describe a case of thrombocytopenia associated with the administration of lansoprazole." | 7.71 | Lansoprazole-induced thrombocytopenia. ( Anderson, CG; Zlabek, JA, 2002) |
| "In this study, we compared the effects of cimetidine and omeprazole on the healing of acetic acid-induced gastric ulcers in 8-, 48-, and 96-week-old rats." | 7.71 | Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole. ( Ishihara, M; Ito, M, 2002) |
| "Indomethacin delays healing of experimental gastric ulcers." | 7.69 | Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. ( Flogerzi, B; Halter, F; Peskar, BM; Schmassmann, A; Tarnawski, A; Varga, L, 1995) |
| "The effects of cimetidine, omeprazole and atropine sulfate on the healing of acetic acid-induced gastric ulcers in rats with limited food intake time (9:00-10:00 a." | 7.69 | Effect of cimetidine and omeprazole on gastric ulcer healing of rats with limited food intake time. ( Ito, M; Kojima, R; Segami, T; Suzuki, Y; Tsukahara, T, 1994) |
| "Daily oral administration of cimetidine or omeprazole markedly accelerated the healing of acetic acid-induced gastric ulcers in rats with a limited food intake time." | 7.69 | Cimetidine and omeprazole accelerate gastric ulcer healing by an increase in gastrin secretion. ( Inaguma, K; Ito, M; Segami, T; Suzuki, Y, 1994) |
| "The efficacy of omeprazole in preventing gastric mucosal injury induced by hemorrhagic shock in rats and the putative mechanisms involved in this effect were investigated in the present study." | 7.69 | Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats. ( Blandizzi, C; Del Tacca, M; Gherardi, G; Marveggio, C; Natale, G, 1994) |
| " The patient, who was being treated with digitoxin for heart failure, reported having taken up to four digitoxin tablets (0." | 7.69 | [Reversible thrombocytopenia due to digitoxin overdose]. ( Kirch, W; Krappweis, J; Petereit, G; Schentke, KU, 1994) |
| "We have examined whether or not repeated treatment with indomethacin delays the healing of kissing gastric ulcers induced in rats." | 7.69 | Effects of leminoprazole, omeprazole and sucralfate on indomethacin-induced delayed healing of kissing gastric ulcers in rats. ( Nozue, C; Okabe, S; Tsukimi, Y, 1996) |
| " This same dose of omeprazole significantly reduced gastric ulcer formation induced by indomethacin despite significant (> 80%) inhibition of gastric mucosal prostaglandin E2 (PGE2) formation." | 7.69 | Omeprazole prevents indomethacin-induced gastric ulcers in rabbits. ( Feldman, M; Kallal, SM; Lee, M, 1996) |
| "We examined the effect of NC-1300-O-3 on the healing of acetic acid-induced gastric ulcers in male Donryu rats." | 7.68 | Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats. ( Inoue, K; Okabe, S; Takagi, K, 1993) |
| "The effect of a proton pump inhibitor, omeprazole (OPZ), in combination with mouse epidermal growth factor (EGF), on the healing of chronic gastric ulcers induced by acetic acid in submandibular glands removed rats (SMR rat) was investigated." | 7.68 | [Effect of proton pump inhibitor, in combination with epidermal growth factor, on the healing of chronic gastric ulcer in submandibular gland removed rats]. ( Imai, S; Itoh, M; Joh, T; Takeuchi, T; Yokoyama, Y, 1992) |
| "Oesophageal candidiasis was diagnosed incidentally at endoscopy in two patients receiving omeprazole therapy." | 7.68 | Oesophageal candidiasis after omeprazole therapy. ( Larner, AJ; Lendrum, R, 1992) |
| "We investigated the effects of cimetidine and omeprazole on angiogenesis in granulation tissue and on the healing of gastric ulcers induced by acetic acid in rats." | 7.68 | Effects of cimetidine and omeprazole on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats. ( Goto, H; Hase, S; Segawa, K; Tsuchida, T; Tsukamoto, Y, 1990) |
| "A double-blind study was conducted to compare gastric ulcer healing time in nontreated dogs with that in dogs treated with either cimetidine or omeprazole." | 7.68 | Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs. ( Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW, 1991) |
| "Repeated administration of indomethacin markedly delays spontaneous healing of experimental gastric ulcers induced in rats." | 7.68 | Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. ( Hirose, H; Okabe, S; Takeuchi, K, 1991) |
| "Epidermal growth factor (EGF) has been shown to enhance healing of experimental gastric ulcers when given subcutaneously or orally in the drinking water." | 7.68 | Effect of epidermal growth factor in combination with sucralfate or omeprazole on the healing of chronic gastric ulcers in the rat. ( Endoh, K; Imai, S; Itoh, M; Iwai, A; Joh, T; Kawai, T; Matsusako, K; Takeuchi, T; Yasue, N; Yokoyama, Y, 1990) |
| "Omeprazole, a gastric mucosal proton pump inhibitor, significantly and dose-dependently prevented the delayed healing of acetic acid-induced gastric ulcers in response to repeatedly administered indomethacin to rats." | 7.68 | Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats. ( Nagai, H; Okabe, S; Wang, JY, 1990) |
| " Acutely induced gastric ulcers or erosions such as Shay ulcers, water-immersion stress-, indomethacin-, aspirin-, or prednisolone-induced erosions were all markedly inhibited by oral or intraduodenal administration of 10-100 mg/kg of omeprazole." | 7.67 | Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. ( Okabe, S; Okada, Y; Yamamoto, O, 1984) |
| "The effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion was investigated in rats." | 7.67 | Effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion in rats. ( Poulsen, SS; Skov Olsen, P; Therkelsen, K, 1988) |
| "We investigated whether the trophic actions of prostaglandins, omeprazole, and indomethacin on gastric mucosa lead to accelerated healing of gastric ulcers in the rat." | 7.67 | Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat. ( Baumgartner, A; Halter, F; Inauen, W; Kayser, S; Koelz, HR; Schürer-Maly, CC; Wyss, PA, 1988) |
| "The influence of omeprazole on the antiulcer effects of histamine, methacholine and pentagastrin on ethanol-induced gastric ulceration was studied." | 7.67 | The influence of omeprazole on the protective effects of secretagogues against ethanol-induced gastric ulceration in rats. ( Cho, CH; Ogle, CW; Wong, SH, 1987) |
| "To compare pharmacokinetic and pharmacodynamic effects of a novel omeprazole formulation against a currently registered product." | 6.84 | Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores. ( Andrews, FM; Nielsen, SG; Raidal, SL; Trope, G, 2017) |
| "To determine the minimal effective dosage of omeprazole oral paste for the prevention of naturally occurring ulcers in horses starting race training." | 6.71 | Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Doucet, MY; Fleishman, C; Holste, JE; McClure, SR; Sifferman, RL; Vrins, A; White, GW, 2005) |
| " The results of this study suggest that omeprazole, employing a once daily dosing schedule, is effective at reducing the severity or eliminating gastric ulcers in Thoroughbreds in active race training." | 6.69 | Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training. ( Holste, J; Nieto, J; Pollmeier, M; Snyder, JR; Thompson, D; Vatistas, NJ, 1999) |
| " At Day 28, 25 of treated horses continued on this dosing regimen while 25 received a half dose (2 mg/kg bwt once daily) and 25 horses were sham-dosed." | 6.69 | Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses. ( Alva, R; Andrews, FM; Bernard, W; Cox, JL; Daurio, CP; Holste, JE; Hughes, FE; Sifferman, RL, 1999) |
| " The optimal dosage and duration of treatment need to be specified." | 6.68 | Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer. ( Fujita, N; Hisano, K; Kobayashi, T; Kurokawa, I; Ochiai, T; Sugiyama, T; Yabana, T; Yachi, A, 1995) |
| "When healing of gastric ulcers is observed using an electronic endoscope with a magnifying function, five types of regenerated mucosa can be distinguished." | 6.68 | Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function. ( Fukuchi, S; Hashimoto, M; Hoshihara, Y; Iguchi, D; Kimura, T; Sugawara, K; Takemoto, T; Tanaka, T; Yamamoto, T, 1995) |
| "Lansoprazole 30 mg/day was administered to 124 gastric ulcer (GU) patients and 57 duodenal ulcer (DU) patients." | 6.68 | Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication. ( Kato, T; Ogoshi, K; Sakagawa, T, 1995) |
| "Pirenzepine has been reported to inhibit gastrin secretion." | 6.68 | Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients. ( Fukino, Y; Hamada, M; Haruma, K; Inoue, M; Kajiyama, G; Kamiyasu, T; Sumii, K; Sumii, M; Tari, A, 1996) |
| "Omeprazole was given once daily." | 6.67 | An open trial on short-term omeprazole therapy for gastric and duodenal ulcers. ( Alvarez, SZ; Espiritu, AC; Perez, JY; Sollano, JD, 1991) |
| "Omeprazole is a very potent and long-acting inhibitor of gastric acid secretion." | 6.38 | Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. ( Jansen, JB; Lamers, CB; Meijer, JL, 1989) |
| "More than 13,000 individuals with duodenal ulcer, gastric ulcer or reflux oesophagitis have now taken part in controlled clinical studies with omeprazole." | 6.16 | The clinical utility and safety of omeprazole. ( Walan, A, 1989) |
| "Gastric ulcer is a common frequent clinical problem affecting all age and gender." | 5.72 | Potential stem cell-Conditioned medium and their derived exosomes versus omeprazole in treatment of experimental model of gastric ulcer. ( Allam, FAFA; Ibrahim, MFG, 2022) |
| "Equine gastric ulcer syndrome (EGUS) is the most common disease of the stomach in horses and treatment is based on the oral administration of omeprazole for at least 28 days." | 5.69 | A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial. ( Busechian, S; Conte, G; Conti, MB; Marchesi, MC; Pieramati, C; Rueca, F; Sgorbini, M; Vitale, V; Zappulla, F, 2023) |
| "Omeprazole and metformin were found to decrease stomach acidity and ulcer index, restored the histological features and increased mucin levels." | 5.62 | The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway. ( AbdelAziz, EY; Menze, ET; Tadros, MG, 2021) |
| " The aim of this systematic review is to evaluate the effectiveness and safety of Chinese medicine combined with omeprazole for GU." | 5.62 | Effectiveness and safety of Chinese medicine combined with omeprazole in the treatment of gastric ulcer: A protocol for systematic review and meta-analysis. ( Liu, L; Wei, M; Xie, C; Zhu, S, 2021) |
| "This study was performed 1) to investigate the prevalence and the severity of gastric ulcers in Thoroughbred racehorses in Korea, 2) to confirm the therapeutic effect of ranitidine and omeprazole, and 3) to compare the efficacy between ranitidine and omeprazole." | 5.51 | Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea. ( Cho, S; Dong, HJ; Han, J; Hwang, H; Kim, Y; Lee, I, 2022) |
| "Stress induced gastric ulcer is a serious health problem in diabetic patients." | 5.48 | Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats. ( Abd El Motteleb, DM; Elshazly, SM; Ibrahim, IAAE, 2018) |
| " Each rat to receive nebivolol and omeprazole was given the agent orally (by gavage) daily for 10 days prior to induction of ulcer by oral dosing with INDO." | 5.43 | Nebivolol prevents indomethacin-induced gastric ulcer in rats. ( El-Ashmawy, NE; El-Bahrawy, HA; Khedr, EG; Selim, HM, 2016) |
| "Pretreatment with omeprazole or MDLA led to an increase in the uptake of Periodic Acid Schiff (PAS) stain in the glandular part of the gastric tissue, raised levels of prostaglandin E2 (PGE2) and superoxide dismutase (SOD), and a reduction in malondialdehyde (MDA) concentrations." | 5.43 | Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Manganese (II) Complex against HCl/Ethanol-Induced Gastric Ulcerations in Rats. ( Adam, H; Al-Obaidi, MM; Ali, HM; Alkotaini, B; Batran, RA; Dhiyaaldeen, SM; El-Ferjani, RM; Hashim, NM; Ibrahim, MY, 2016) |
| " Anecdotally, many practitioners prescribe omeprazole concurrently with phenylbutazone to reduce development of equine gastric ulcer syndrome (EGUS), but the efficacy and safety of this practice remains unknown." | 5.41 | Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS). ( Andrews, FM; Banse, HE; Chapman, A; Garza, F; Keowen, M; Paul, L; Ricord, M; Yñiguez, FJM, 2021) |
| " The CGA is well absorbed orally, and its effects on gastric ulcer have not been previously reported." | 5.39 | Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer. ( de Melo, IL; de Oliveira e Silva, AM; Farsky, SH; Machado, ID; Mancini-Filho, J; Santin, JR; Shimoyama, AT, 2013) |
| " Dose-response studies on gastroprotection in stress and indomethacin-induced ulcer and inhibition of pylorus ligation-induced acid secretion indicate that omeprazole significantly blocks gastric lesions at lower dose (2." | 5.32 | A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. ( Ali, E; Bandyopadhyay, U; Banerjee, RK; Biswas, K; Chattopadhyay, I; Varadaraj, A, 2003) |
| "Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output." | 5.32 | Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004) |
| "Treatment with omeprazole also failed to bring about healing of the ulceration which, at times, measured up to 10 cm in diameter." | 5.28 | Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration. ( Gail, K; Mihaljevic, L; Stolte, M, 1991) |
| " Chronic administration of hydrocortisone sodium phosphate resulted in a significant delay of ulcer healing induced by acetic acid." | 5.28 | Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat. ( Eastwood, GL; Kuwayama, H; Matsuo, Y, 1991) |
| "To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome." | 5.27 | Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome. ( Bush, J; Franklin, S; van den Boom, R, 2018) |
| "To further investigate the presence of a dose relationship in the treatment of gastric ulceration under conditions that may favour omeprazole efficacy such as administration prior to exercise and after a brief fast, and potential differences between the response of squamous and glandular ulceration to omeprazole therapy." | 5.20 | A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2015) |
| "To compare: 1) the efficacy of 2 doses of omeprazole in the treatment of primary squamous and glandular gastric ulceration; and 2) the healing response of primary squamous and glandular gastric ulceration to acid suppression therapy." | 5.19 | A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2014) |
| " EC-ASA 325 mg in a secondary cardiovascular disease prevention population taking aspirin 325 mg daily for ≥3 months and at risk for ASA-associated gastric ulcers (GUs)." | 5.19 | PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies. ( Cryer, BL; Eisen, GM; Fort, JG; Goldstein, JL; Lanas, A; Miller, AB; O'Connor, C; Scheiman, JM; Whellan, DJ; Zhang, Y, 2014) |
| "A total of 158 patients (155 early gastric cancers and three adenomas) were randomly assigned to the PPI group (omeprazole 20 mg/day) or H(2) RA group (famotidine 40 mg/day) in a prospective randomized controlled trial." | 5.16 | Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. ( Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T, 2012) |
| "Melatonin (MT) and its precursor L-tryptophan (TRP) are implicated in the protection of gastric mucosa against aspirin-induced lesions and in the acceleration of healing of idiopathic gastro-duodenal ulcers, but no information is available whether these agents are also effective in healing of gastroduodenal ulcers accompanied by Helicobacter pylori (H." | 5.15 | Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans. ( Bielanski, W; Brzozowski, T; Celinski, K; Cichoz-Lach, H; Konturek, PC; Konturek, SJ; Slomka, M, 2011) |
| " This study evaluated and compared it with a reference PPI, omeprazole, in the treatment of gastric and duodenal ulcers." | 5.14 | Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers. ( Goh, KL; Ho, KY; Kim, DY; Kuan, A; Mahachai, V; Yoon, HM; Zaño, F, 2009) |
| "To study efficacy of a combination of proton pump inhibitor (PPI) and bismuth tripotassium dicitrate (BTD) in gastric ulcers (GU) induced by non-steroid anti-inflammatory drugs (NSAD) in rheumatic patients with factors affecting PPI efficacy." | 5.14 | [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate]. ( Karateev, AE; Nasonov, EL; Pakhomova, IG; Uspenskiĭ, IuP, 2009) |
| "A large percentage of performance horses develop gastric ulcers and many of those horses are treated with omeprazole." | 5.12 | Effect of omeprazole on markers of performance in gastric ulcer-free standardbred horses. ( Albeirci, JM; Gordon, ME; Manso Filho, HC; McKeever, JM; McKeever, KH, 2006) |
| "To determine the effects of 8 days of light to heavy exercise on gastric ulcer development in horses and determine the efficacy of omeprazole paste in preventing gastric ulceration." | 5.12 | Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration. ( Cramer, LG; Fleishman, C; Holste, JE; McClure, SR; Murray, MJ; Sifferman, R; White, G, 2007) |
| "To observe the histological changes of gastric mucosa in patients with active gastric ulcer before and after treatment by Qifang Weitong Powder combined with omeprazole (QWP-Op)." | 5.12 | [Morphological observation on gastric mucosa membrane of patients with gastric ulcer treated with combined use of Qifang Weitong Powder and omeprazole]. ( Deng, C; Li, GX; Luo, WS, 2007) |
| "To evaluate the effect of a single dose of rebeprazole (RAB) versus omeprazole (OME) on acid suppression and symptom relief in patients with gastric ulcer." | 5.11 | [The effect of rabeprazole on gastric pH in patients with gastric ulcer]. ( Ke, MY, 2004) |
| "The main purpose of this study was to compare omeprazole (ome) plus two antibiotics (OMC) with omeprazole plus placebo (OP) with regard to gastric ulcer relapse for a period of 2 years in patients who were Helicobacter pylori-positive at inclusion." | 5.11 | Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. ( Backman, M; Befrits, R; Hedenborg, L; Leijonmarck, CE; Sjöstedt, S; Tour, R, 2004) |
| "This analysis compared the efficacy of misoprostol, lansoprazole, and placebo in reducing the risk of gastric or duodenal ulcer recurrence in patients taking NSAIDs and low-dose aspirin." | 5.11 | Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. ( Amer, F; Christopoulos, NG; Goldstein, JL; Huang, B, 2004) |
| "Horses with gastric ulcers were treated with omeprazole at a dosage of 4 mg/kg (1." | 5.11 | Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Fleishman, C; Holste, JE; Hughes, FE; McClure, SR; Sifferman, RL; White, GW, 2005) |
| "To compare effects of a commercially available omeprazole paste and a compounded omeprazole suspension on healing of gastric ulcers in Thoroughbred racehorses in active training." | 5.10 | Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training. ( Aleman, MR; Nieto, JE; Pipers, FS; Smith, DC; Snyder, JR; Spier, S; Stanley, S, 2002) |
| " pylori-positive patients with active gastric ulcer were randomized to receive pantoprazole (40 mg) (P) and two of three antibiotics: clarithromycin (500 mg) (C), metronidazole (500 mg) (M) or amoxicillin (1000 mg) (A)." | 5.10 | Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. ( Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S, 2003) |
| "Patients receiving lansoprazole (15 or 30 mg) remained free from gastric ulcer longer than those who received placebo (P<." | 5.10 | Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. ( Agrawal, NM; Campbell, DR; Collis, C; Graham, DY; Haber, MM; Huang, B; Lukasik, NL, 2002) |
| " Medical treatment included omeprazole, clarithromycin, and amoxicillin for 7 days followed by omeprazole for 3 weeks for duodenal ulcer and 5 weeks for gastric ulcer." | 5.10 | [Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication]. ( Quandalle, P; Tran, TT, 2002) |
| " This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection." | 5.10 | Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. ( Aoyagi, K; Esaki, M; Fujishima, M; Kuwano, Y; Matsumoto, T; Shimizu, M, 2002) |
| "To study the efficacy of omeprazole triple therapy in the eradication of Helicobacter pylori in patients with active gastric ulcer, and to assess healing and relapse of gastric ulcer." | 5.09 | The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. ( Bayerdörffer, E; Diete, U; Gil, J; Lind, T; Malfertheiner, P; Misiuna, P; O'Morain, C; Sipponen, P; Spiller, RC; Stasiewicz, J; Treichel, H; Ujszászy, L; Unge, P; Zanten, SJ; Zeijlon, L, 1999) |
| " pylori infection and duodenal ulcer, gastric ulcer or non-ulcer dyspepsia were randomly assigned to a 1 week course of either famotidine 80 mg b." | 5.09 | Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial. ( Brandstätter, G; Dragosics, B; Gschwantler, M; Hentschel, E; Hirschl, AM; Klimpfinger, M; Oberhuber, G; Pasching, E; Schütze, K; Weiss, W; Wimmer, M; Wurzer, H, 1999) |
| "Omeprazole has been shown to promote healing of spontaneously occurring gastric ulcers in horses when administered for 28 days at a dose of 4 mg/kg bwt/day and to prevent recurrence of ulcers in almost all horses when treatment is continued at a dose of at least 2 mg/kg bwt/day." | 5.09 | Safety of omeprazole paste in foals and mature horses. ( Attebery, DK; Cox, JL; Daurio, C; Plue, RE; Wall, HG; Wallace, DH, 1999) |
| "A multicentre, blinded, randomised complete-block, field trial was conducted with 140 horses and foals age 4 weeks-28 years to determine if omeprazole paste is effective and safe in promoting healing of spontaneous gastric ulcers under a variety of field conditions and in different breeds and ages of horses." | 5.09 | Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial. ( Cox, JL; Ericcson, GF; Holste, JE; MacAllister, CG; McClure, SR; Sifferman, RL; Vatistas, NJ; White, GW, 1999) |
| " In a prospective clinical trial, primed infusions of different dosages of omeprazole (8 or 4 mg/h) after a bolus (40 mg) produced consistently high intragastric pH values in patients with bleeding duodenal ulcer." | 5.09 | Effect of intragastric pH on control of peptic ulcer bleeding. ( Dai, S; Jia, L; Li, Y; Nie, Y; Sha, W; She, Q; Wu, H; Yu, W, 2000) |
| "In patients who require continuous treatment with NSAIDs, lansoprazole is superior to ranitidine for healing of NSAID-associated gastric ulcers." | 5.09 | Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. ( Agrawal, NM; Campbell, DR; Haber, MM; Huang, B; Lukasik, NL; Safdi, MA, 2000) |
| "5) with rheumatoid arthritis or osteoarthritis, requiring chronic intake of NSAIDs (at least 8 weeks prior to the start of the study), were randomised and enrolled to receive either 40 mg pantoprazole (n=70) or placebo (n=34) once daily, for 12 weeks." | 5.09 | Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. ( Bianchi Porro, G; Imbesi, V; Lazzaroni, M; Montrone, F; Santagada, T, 2000) |
| "To clarify whether the depth of ulceration evaluated by endoscopic ultrasonography (EUS) influences a modified dual therapy with amoxicillin and lansoprazole for the treatment of Helicobacter pylori-positive patients with gastric ulcer." | 5.09 | Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer? ( Kawashima, A; Motoo, Y; Ohtsubo, K; Okai, T; Sakai, J; Sawabu, N; Watanabe, H, 2000) |
| " Patients with gastric ulcer (GU) or duodenal ulcer (DU) were enrolled in this study; 583 eligible patients (GU, 325; DU, 258) were administered lansoprazole (30 mg/day for 8 weeks for GU, and the same dosage for 6 weeks for DU) as first-line therapy, and a half dose of H2RA as maintenance therapy for 12 months." | 5.09 | Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor. ( Asaka, M; Asaki, S; Ashida, K; Harasawa, S; Hoshihara, Y; Kajiyama, G; Kaneko, E; Kobayashi, K; Muto, Y; Nakamura, T; Nakazawa, S; Ogawa, N; Sakaki, N; Takemoto, T; Yao, T, 2000) |
| "Controlled trials were conducted to determine if treatment with the benzimidazole compound, omeprazole, would prevent gastric ulceration associated with feed withdrawal." | 5.09 | The use of omeprazole to alleviate stomach ulcers in swine during periods of feed withdrawal. ( Dewey, CE; Friendship, RM; Melnichouk, SI, 2000) |
| "A total of 102 Helicobacter pylori-positive patients with gastric ulcer were randomly allocated to three groups: rabeprazole 10 mg (RAC10), rabeprazole 20 mg (RAC20) or rabeprazole 40 mg (RAC40) plus amoxicillin 750 mg and clarithromycin 200 mg twice daily for 7 days." | 5.09 | Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. ( Asaka, M; Hige, S; Hokari, K; Ishizuka, J; Kagaya, H; Kato, M; Komatsu, Y; Kudo, M; Miyagishima, T; Mizushima, T; Nishikawa, K; Saito, M; Sugiyama, T; Takeda, H, 2001) |
| " pylori) infection is known to affect the gastric microcirculation, and cetraxate is reported to accelerate gastric ulcer healing, possibly by augmenting gastric mucosal blood flow (MBF)." | 5.09 | Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers. ( Adachi, K; Fujishiro, H; Ishihara, S; Kawamura, A; Kazumori, H; Kinoshita, Y; Moriyama, N; Okuyama, T; Sato, H; Suetsugu, H; Watanabe, M, 2001) |
| "We examined the effects of lansoprazole and famotidine on gastric basic fibroblast growth factor (bFGF) levels and ulcer healing in patients with gastric ulcer." | 5.08 | Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine. ( Fukuda, M; Higashi, T; Imaizumi, T; Kawano, S; Miura, N; Miyajima, K; Mukuda, T; Noguchi, M; Tatsumi, T; Tsuji, S, 1995) |
| "A randomized, single-blind study was designed to assess the effect of lansoprazole alone and lansoprazole plus amoxicillin on the healing and eradication rates in Helicobacter pylori-associated peptic ulcer disease." | 5.08 | Clinical efficacy of lansoprazole in eradication of Helicobacter pylori. ( Asaka, M; Kagaya, H; Katagiri, M; Katoh, M; Kudoh, M; Takeda, H, 1995) |
| "This study attempted to determine the efficacy of lansoprazole plus clarithromycin therapy in the eradication of Helicobacter pylori in gastric ulcer patients." | 5.08 | Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. ( Aisawa, T; Akagi, T; Fukuda, S; Fukushi, M; Mizuki, I; Munakata, A; Ohkawa, K; Sakata, Y; Shimoyama, T; Yoshida, Y, 1995) |
| "We studied the action on acid secretion of lansoprazole compared with famotidine by 24-h intragastric pH monitoring, evaluated its clinical effects prospectively, and assessed the importance of acid inhibition in gastric ulcer patients." | 5.08 | Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine. ( Ashida, K; Katsu, K; Miyoshi, H; Sakaguchi, M; Umegaki, E, 1995) |
| "To compare the efficacy of lansoprazole and famotidine in the treatment of gastric ulcer, 24 patients with gastric ulcer were treated for 8 weeks." | 5.08 | Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial. ( Motoo, Y; Okai, T; Sawabu, N; Songür, Y; Watanabe, H, 1995) |
| "The effects of lansoprazole (30 mg/day) in 18 patients with gastric ulcers and the quality of ulcer healing were studied using endoscopy (including dye endoscopy) and endoscopic ultrasonography (EUS)." | 5.08 | Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings. ( Ajima, H; Ejiri, Y; Ishihata, R; Kasukawa, R; Kondo, Y; Kuwana, T; Mukai, S; Obara, K; Okubo, Y; Yokogi, K, 1995) |
| "The effect of lansoprazole, a new benzimidazole proton pump inhibitor, on the relationship between ulcer healing and changes in mucin content was studied in gastric ulcer patients." | 5.08 | Effects of lansoprazole on gastric ulcer healing and mucin content. ( Ishii, K; Komuro, Y; Miyake, Y; Oida, M; Saigenji, K; Tanabe, S, 1995) |
| "This study reports preliminary results of a controlled, multicenter trial on the quality of ulcer healing induced by lansoprazole (LPZ) or roxatidine (R) in gastric ulcer (GU) or duodenal ulcer (DU) patients." | 5.08 | Quality of peptic ulcer healing induced by lansoprazole and roxatidine. ( Fujino, MA; Kobayashi, K; Morozumi, A; Ohtsuka, H; Sano, S; Suzuki, Y; Tachikawa, H; Uchida, N; Ueda, F; Yamamoto, Y, 1995) |
| "The clinical usefulness of lansoprazole in the healing of gastric and duodenal ulcers, the S2-stage shift rate (white scarring rate), and endoscopic healing rate with respect to degree of gastric mucosal atrophy were investigated." | 5.08 | Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group. ( Asaki, S; Hongo, M; Sakurada, H; Sato, A; Takeda, T; Toyota, T, 1995) |
| "In the present study, the effects of short-term treatment with lansoprazole on healing and recurrence of peptic ulcer were investigated." | 5.08 | The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody. ( Akimoto, K; Fukujin, H; Katoaka, A; Mashima, H; Mine, T; Nagasawa, J; Tajima, A; Takano, T; Tsuchida, T; Yasuda, H, 1995) |
| "A multicenter, double-blind study was conducted in 268 patients to compare the safety and efficacy of 15, 30, and 60 mg of lansoprazole and placebo in the treatment of gastric ulcer." | 5.08 | Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer. ( Avner, DL; Berry, W; Erfling, W; McFarland, M; Movva, R; Nelson, KJ, 1995) |
| "Pantoprazole appears to be superior to ranitidine in gastric ulcer healing." | 5.08 | Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. ( Hotz, J; Plein, K; Rose, K; Schönekäs, H, 1995) |
| "The proton pump inhibitors pantoprazole and omeprazole were compared in a randomized, double-blind study in 219 patients with benign gastric ulcers." | 5.08 | Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995) |
| " pylori infection and gastric ulcers unrelated to the use of nonsteroidal antiinflammatory drugs, one week of antibacterial therapy without acid suppression heals the ulcers as well as omeprazole and reduces the rate of their recurrence." | 5.08 | Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. ( Cheng, AF; Chung, SC; Leung, VK; Li, AK; Li, MK; Ling, TK; Ng, EK; Sung, JJ; Yung, MY, 1995) |
| "The purpose of this study was to clarify the effect of lansoprazole on basic fibroblast growth factor (bFGF) during the healing of gastric ulcers in comparison with famotidine and rebamipide." | 5.08 | Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa. ( Akiba, Y; Inoue, J; Ishii, H; Ito, T; Nakamura, M; Oda, M; Tsuchiya, M, 1995) |
| "During a period of 1 year 152 patients with gastric ulcers were randomly assigned to one of two treatment regimens: omeprazole 20 mg daily in the morning for 8 weeks (74 patients), or bismuth subsalicylate 600 mg three times daily for 8 weeks combined with 500 mg amoxicillin twice daily and 1000 mg tinidazole twice daily for the first 10 days (triple therapy) (78 patients)." | 5.08 | Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. ( Bästlein, E; Bayerdörffer, E; Bolle, KH; Hatz, R; Heldwein, W; Höchter, W; Klann, H; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Ruckdeschel, G; Simon, T; Sommer, A; Stolte, M; Weingart, J, 1996) |
| "The proton-pump inhibitor, lansoprazole, a more potent gastric acid inhibitor with a longer action than H2-receptor antagonists, should heal refractory gastric ulcers more effectively." | 5.08 | A trial of lansoprazole in refractory gastric ulcer. ( Girdwood, AH; Louw, JA; Marks, IN; Simjee, AE; van Rensburg, CJ, 1996) |
| "The purpose of this multicenter, randomized, double-blind study, conducted in 520 patients, was to compare the efficacy and safety of omeprazole (40 and 20 mg once daily) with placebo in the treatment of benign gastric ulcer." | 5.08 | Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. ( Colón Pagán, JR; Gilde, LR; Kogut, DG; McCullough, AJ; Shah, U; Simon, TJ; Valenzuela, JE; Whipple, J, 1996) |
| " pylori infection in patients with chronic gastritis (CG), duodenal ulcer (DU), and gastric ulcer (GU) after two dual therapies (omeprazole with either amoxycillin or clarithromycin)." | 5.08 | Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. ( Carpintero, P; García Grávalos, R; Hermida, C; Lara, S; Moreno, JA; Pajares, JM; Santander, C, 1996) |
| " pylori-positive gastritis with or without peptic ulcer, and compared with the classic 'Bazzoli regimen' (OCT: omeprazole, clarithromycin, tinidazole) in 60 matched patients." | 5.08 | Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. ( Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A, 1997) |
| "In two parallel studies, 20 patients with bleeding duodenal ulcers and 20 patients with bleeding gastric ulcers were randomly assigned to receive either ranitidine (0." | 5.08 | Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. ( Blum, AL; Börsch, G; Labenz, J; Leusing, C; Peitz, U; Tillenburg, B, 1997) |
| "Seventeen Thoroughbred horses with moderate to severe gastric ulceration were purchased from a race track within 10 days of racing and were treated once daily with either omeprazole (9 horses) or vehicle (8 horses) and evaluated gastroscopically for ulcer healing." | 5.08 | Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses. ( Eagleson, J; Eichorn, ES; Haven, ML; Hickey, GJ; Murray, MJ; Zhang, D, 1997) |
| "Our aim was to investigate the efficacy of omeprazole and amoxicillin in curing Helicobacter pylori infection in gastric ulcer patients." | 5.08 | Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany. ( Bayerdörffer, E; Bolle, KH; Fischer, G; Hatz, R; Höchter, W; Huber, F; Klann, H; Lehn, N; Meining, A; Simon, T; Sommer, A; Stolte, M; Weingart, J, 1998) |
| "Our purpose was to compare the safety and efficacy of lansoprazole 15 mg and 30 mg with placebo in preventing recurrence in 49 patients with a history of gastric ulcer." | 5.08 | Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer. ( Campbell, D; Haber, M; Jennings, DE; Kovacs, TO; Richter, J; Rose, P, 1998) |
| "Rabeprazole, a new proton pump inhibitor, was studied in patients with acid-peptic-related diseases (duodenal ulcer, gastric ulcer, GERD) in three placebo-controlled, double-blind, randomized clinical trials." | 5.08 | Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group. ( Bassion, S; Cloud, ML; Enas, N; Humphries, TJ, 1998) |
| "The aim of the present study was to evaluate the efficacy of omeprazole coupled with amoxicillin in the eradication of Helicobacter pylori and healing and prevention of gastric ulcer recurrence." | 5.08 | Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. ( Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Maconi, G; Perego, M; Solcia, E, 1997) |
| " Omeprazole was significantly superior to sucralfate in inducing gastric ulcer healing after both 4 (87 vs." | 5.08 | Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer. ( Bianchi Porro, G; Lazzaroni, M; Manzionna, G; Petrillo, M, 1998) |
| "In this randomized, double-blind, multicentre study, conducted at 25 European sites, rabeprazole and omeprazole were compared in patients with active gastric ulcers." | 5.08 | Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group. ( Beker, JA; Bell, NE; Dekkers, CP; Gabryelewicz, A; Humphries, TJ; Thjodleifsson, B, 1998) |
| " pylori-positive gastric ulcer patients were assigned at random to two groups; in addition to dual therapy (amoxicillin 500 mg thrice daily and lansoprazole 30 mg every morning for two weeks), one group received rebamipide 100 mg thrice daily for eight weeks, while the other group received teprenone 50 mg thrice daily for eight weeks." | 5.08 | Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients. ( Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H, 1998) |
| "The effects of trimebutine maleate (TM), a prokinetic drug, on gastrointestinal motility in patients with gastric ulcer were investigated." | 5.08 | Effects of trimebutine maleate on gastric motility in patients with gastric ulcer. ( Andou, T; Fujinami, T; Hara, M; Hirako, M; Kamiya, T; Kobayashi, Y; Misu, N; Nagao, T, 1998) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 5.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| " pylori-positive gastroduodenal ulcer bleeding, which could be commenced intravenously after endoscopic diagnosis, and to assess the effect of omeprazole pretreatment on bacterial eradication." | 5.07 | Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study. ( Adamek, RJ; Freitag, M; Opferkuch, W; Rühl, GH; Wegener, M, 1994) |
| "Serum gastrin levels in 44 peptic ulcer patients (26 gastric ulcer patients and 18 duodenal ulcer patients) were determined after they had been treated with omeprazole (OPZ) (20 mg/day) alone or in combination with pirenzepine (PZP) (100 mg/day)." | 5.07 | Serum gastrin levels following administration of omeprazole alone or in combination with pirenzepine. ( Arakawa, Y; Ito, K; Iwasaki, A; Kawamura, Y; Matsuo, Y; Miyazawa, K; Sakai, Y; Tashiro, Y, 1994) |
| "The goals of this study were to assess the effectiveness of a new triple therapy consisting of amoxicillin and metronidazole with plaunotol in the eradication of Helicobacter pylori infection in humans, and to determine whether this treatment regimen reduces the rate of recurrence of gastric ulcer in patients infected with H." | 5.07 | Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate. ( Karita, M; Morshed, MG; Okita, K; Ouchi, K, 1994) |
| "We compared the efficacy and short-term safety of lansoprazole against ranitidine in the healing of gastric ulcer." | 5.07 | Rapid healing of gastric ulcers with lansoprazole. ( Ahlberg, J; Bardhan, KD; Hislop, WS; Lindholmer, C; Long, RG; Morgan, AG; Sjostedt, S; Smith, PM; Stig, R; Wormsley, KG, 1994) |
| "To compare the efficacy of two omeprazole/amoxicillin regimens concerning Helicobacter pylori eradication, ulcer healing, pain relief, and safety in patients with gastric ulcer disease." | 5.07 | Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. ( Bertrams, J; Börsch, G; Labenz, J; Rühl, GH, 1994) |
| "Patients (106) with peptic ulceration of the oesophagus, stomach and duodenum, unresponsive to 3 or more months of high-dose treatment with ranitidine, were initially given pantoprazole (40-80 mg, p." | 5.07 | Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. ( Brunner, G; Harke, U, 1994) |
| "We studied the effectiveness of lansoprazole and ranitidine in promoting gastric ulcer healing in a multicentre double-blind trial, by comparing the proportion of healed ulcers after 4 and 8 weeks of treatment." | 5.07 | Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. ( Bigard, MA; Bommelaer, G; Colin, R; Dupas, JL; Lemaire, M; Michel, P; Rambaud, JC; Verwaerd, JC, 1994) |
| " pylori-positive gastroduodenal ulcer disease were treated with a 14-day course of 20 mg omeprazole bid orally, combined with either 1 g amoxicillin tid intravenously (n = 15) or 500 mg amoxicillin six times daily orally (n = 16)." | 5.07 | Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. ( Adamek, RJ; Freitag, M; Labenz, J; Opferkuch, W; Rühl, GH; Wegener, M, 1994) |
| "Forty-two patients with peptic ulceration of the duodenum, stomach or oesophagus, who had not responded to 3 or more months of high-dose treatment with ranitidine (450 or 600 mg/day), were treated with oral lansoprazole at 30-60 mg daily." | 5.07 | An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. ( Arnold, R; Brunner, G; Fuchs, W; Hennig, U, 1993) |
| " Double-blind comparative studies with a beta-blocker, famotidine, in gastric ulcer (study 1) and in duodenal ulcer (study 2) were conducted." | 5.07 | [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer]. ( Ogawa, N, 1992) |
| " Altogether 107 patients (duodenal ulcer, n = 88; prepyloric ulcer, n = 14; gastric ulcer, n = 3; mixed sites, n = 2) with refractory peptic ulcer - that is ulcer unhealed after at least two months' treatment with cimetidine 0." | 5.07 | Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. ( Bardhan, KD; Bianchi Porro, G; Carroll, NJ; Daly, MJ; Hinchliffe, RF; Lazzaroni, M; Morris, P; Naesdal, J; Petrillo, M; Thompson, M, 1991) |
| "The primary aim of this double-blind, randomized Italian multicenter trial was to compare the healing rates in patients with benign gastric ulcers after 4-8 weeks treatment with either omeprazole 20 mg uid or ranitidine 150 mg bid." | 5.07 | Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole. ( , 1991) |
| "We studied omeprazole and ranitidine in promoting duodenal ulcer healing in a multicentre trial by comparing the proportion of healed ulcers after two, four, and eight weeks of treatment." | 5.06 | Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group. ( , 1990) |
| "This study was an open evaluation of omeprazole, 20 mg or 40 mg once daily, for the treatment of gastric ulcer." | 5.06 | Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients. ( Domingo, EO; Gloria, VI; Makalinao, AU; Rasco, ET; Sy, CT; Zano, FM, 1989) |
| "Endoscopic evidence of accelerated healing of type I gastric ulcers after four weeks of omeprazole." | 5.06 | Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group. ( , 1989) |
| "Twenty-seven patients with peptic ulcer (19 with duodenal ulcer (DU) and eight with gastric ulcer (GU] refractory to H2-antagonists were treated with 40 mg of omeprazole once daily for 4-8 weeks, depending on the rate of ulcer healing." | 5.06 | Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists. ( Chelvam, P; Wong, EC, 1989) |
| "Two hundred and seventeen gastric ulcer patients whose ulcers had healed during omeprazole (30 mg) or cimetidine (1 g) treatment entered a follow-up study for 6 months." | 5.06 | Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group. ( , 1989) |
| "In a randomised, double blind, parallel group study in patients with symptomatic gastric ulcer (94% greater than or equal to 5 mm diameter), 102 received omeprazole 20 mg om and 87 cimetidine 400 mg bd." | 5.06 | Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. ( Bate, CM; Bateson, MC; Bradby, GV; Crowe, JP; Hislop, WS; Peers, EM; Richardson, PD; Wilkinson, SP; Willoughby, CP, 1989) |
| " Clinical trials of omeprazole, a substituted benzimidazole, indicate that it is safe and effective for short-term treatment of patients with duodenal or gastric ulcer, and it is highly effective for long-term treatment of patients with Zollinger-Ellison syndrome." | 5.06 | Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase. ( Gardner, JD; Jensen, RT; McArthur, KE, 1986) |
| "We conducted a six week double blind randomised study of 176 patients with prepyloric gastric ulcer to determine whether the proton pump inhibitor, omeprazole 30 mg daily would accelerate healing and pain relief, as compared with cimetidine 1 g daily." | 5.06 | Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. ( Astrup, L; Bendtsen, F; Bytzer, P; Havelund, T; Lauritsen, K; Laursen, LS; Linde, J; Olsen, JH; Rune, SJ; Wulff, HR, 1988) |
| "The effectiveness of omeprazole (20 mg orally each morning) or ranitidine (150 mg orally twice daily) in the treatment of gastric ulcer was compared in 184 out-patient in a randomized, endoscopically controlled multi-centre double-blind ("double dummy") trial." | 5.05 | [Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. ( Berger, J; Classen, M; Dammann, HG; Domschke, W; Hüttemann, W; Londong, W; Rehner, M; Scholten, T; Simon, B; Witzel, L, 1985) |
| "In preventing gastric ulcer occurrence, omeprazole prophylaxis was superior to sham in training horses (7 trials, 566 horses, RR 0." | 5.01 | Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis. ( Mason, LV; Mason, RJ; Moroney, JR, 2019) |
| "The proton pump inhibitors (PPIs) lansoprazole (LPZ) and omeprazole (OPZ) have been widely used for more than 20 years in the treatment of acid-related diseases such as gastro-duodenal ulcers and reflux esophagitis." | 4.89 | Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity. ( Satoh, H, 2013) |
| "Esomeprazole (Nexium); S-omeprazole) is a single optical isomer proton-pump inhibitor (PPI) approved for the management of reflux oesophagitis, the symptomatic treatment of gastro-oesophageal reflux disease (GORD), the prevention and healing of NSAID-associated gastric ulcer disease (and the prevention of NSAID-associated duodenal ulcers in the UK), the treatment of Helicobacter pylori infection and associated duodenal ulcer disease (and prevention of relapse of H." | 4.84 | Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults. ( Blick, SK; Croxtall, JD; Keating, GM; Lyseng-Williamson, KA; McKeage, K, 2008) |
| " To evaluate the efficacy of the new PPI rabeprazole, 12 controlled clinical trials were conducted worldwide-three for each indication (erosive or ulcerative GERD healing, long-term GERD healing maintenance, duodenal ulcer healing, and gastric ulcer healing)." | 4.81 | Efficacy of rabeprazole once daily for acid-related disorders. ( Bardhan, KD; Barth, J; Lanza, F; Niecestro, R; Perdomo, C, 2001) |
| " pylori infection, indomethacin and their combination affects the healing of gastric ulcers and whether or not such factors provoke a relapse of healed acetic acid ulcers; and 2) whether or not eradication of the bacteria with drugs at specified times after infection prevents the development of mucosal changes, including gastric adenocarcinoma." | 4.81 | [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. ( Ebata, M; Keto, Y; Okabe, S, 2001) |
| " In 8-week studies, among patients with gastro-oesophageal reflux disease (GORD), rabeprazole 20 mg/day or 10mg twice daily was as effective as omeprazole and superior to ranitidine in the healing of GORD." | 4.81 | Rabeprazole: an update of its use in acid-related disorders. ( Carswell, CI; Goa, KL, 2001) |
| " Early indications that acid suppression was effective in the management of NSAID-related peptic ulcers came from studies showing that gastric ulcers could be healed by omeprazole in patients who continued to take NSAIDs." | 4.80 | Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression. ( Armstrong, D; Lad, R, 1999) |
| " Although PPIs have been introduced into the therapy of acute peptic ulcer disease at different daily, oral doses of 20 mg (omeprazole and rabeprazole), 30 mg (lansoprazole) and 40 mg (pantoprazole), the data suggest that the optimal dose of lansoprazole, omeprazole and pantoprazole, with respect to the acute treatment of peptic ulcers and moderate to severe gastroesophageal reflux disease (GERD), is about 30-40 mg daily." | 4.80 | Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis. ( Horbach, S; Kromer, W; Lühmann, R, 1999) |
| " Previous studies have shown that misoprostol is effective in reducing the incidence of gastric and duodenal ulcers as well as serious gastrointestinal complications." | 4.80 | [Present position in the prevention and therapy of NSAID-induced ulcers]. ( Beglinger, C; Lehmann, FS, 1999) |
| " Healing rates for rabeprazole were equivalent to omeprazole in all indications, and superior (GORD healing and duodenal ulcer healing) or equivalent (gastric ulcer healing) to the histamine 2-receptor antagonist ranitidine." | 4.80 | The benefit/risk profile of rabeprazole, a new proton-pump inhibitor. ( Barth, J; Johnson, D; Jokubaitis, L; Perdomo, C, 2000) |
| "This paper is a meta-analysis of 30 published, double-blind clinical trials comparing omeprazole with ranitidine or cimetidine for the treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis." | 4.79 | Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. ( Carlsson, R; Eriksson, S; Långström, G; Naesdal, J; Rikner, L, 1995) |
| "The clinical efficacy of the proton pump inhibitor pantoprazole has been compared with ranitidine in a number of clinical studies in patients with either duodenal or gastric ulcer(s) or gastro-oesophageal reflux disease." | 4.79 | Clinical efficacy of pantoprazole compared with ranitidine. ( Bader, JP; Delchier, JC, 1994) |
| "The efficacy and safety of pantoprazole in the treatment of duodenal and gastric ulcers has been compared with that of the first proton pump inhibitor omeprazole in two (previously reported) clinical studies." | 4.79 | A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole. ( Rehner, M; Schepp, W; Witzel, L, 1994) |
| " The results of the randomized, double-blind, controlled trials show that misoprostol is the only antiulcer drug proven to be effective in the prevention of NSAID-induced gastric and duodenal ulcers as well as for reducing serious upper gastrointestinal complications (perforation and/or haemorrhage)." | 4.79 | Prevention of NSAID-gastropathy. ( Ardizzone, S; Bianchi Porro, G, 1996) |
| " In the treatment of gastric ulcer, analysis of all studies that have compared lansoprazole, a newly developed proton pump inhibitor, and H2-receptor antagonists has shown a statistically significant difference for a higher healing rate with lansoprazole." | 4.78 | Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. ( Florent, C, 1993) |
| "In duodenal ulcer studies comprising more than 2,000 patients the efficacy of omeprazole in doses of 20-40 mg once daily has been compared with the recommended doses of the H2-receptor antagonists cimetidine and ranitidine." | 4.77 | Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer. ( de Bruijne, JW; Lamers, CB; Snel, P, 1989) |
| "Arguments in favour of the use of omeprazole outweight the arguments against its use in the treatment of all peptic disorders--duodenal ulcer, gastric ulcer and reflux oesophagitis." | 4.77 | Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis. ( Bium, AL, 1989) |
| "Due to its potent and long-lasting antisecretory properties is omeprazole, the first clinically used H+/K+-adenosine triphosphatase inhibitor, highly effective in healing of duodenal and gastric ulcers and reflux oesophagitis." | 4.77 | H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases. ( Lamers, CB, 1989) |
| "To observe the effect of lansoprazole and omeprazole combined with antibiotics on gastric juice pH and inflammatory factors in elderly patients with Hp positive gastric ulcer." | 4.31 | Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer. ( Chen, B; Gao, N; Yan, S, 2023) |
| "this study was aimed to see if propolis, ginseng in normal or nano form, and amygdalin might help in preventing the ulcerative effects of absolute ethanol." | 4.31 | Effectiveness of natural biomaterials in the protection and healing of experimentally induced gastric mucosa Ulcer in rats. ( Abdel-Gawad, DRI; El-Banna, AH; El-Banna, HA; El-Ela, FIA; Hassan, WH; Ibrahim, MA; Kamel, S; Moawad, UK, 2023) |
| " The well-known drug omeprazole is a proton pump inhibitor used for curing gastric ulcer." | 4.12 | Omeprazole prevents stress induced gastric ulcer by direct inhibition of MMP-2/TIMP-3 interactions. ( Bagchi, A; Chowdhury, N; Maiti, NC; Pal, U; Rudra, DS; Swarnakar, S, 2022) |
| " Therefore, the present study was performed to evaluate the gastroprotective effect of cinnamon on ethanol-induced gastric ulcer in comparison to omeprazole." | 4.12 | The ameliorative effects of cinnamon oil against ethanol-induced gastric ulcer in rats by regulating oxidative stress and promoting angiogenesis. ( Abdel-Hameed, EMM; Abdel-Kawi, SH; Fekry, G; Hashem, KS; Saad, MK, 2022) |
| " Male Sprague-Dawley (SD) rats were divided into six groups: normal control, ulcer control, omeprazole (30 mg/kg), and three ZJP groups (1." | 4.12 | Integrated serum pharmacochemistry and investigation of the anti-gastric ulcer effect of Zuojin pill in rats induced by ethanol. ( Che, X; Li, D; Ren, Y; Xu, Q; Yin, Y; Yu, C; Zhang, J; Zhao, J, 2022) |
| "We used two well-established mouse models of gastric ulcer (GU) induced by oral administration of EtOH (80% solution in water) or diclofenac (30 mg/kg, p." | 4.02 | AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice. ( Binienda, A; Fichna, J; Kordek, R; Majchrzak, K; Małecka-Panas, E; Salaga, M; Zatorski, H; Zielińska, M, 2021) |
| " The in vivo antiulcer study at three different doses (50, 100, and 200 mg/kg) against ethanol-induced gastric ulcer in male albino rats, compared to omeprazole (20 mg/kg) as a standard proton pump inhibitor antiulcer drug, revealed that the tested extract, at the middle and the highest doses, featured comparable or even superior activities relative to omeprazole as deduced from histopathological examination, in particular with regard to reducing inflammatory cell infiltration and ceasing mucosal haemorrhage." | 3.96 | In vivo antiulcer activity, phytochemical exploration, and molecular modelling of the polyphenolic-rich fraction of Crepis sancta extract. ( Al-Jawabri, NA; Albohy, A; Aldalaien, SM; Disi, AM; Ebada, SS; Proksch, P; Youssef, FS, 2020) |
| " Patchouli Alcohol (PA), the main extract of Pogostemonis Herba, have demonstrated benefits in treating gastric ulcer (GU) with low toxicity." | 3.96 | A potential drug combination of omeprazole and patchouli alcohol significantly normalizes oxidative stress and inflammatory responses against gastric ulcer in ethanol-induced rat model. ( Chen, YR; Guo, YL; Wang, B; Wang, ZC; Xie, L; Zhang, LY; Zhang, T, 2020) |
| "After antifungal treatment with fluconazole, the patient's clinical symptoms gradually disappeared with the healing of gastric ulcer, which never recurred in this patient until 3 months after follow-up." | 3.91 | A rare case report of fungal esophagitis combined with giant gastric ulcer in an immunocompetent patient. ( Jianping, C; Juan, D; Liang, M; Liwen, Z; Yanbo, D; Yun, Z, 2019) |
| "The aim of this paper was to observe the combination therapy with total triterpenoids of Chaenomeles speciosa and omeprazole on indomethacin-induced gastric ulcer in rats, and explore its possible mechanism." | 3.91 | [Therapeutic effect of total triterpenoids of Chaenomeles speciosa combined with omeprazole on gastric ulcer induced by indomethacin in rats]. ( He, HB; He, YM; Li, XM; Li, XQ; Qin, HL; Wang, JZ; Xiong, XJ; Zhang, YF; Zou, K, 2019) |
| "Aspirin combination is prescribed for its thrombolytic activity where gastric ulceration is the major side effect of aspirin which can be prevented by combining it with proton pump inhibitor omeprazole." | 3.88 | Stability Indicating Liquid Chromatographic Method for Simultaneous Determination of Aspirin and Omeprazole. ( Patel, AD; Patel, VB; Shah, DA, 2018) |
| "This research was conducted to evaluate the hypothesis that gastric ulcers caused by the NSAID diclofenac sodium (DCF) can be prevented by the soluble epoxide hydrolase inhibitor TPPU." | 3.85 | Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers. ( Goswami, SK; Hammock, BD; Inceoglu, B; Morisseau, C; Rand, AA; Thomas, M; Wan, D; Yang, GY; Yang, J, 2017) |
| "In our study, oral administration of omeprazole for 1 week was sufficient to achieve healing of ESD-induced artificial gastric ulcers." | 3.81 | Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study. ( Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A, 2015) |
| "Mangiferin (MF), a xanthonoid from Mangifera indica, has been proved to have antisecretory and antioxidant gastroprotective effects against different gastric ulcer models; however, its molecular mechanism has not been previously elucidated." | 3.81 | Mangiferin Mitigates Gastric Ulcer in Ischemia/ Reperfused Rats: Involvement of PPAR-γ, NF-κB and Nrf2/HO-1 Signaling Pathways. ( Abd-Ellah, MF; Attia, AS; El-Abhar, HS; Mahmoud-Awny, M, 2015) |
| " Aspirin 150 mg/kg was used to induce gastric ulcer in all groups except normal control." | 3.81 | Histopathological evaluation of gastro protective effect of Berberis vulgaris (Zereshk) seeds against aspirin induced ulcer in albino mice. ( Ali, A; Aslam, B; Javed, I; Khaliq, T; Majeed, W; Muhammad, F; Raza, A, 2015) |
| "The present work is an attempt to elucidate the antiulcer activity of indole-3-carbinol (I3C), which is one of the anticarcinogenic phytochemicals found in the vegetables of Cruciferae family such as broccoli and cauliflower, alone or in combination with omeprazole (OMP), a proton pump inhibitor, to diminish the effects of induced acute gastric ulcer by aspirin (ASA) in male albino rats." | 3.80 | Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats. ( Abd-Elmageid, SA; Alshailabi, EM; El-Shinnawy, NA, 2014) |
| " Chebulinic acid was evaluated against cold restraint (CRU), aspirin (AS), alcohol (AL) and pyloric ligation (PL) induced gastric ulcer models in rats." | 3.79 | Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers. ( Agrawal, M; Madhur, G; Mishra, V; Narender, T; Onasanwo, SA; Palit, G; Pandey, HP; Rastogi, P, 2013) |
| " Peganine hydrochloride was evaluated against cold restraint (CRU), aspirin (AS), alcohol (AL) and pyloric ligation (PL) induced gastric ulcer models in rats." | 3.79 | Anti-secretory and cyto-protective effects of peganine hydrochloride isolated from the seeds of Peganum harmala on gastric ulcers. ( Barthwal, MK; Khaliq, T; Mishra, V; Narender, T; Palit, G; Pandey, HP; Singh, VK; Tiwari, S, 2013) |
| "The aim of this study which was structured with the objective of determination of the optimum protective therapy against the long term NSAID therapy-induced ulcers was to compare the gastro-protective effects of various antiulcer drugs (ranitidine, omeprazole, bismuth and misoprostol) alone or in combination with each other in different doses on indomethacin-induced gastric ulcers in rats." | 3.78 | Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats. ( Apikoglu-Rabus, S; Cevikbas, U; Izzettin, FV; Okuyan, B; Sancar, M, 2012) |
| "The aim of the present study was to determine the anti-ulcer activity of a methanol extract of Bauhinia purpurea leaf (MEBP)." | 3.78 | Methanol extract of Bauhinia purpurea leaf possesses anti-ulcer activity. ( Abdul Hisam, EE; Hasiah, AH; Norhafizah, M; Othman, F; Rofiee, MS; Vasudevan, M; Zakaria, ZA, 2012) |
| " They were subjected to the absolute ethanol- and indomethacin-induced gastric ulcer, and pyloric ligation assays after 30 min." | 3.78 | Antiulcer activity of the chloroform extract of Bauhinia purpurea leaf. ( Hamid, HA; Hisam, EE; Mohtaruddin, N; Othman, F; Rofiee, MS; Zakaria, ZA, 2012) |
| "Ample of evidence proved the gastroprotective effect of thymoquinone (TQ), the main constituent of Nigella sativa oil; however, the full mechanistic cassette on the gastric ulcer etiopathogenesis is not fully elucidated." | 3.78 | Thymoquinone: Novel gastroprotective mechanisms. ( Hanan, el-A; Magdy, MA; Nabila, el-M, 2012) |
| " Anti-ulcer activity was evaluated against cold restraint (CRU), pyloric ligation (PL), aspirin (ASP), alcohol (AL) induced gastric ulcer and histamine (HA) induced duodenal ulcer model and further confirmed through in vitro assay of H(+) K(+)-ATPase activity and plasma gastrin level." | 3.77 | Anti-ulcer constituents of Annona squamosa twigs. ( Dev, K; Maurya, R; Palit, G; Sahai, M; Sharma, R; Singh, N; Yadav, DK, 2011) |
| "The modulation of the cyclooxygenase-independent pathway by black tea (BT) and its constituent theaflavins (TFs) during their healing action against indomethacin-induced stomach ulceration in mice was investigated." | 3.77 | Black tea and theaflavins suppress various inflammatory modulators and i-NOS mediated nitric oxide synthesis during gastric ulcer healing. ( Adhikary, B; Bandyopadhyay, SK; Chand, S; Chattopadhyay, S; Yadav, SK, 2011) |
| " Therefore, we examined the potential of the green tea-derived polyphenol epigallocatechin gallate (EGCG) to treat indomethacin-induced stomach ulcers in mice." | 3.77 | Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice. ( Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK, 2011) |
| "The modulation of the cyclooxygenase-independent pathway by the green tea-derived polyphenol, epigallocatechin gallate (EGCG) during its healing action against indomethacin (IND)-induced stomach ulceration in mice was investigated." | 3.77 | Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate. ( Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK, 2011) |
| "Lansoprazole is an effective acid pump inhibitor acting at the final enzymatic step of the acid secretory pathway of the parietal cell, decreasing gastric acid secretion regardless of the primary stimulus." | 3.77 | Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. ( Barradell, LB; Faulds, D; McTavish, D, 1992) |
| "The healing activity of black tea (BT) and BT fermented with Candida parapsilosis and kombucha culture, designated as CT and KT respectively against the indomethacin-induced stomach ulceration has been studied in a mouse model." | 3.76 | Comparative healing property of kombucha tea and black tea against indomethacin-induced gastric ulceration in mice: possible mechanism of action. ( Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Hassarajani, SA; Maity, B; Narayan, G, 2010) |
| "Omeprazole has given healing rates of 58-83% after treatment for 2 weeks and 84-100% after 4 weeks." | 3.76 | Clinical experience with omeprazole: assessment of efficacy and safety. ( Walan, A, 1989) |
| "Omeprazole is a valuable alternative in modern treatment of gastric ulcer, being superior to histamine H2-receptor antagonists." | 3.76 | Omeprazole in the acute treatment of gastric ulcer. ( Classen, M; Schepp, W, 1989) |
| "The healing rate of gastrocutaneous fistula in rat (2-mm-diameter stomach defect, 3-mm-diameter skin defect) validates macro/microscopically and biomechanically a direct skin wound/stomach ulcer relation, and identifies a potential therapy consisting of: (i) stable gastric pentadecapeptide BPC 157 [in drinking water (10 microg/kg) (12 ml/rat/day) or intraperitoneally (10 microg/kg, 10 ng/kg, 10 pg/kg)], (ii) atropine (10 mg/kg), ranitidine (50 mg/kg), and omeprazole (50 mg/kg), (iii) 6-alpha-methylprednisolone (1 mg/kg) [intraperitoneally, once daily, first application at 30 min following surgery; last 24 h before sacrifice (at postoperative days 1, 2, 3, 7, 14, and 21)]." | 3.75 | Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. ( Anic, T; Batelja, L; Berkopic, L; Blagaic Boban, A; Brcic, L; Cesarec, V; Coric, M; Dolovski, Z; Drmic, D; Ilic, S; Ivica, M; Klicek, R; Kocman, I; Kolenc, D; Lovric Bencic, M; Mise, S; Radic, B; Seiwerth, S; Sever, M; Sikiric, P; Skorjanec, S; Staresinic, M; Tonkic, A; Zoricic, I, 2009) |
| "The role of the arginine-metabolism in the healing action of the Myristica malabarica phenol malabaricone B (mal B) and omeprazole against indomethacin-induced stomach ulceration in mouse was investigated." | 3.75 | Regulation of arginase/nitric oxide synthesis axis via cytokine balance contributes to the healing action of malabaricone B against indomethacin-induced gastric ulceration in mice. ( Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Maity, B, 2009) |
| "Bisabolangelone is the main anti-ulcer active compound of Angelica polymorpha, and remarkably preventive and therapeutic action on gastric ulcer." | 3.75 | The anti-ulcer activities of bisabolangelone from Angelica polymorpha. ( Cai, Z; Cheng, F; Dan, F; Guo, Z; Wang, J; Yang, J; Zhu, L; Zou, K, 2009) |
| " Beginning on day 14, horses were administered omeprazole (4 mg/kg, PO, q 24 h until day 56) or no drug (10 horses/group) and underwent alternating 24-hour periods of feeding and feed withholding for 10 days to induce gastric ulceration." | 3.75 | Effect of gastric ulceration on physiologic responses to exercise in horses. ( Jones, JH; Nieto, JE; Snyder, JR; Vatistas, NJ, 2009) |
| "The ethanol extract of Toona ciliata Roemer (heart wood) was evaluated for its anti-ulcer activity against aspirin plus pylorous ligation induced gastric ulcer (antisecretory), HCl-ethanol induced ulcer (cytoprotective) and water immersion stress induced ulcer in rats." | 3.74 | Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood). ( Gopalakrishnan, G; Kavimani, S; Malairajan, P; Narasimhan, S; Veni, KJ, 2007) |
| "Gastric ulcers were induced in male rats by serosal application of acetic acid." | 3.74 | [Effect of mucosal protective on the quality of gastric ulcer healing]. ( Chen, K; Chen, SJ; Deng, YY; Liu, WL; Qian, Y; Si, JM; Sun, KK; Wang, LJ; Wu, JG; Zhu, YF, 2007) |
| " The aim of this study was to assess the gastroprotective effects of an aqueous suspension of the ethanolic extract from leaves and flowers of Guazuma ulmifolia in a model of acute gastric ulcer induced by diclofenac as ulcerogenic agent, using the proton pump inhibitor omeprazole as a protection reference." | 3.74 | The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions. ( Berenguer, B; De la Puerta, R; Martín-Calero, MJ; Miño, P; Quílez, A; Sánchez-Fidalgo, S; Trabadela, C, 2007) |
| "The healing activity of the methanol extract of the spice rampatri, Myristica malabarica, (RM) and omeprazole against indometacin-induced stomach ulceration has been studied in a mouse model." | 3.74 | Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration. ( Bandyopadhyay, SK; Banerjee, D; Bauri, AK; Chattopadhyay, S; Maity, B, 2007) |
| "The healing activity of malabaricone B and malabaricone C, the major antioxidant constituents of the spice Myristica malabarica against the indomethacin-induced gastric ulceration in mice has been studied." | 3.74 | Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. ( Bandyopadhyay, SK; Banerjee, D; Bauri, AK; Chattopadhyay, S; Guha, RK, 2008) |
| "To investigate the protective effects of sildenafil citrate (SC) on indomethacin-induced gastric ulcer in a rat model." | 3.74 | The role of sildenafil citrate in the protection of gastric mucosa from nonsteroidal anti-inflammatory drug-induced damage. ( Atamanalap, SS; Aydinli, B; Başoğlu, M; Gündoğdu, C; Gürsan, N; Kiziltunç, A; Oren, D; Oztürk, G; Polat, KY; Süleyman, H; Yildirgan, MI, 2007) |
| "The drugs, mal B and mal C could effectively heal indomethacin-induced stomach ulceration in mice by promoting angiogenesis." | 3.74 | Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration. ( Bandivdeker, AH; Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Maity, B, 2008) |
| "Gastric ulcer patients (n=88) were assigned either to the group receiving Helicobacter pylori eradication treatment (54 patients) or to the control group (34 patients; omeprazole treatment for 4 weeks) and were followed up for 1-year or until gastric ulcer relapsed." | 3.74 | Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study. ( Jonaitis, L; Kiudelis, G; Kupcinskas, L, 2008) |
| "Indomethacin caused maximum stomach ulceration in mice on the 3rd day, which was associated with reduction of plasma total antioxidant status (TAS), COX-1, COX-2, mucosal PGE(2), VEGF, and vWF, along with an increase in endostatin levels." | 3.74 | Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice. ( Bandyopadhyay, SK; Banerjee, D; Bhattacharya, S; Chattopadhyay, S, 2008) |
| " The extract at 400 mg/kg body weight, once daily, orally has a significant effect in cold restraint (CRU, 2 h cold restraint stress), aspirin (ASA, 150 mg/kg body weight, orally), alcohol (AL, 1 ml/200 gm of absolute alcohol) and pyloric ligation (PL, 4h ligation) induced gastric ulcer models as it showed protection index of 71." | 3.73 | Allophylus serratus: a plant with potential anti-ulcerogenic activity. ( Dharmani, P; Maurya, R; Mishra, PK; Palit, G; Singh Chauhan, V, 2005) |
| "The present study was designed to investigate anti-ulcerogenic property of ethanolic extract of Desmodium gangeticum (DG) against cold restraint (CRU, 2 hr cold restraint stress), aspirin (ASP, 150 mg/kg orally), alcohol (AL, absolute alcohol 1 ml/200gm) and pyloric ligation (PL, 4 hr pylorus ligation) induced gastric ulcer models in Sprague Dawley rats, and histamine (HST, 0." | 3.73 | Desmodium gangeticum: a potent anti-ulcer agent. ( Chauhan, VS; Dharmani, P; Maurya, R; Mishra, PK; Palit, G, 2005) |
| "Subcutaneous administration of leptin, two PPIs lansoprazole and omeprazole or H(2)-receptor antagonist ranitidine 30 min before AE or Indo produced a dose-dependent and reproducible inhibition of gastric ulcers (GUs)." | 3.73 | Mechanisms of action of leptin in preventing gastric ulcer. ( Adem, A; Adeyemi, EO; Bastaki, SA; Chandranath, IS; Fahim, M; Hasan, MY, 2005) |
| "Patients with gastric ulcers were allocated to an untreated control group, consisting of patients with active ulcers (GA), healing ulcers (GH), and ulcer scars (GS) or a PPI group (P; given rabeprazole at 20 mg/day), or an H2-blocker group (H; given nizatidine at 800 mg/day)." | 3.73 | Effects of antisecretory agents on angiogenesis during healing of gastric ulcers. ( Akimoto, M; Hashimoto, H; Maeda, A; Shigemoto, M; Yamashita, K, 2005) |
| " In the present study we have compared the expression profile of COX-2 protein, prostaglandin E2 (PGE2) levels and myeloperoxidase activity in acetic acid induced chronic gastric ulcer model in rats treated with omeprazole, misoprostol and COX-2 selective nonsteroidal anti-inflammatory drug (NSAID) celecoxib." | 3.73 | Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing. ( Gautam, P; Poonam, D; Vinay, CS, 2005) |
| " When the effect of test compound was evaluated on the 15th day after acetic acid injection to rats, repeated oral administration of tea catechin (25, 50, 100 mg/kg twice daily) dose-dependently accelerated the healing of acetic acid-induced chronic gastric ulcers." | 3.73 | Anti-ulcer effect of tea catechin in rats. ( Hamaishi, K; Ito, M; Kojima, R, 2006) |
| "The efficacy of a paste formulation of the H+, K+, -ATPase inhibitor omeprazole was evaluated in standardbred racehorses for the treatment and prevention of gastric ulcers." | 3.72 | Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada. ( Alva, R; Dionne, R; Doucet, MY; Ericsson, G; Vrins, AA, 2003) |
| "Results suggest that the proprietary formulation of omeprazole was associated with a significantly lower risk of moderate or severe gastric ulceration, compared with no treatment, in racehorses in active race training, whereas other antiulcer medications were not." | 3.72 | Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications. ( Haddock, M; Orsini, JA; Rabuffo, TS; Smith, G; Stine, L; Sullivan, EK, 2003) |
| " pylori infection who had gastritis, duodenal ulcer (DU) or gastric ulcer (GU) received 1 week's triple therapy of lansoprazole 30 g once daily (OD), amoxycillin 250 mg qid and clarithromycin 250 mg tid." | 3.72 | Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection. ( Uthaisaengsook, W, 2003) |
| " pylori infected patients with gastric ulcer and duodenal ulcer completed the triple therapy with 10 mg of rabeprazole b." | 3.72 | Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype. ( Bae, JS; Jung, HS; Kim, HJ; Lee, JK; Lee, SB; Park, SJ; Park, SM; Ryu, JK, 2003) |
| "Following induction of gastric ulcers by intermittent feed deprivation, horses underwent sucrose permeability testing (administration of sucrose by nasogastric intubation followed by collection of urine at 2 and 4 hours after intubation) and gastric endoscopy." | 3.72 | Evaluation of urine sucrose concentration for detection of gastric ulcers in horses. ( Cohen, ND; Meddings, JB; O'Conner, MS; Pipers, F; Roussel, AJ; Steiner, JM; Williams, DA, 2004) |
| " We examined the roles of TNF-alpha and dynamics of chemokine expression in gastric ulceration including ulcer recurrence and indomethacin-induced injury." | 3.72 | Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Shiba, M; Tominaga, K; Watanabe, T, 2004) |
| "The effect of fenugreek seeds (Trigonella foenum graecum) compared to omeprazole was studied on ethanol-induced gastric ulcer." | 3.71 | Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats. ( Anuradha, CV; Pandian, RS; Viswanathan, P, 2002) |
| " H pylori infection does not affect duodenal ulcer healing and enhances gastric ulcer healing by ranitidine and possibly other acid suppressing treatments." | 3.71 | Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. ( Hawkey, CJ; Långström, G; Naesdal, J; Swannell, AJ; Wilson, I; Yeomans, ND, 2002) |
| "The gastroprotective effect of the labdane diterpene solidagenone was assessed on gastric ulcer in rats." | 3.71 | Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats. ( Astudillo, L; Bustamante, C; Rodríguez, JA; Schmeda-Hirschmann, G, 2002) |
| " In the present study, we investigated the protective effects of these compounds against gastric ulcers induced by acidified ethanol (AE) and indomethacin." | 3.71 | A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat. ( Bastaki, SM; Chandranath, SI; Singh, J, 2002) |
| "To describe a case of thrombocytopenia associated with the administration of lansoprazole." | 3.71 | Lansoprazole-induced thrombocytopenia. ( Anderson, CG; Zlabek, JA, 2002) |
| " pylori infection, indomethacin, and their combination affects the healing of gastric ulcers and whether or not such factors provoke a relapse of healed gastric ulcers in Mongolian gerbils." | 3.71 | Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils. ( Ebata, M; Keto, Y; Okabe, S; Tomita, K, 2002) |
| "The gastroprotective effect of the triterpene oleanolic acid (OA) was assessed on gastric ulceration in rats." | 3.71 | Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice. ( Astudillo, L; Rodriguez, JA; Schmeda-Hirschmann, G, 2002) |
| "In this study, we compared the effects of cimetidine and omeprazole on the healing of acetic acid-induced gastric ulcers in 8-, 48-, and 96-week-old rats." | 3.71 | Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole. ( Ishihara, M; Ito, M, 2002) |
| "Both patients with gastric ulcer and healthy volunteers exhibited increased deconjugation of bile acids caused by bacterial overgrowth in the jejunum and fat malabsorption after omeprazole treatment." | 3.70 | Omeprazole induces altered bile acid metabolism. ( Fukumura, M; Koide, K; Machida, M; Shindo, K; Yamazaki, R, 1998) |
| "Gastric juice pH, ammonia concentration in gastric juice, serum gastrin level, and grade of gastritis in accordance with the Sydney System were determined for patients with gastric ulcer (GU) and duodenal ulcer (DU) before and after treatment with lansoprazole and amoxicillin, and results were compared with those of H." | 3.70 | Effect of Helicobacter pylori infection on gastric juice pH. ( Arai, H; Baba, S; Furuta, T; Futami, H; Hanai, H; Kajimura, M; Kaneko, E; Takashima, M, 1998) |
| " Ceftiofur sodium for the treatment of various bacterial infections." | 3.70 | An overview of selected diseases and drug needs in the llama and alpaca industries. ( Smith, BB, 1998) |
| "We investigated the effect of probucol, a lipid-lowering agent with antioxidant properties, on HCl plus ethanol-induced gastric mucosal injury and on the healing of acetic acid-induced gastric ulcers in rats." | 3.70 | Anti-ulcer effects of antioxidants: effect of probucol. ( Ishihara, M; Ito, M; Suzuki, Y, 1998) |
| " CR 2945 was about as efficacious as ranitidine against the indomethacin- and ethanol-induced gastric ulcers and the cysteamine-induced duodenal ulcer in rats." | 3.70 | Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. ( Impicciatore, M; Letari, O; Makovec, F; Mennuni, L; Revel, L, 1999) |
| " The aim of the present study was to investigate the pathogenesis of these gastric ulcers and to examine the effects of two antiulcer drugs; a proton pump inhibitor (2{[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]methyl-sulfinyl}-1H -benzimidazole sodium salt, rabeprazole) and a mucosal protective drug (geranylgeranylacetone, GGA), on the gastric ulcers." | 3.70 | Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice. ( Azuma, T; Dojyo, M; Ito, S; Ito, Y; Kato, T; Kohli, Y; Kuriyama, M; Miyaji, H; Suto, H; Yamazaki, Y, 1999) |
| " Treatment for gastric ulcer with proton pump inhibitor (omeprazole) and aluminium hydroxide gel improved her eruptions and her pruritus resolved." | 3.70 | A case of prurigo and lichenified plaques successfully treated with proton pump inhibitor. ( Ohtsuka, T; Yamakage, A; Yamazaki, S, 1999) |
| "Ulcer-healing drugs should be continued after a 2-week course of omeprazole-containing anti-Helicobacter therapy for gastric ulcers and large peptic ulcers that have bled, but can be omitted in most patients with a bleeding duodenal ulcer." | 3.70 | Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. ( Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC, 2000) |
| "Indomethacin delays healing of experimental gastric ulcers." | 3.69 | Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. ( Flogerzi, B; Halter, F; Peskar, BM; Schmassmann, A; Tarnawski, A; Varga, L, 1995) |
| "To evaluate endogenous and exogenous factors affecting the quality of ulcer healing produced by proton pump inhibitors, gastric acid pH, serum gastrin, and serum pepsinogen (PG) I and II were measured in peptic ulcer patients before and after treatment with lansoprazole 30 mg once daily." | 3.69 | Factors affecting quality of ulcer healing after lansoprazole treatment. ( Hanai, H; Ito, G; Kaneko, E; Nakagawara, M; Nawano, M; Ooi, S; Watanabe, F, 1995) |
| "We studied the detailed surface structure and changes in the regenerated mucosa during the course of healing of recurrent gastric ulcers treated with lansoprazole or famotidine, using a magnifying electronic endoscope (videoendoscope) and a dye contrast method." | 3.69 | Mucosal regeneration of gastric ulcer confirmed by electronic endoscopy. ( Fukuchi, S; Hashimoto, M; Hoshihara, Y; Iguchi, D; Kimura, T; Sugawara, K; Takemoto, T; Tanaka, T; Yamamoto, T, 1995) |
| "The effects of cimetidine, omeprazole and atropine sulfate on the healing of acetic acid-induced gastric ulcers in rats with limited food intake time (9:00-10:00 a." | 3.69 | Effect of cimetidine and omeprazole on gastric ulcer healing of rats with limited food intake time. ( Ito, M; Kojima, R; Segami, T; Suzuki, Y; Tsukahara, T, 1994) |
| "Daily oral administration of cimetidine or omeprazole markedly accelerated the healing of acetic acid-induced gastric ulcers in rats with a limited food intake time." | 3.69 | Cimetidine and omeprazole accelerate gastric ulcer healing by an increase in gastrin secretion. ( Inaguma, K; Ito, M; Segami, T; Suzuki, Y, 1994) |
| "The efficacy of omeprazole in preventing gastric mucosal injury induced by hemorrhagic shock in rats and the putative mechanisms involved in this effect were investigated in the present study." | 3.69 | Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats. ( Blandizzi, C; Del Tacca, M; Gherardi, G; Marveggio, C; Natale, G, 1994) |
| ") inhibited mepirizole-induced duodenal ulcers." | 3.69 | YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. ( Akuzawa, S; Ito, H; Kamato, T; Kobayashi, A; Miyata, K; Nagakura, Y; Nishida, A; Takinami, Y; Yamano, M; Yuki, H, 1994) |
| " The patient, who was being treated with digitoxin for heart failure, reported having taken up to four digitoxin tablets (0." | 3.69 | [Reversible thrombocytopenia due to digitoxin overdose]. ( Kirch, W; Krappweis, J; Petereit, G; Schentke, KU, 1994) |
| "We have examined whether or not repeated treatment with indomethacin delays the healing of kissing gastric ulcers induced in rats." | 3.69 | Effects of leminoprazole, omeprazole and sucralfate on indomethacin-induced delayed healing of kissing gastric ulcers in rats. ( Nozue, C; Okabe, S; Tsukimi, Y, 1996) |
| "We investigated the effects of cimetidine, omeprazole and atropine, antisecretory anti-ulcer agents, on the healing of gastric and duodenal ulcers simultaneously induced in the same rats." | 3.69 | Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats. ( Ito, M; Segami, T; Suzuki, Y, 1996) |
| " This same dose of omeprazole significantly reduced gastric ulcer formation induced by indomethacin despite significant (> 80%) inhibition of gastric mucosal prostaglandin E2 (PGE2) formation." | 3.69 | Omeprazole prevents indomethacin-induced gastric ulcers in rabbits. ( Feldman, M; Kallal, SM; Lee, M, 1996) |
| "Two patients who developed gastric giardiasis after 2 weeks of treatment with omeprazole 20 mg b." | 3.69 | Proton-pump inhibition and gastric giardiasis: a causal or casual association? ( Bourgain, C; Devis, G; Fernandes, E; Reynaert, H; Smekens, L, 1995) |
| " The ulcers became scars after treatment with omeprazole, which cause in severe pyloric stenosis." | 3.69 | Endoscopic hydrostatic balloon dilation of ulcer-induced pyloric stenosis in rheumatoid arthritis and secondary amyloidosis. ( Aoyagi, K; Eguchi, K; Fujishima, M; Hizawa, K; Ohta, Y; Satou, H, 1997) |
| " and omeprazole 20 mg daily for one week, followed by 20 mg omeprazole daily for further 3 weeks) in a prospective study of 36 patients with Helicobacter pylori-associated ulcers (10 gastric ulcers, 26 duodenal ulcers)." | 3.69 | [Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease]. ( Kobler, E; Reinhart, WH; Werth, B; Wüst, W, 1997) |
| " The antiulcerogenic effects of cisapride, a potent benzamide-stimulating gastrointestinal motility agent, were studied on cold-resistant and pylorus-ligated gastric ulcers." | 3.69 | Effects of cisapride on ulcer formation and gastric secretion in rats: comparison with ranitidine and omeprazol. ( Alarcón de la Lastra, C; La Casa, M; López, A; Martin, MJ; Motilva, V, 1996) |
| "We examined the effect of NC-1300-O-3 on the healing of acetic acid-induced gastric ulcers in male Donryu rats." | 3.68 | Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats. ( Inoue, K; Okabe, S; Takagi, K, 1993) |
| "The effect of a proton pump inhibitor, omeprazole (OPZ), in combination with mouse epidermal growth factor (EGF), on the healing of chronic gastric ulcers induced by acetic acid in submandibular glands removed rats (SMR rat) was investigated." | 3.68 | [Effect of proton pump inhibitor, in combination with epidermal growth factor, on the healing of chronic gastric ulcer in submandibular gland removed rats]. ( Imai, S; Itoh, M; Joh, T; Takeuchi, T; Yokoyama, Y, 1992) |
| "The chromoendoscopic features of healed gastric ulcers were investigated by the methylene blue test." | 3.68 | [Evaluation of chromo-endoscopy for diagnosis of histological repair of gastric ulcer]. ( Iishi, H; Okuda, S; Tatsuta, M, 1992) |
| "Seven patients with refractory gastric ulcers against H2-blocker therapy, were treated with omeprazole, and the endoscopic findings serially followed." | 3.68 | [Endoscopic studies on refractory gastric ulcers, especially, linear ulcers, treated with proton pump inhibitor]. ( Takada, A; Takase, S, 1992) |
| "Oesophageal candidiasis was diagnosed incidentally at endoscopy in two patients receiving omeprazole therapy." | 3.68 | Oesophageal candidiasis after omeprazole therapy. ( Larner, AJ; Lendrum, R, 1992) |
| "This study was designed to clarify effects of proton pump inhibitors, E-3810(2-([4-(3-methoxypropoxy)-3methylpyridine-2-yl]methyl- sulfinyl)-1H-benzimidazol sodium salt) and omeprazole (CAS 73590-58-6), on water immersion stress-induced gastric ulcers in relation to mucosal prostaglandins (PGs) and leukotrienes (LTs)." | 3.68 | Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats. ( Goto, H; Hoshino, H; Kuroiwa, M; Nakazawa, S; Ohara, A; Ozawa, T; Sugiyama, S; Tsukamoto, Y, 1991) |
| "We investigated the effects of cimetidine and omeprazole on angiogenesis in granulation tissue and on the healing of gastric ulcers induced by acetic acid in rats." | 3.68 | Effects of cimetidine and omeprazole on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats. ( Goto, H; Hase, S; Segawa, K; Tsuchida, T; Tsukamoto, Y, 1990) |
| "A double-blind study was conducted to compare gastric ulcer healing time in nontreated dogs with that in dogs treated with either cimetidine or omeprazole." | 3.68 | Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs. ( Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW, 1991) |
| "Repeated administration of indomethacin markedly delays spontaneous healing of experimental gastric ulcers induced in rats." | 3.68 | Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. ( Hirose, H; Okabe, S; Takeuchi, K, 1991) |
| "Epidermal growth factor (EGF) has been shown to enhance healing of experimental gastric ulcers when given subcutaneously or orally in the drinking water." | 3.68 | Effect of epidermal growth factor in combination with sucralfate or omeprazole on the healing of chronic gastric ulcers in the rat. ( Endoh, K; Imai, S; Itoh, M; Iwai, A; Joh, T; Kawai, T; Matsusako, K; Takeuchi, T; Yasue, N; Yokoyama, Y, 1990) |
| "Omeprazole, a gastric mucosal proton pump inhibitor, significantly and dose-dependently prevented the delayed healing of acetic acid-induced gastric ulcers in response to repeatedly administered indomethacin to rats." | 3.68 | Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats. ( Nagai, H; Okabe, S; Wang, JY, 1990) |
| " Acutely induced gastric ulcers or erosions such as Shay ulcers, water-immersion stress-, indomethacin-, aspirin-, or prednisolone-induced erosions were all markedly inhibited by oral or intraduodenal administration of 10-100 mg/kg of omeprazole." | 3.67 | Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. ( Okabe, S; Okada, Y; Yamamoto, O, 1984) |
| "Basal and pentagastrin stimulated gastric acid secretions were measured in 20 patients with duodenal ulcer before and after one week of treatment with oral omeprazole 20 mg daily." | 3.67 | [Omeprazole in peptic ulceration: acid inhibition and endoscopic healing]. ( Chen, SP; Ke, MY; Mai, CR, 1989) |
| "The inhibitory effect of omeprazole on acid formation has been studied in vitro in gastric glands and partly purified H+,K+-ATPase, prepared from mucosa obtained either from healthy subjects by gastroscopic biopsy or from gastric ulcer patients during antrectomy." | 3.67 | Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa. ( Elander, B; Fellenius, E; Leth, R; Olbe, L; Wallmark, B, 1986) |
| "The effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion was investigated in rats." | 3.67 | Effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion in rats. ( Poulsen, SS; Skov Olsen, P; Therkelsen, K, 1988) |
| " However they possess antiulcer properties lower than the reference compound against Indomethacin-induced gastric ulcers." | 3.67 | [Synthesis and anti-ulcer activity of some new compounds with arylthiomethyl-pyridine structure]. ( Evangelista, S; Ghelardoni, M; Meli, A; Pestellini, V; Viti, G, 1988) |
| "We investigated whether the trophic actions of prostaglandins, omeprazole, and indomethacin on gastric mucosa lead to accelerated healing of gastric ulcers in the rat." | 3.67 | Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat. ( Baumgartner, A; Halter, F; Inauen, W; Kayser, S; Koelz, HR; Schürer-Maly, CC; Wyss, PA, 1988) |
| "36 patients with chronic gastric or oesophageal peptic ulceration (including 6 with antrectomy), resistant to high-dose ranitidine treatment for at least 3 months, were successfully treated with 40-60 mg of omeprazole daily for periods between 1 and 2 years." | 3.67 | Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. ( Brunner, G; Creutzfeldt, W; Jacubaschke, U; Lamberts, R; Maas, S; Stöckmann, F, 1988) |
| "The influence of omeprazole on the antiulcer effects of histamine, methacholine and pentagastrin on ethanol-induced gastric ulceration was studied." | 3.67 | The influence of omeprazole on the protective effects of secretagogues against ethanol-induced gastric ulceration in rats. ( Cho, CH; Ogle, CW; Wong, SH, 1987) |
| " Omeprazole, which blocks the terminal step of acid secretion--the proton pump, can produce long-lasting achlorhydria." | 3.67 | Effect of omeprazole on acute gastric stress ulceration in cervical cord transected rats. ( Hardy, KJ; MacLellan, DG; Shulkes, A, 1987) |
| "Omeprazole treatment increased R-R intervals (P = ." | 3.30 | Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses. ( Berryhill, EH; Finno, CJ; Knych, H; Louie, EW; Morgan, JM; Nieto, J; Wensley, F, 2023) |
| "Omeprazole was found to be the most effective PPI in the management of APDs due to its rapid action, good antioxidant effects, and effectiveness against nocturnal acid breakthroughs." | 3.01 | Over 30 Years of Omeprazole. ( Sharma, P, 2023) |
| "A prospective, blinded randomized interventional study was trial, conducted in 3 parts: (a) bioavailability study, (b) dose titration study, and (c) comparative clinical pharmacodynamic study, each using a blocked crossover design." | 3.01 | Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses. ( Edwards, S; Hughes, KJ; Jacobson, GA; Narkowicz, CK; Raidal, SL; Wise, JC, 2021) |
| "To compare pharmacokinetic and pharmacodynamic effects of a novel omeprazole formulation against a currently registered product." | 2.84 | Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores. ( Andrews, FM; Nielsen, SG; Raidal, SL; Trope, G, 2017) |
| " No serious adverse events were observed in any of the patients in either group." | 2.80 | Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m ( Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S, 2015) |
| "omeprazole was 6." | 2.74 | Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. ( Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Shah, AH; Sodhi, JS; U-Saif, R; Yatoo, GN; Zargar, SA, 2009) |
| " The absorption rate is not related to food." | 2.71 | [Therapeutic effect of gastrozolum in stomach ulcers]. ( Dolgova, NIu; Goncharenko, LS; Kuz'mina, OS; Lopatina, IN; Manannikov, IV; Melik-Ogandzhanian, NB; Serova, TI; Sukhareva, GV; Trubitsina, IE; Tsaregorodtseva, TM; Zarudnaia, SI, 2003) |
| "To determine the minimal effective dosage of omeprazole oral paste for the prevention of naturally occurring ulcers in horses starting race training." | 2.71 | Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Doucet, MY; Fleishman, C; Holste, JE; McClure, SR; Sifferman, RL; Vrins, A; White, GW, 2005) |
| "Omeprazole was more effective than ranitidine in healing gastric squamous ulcers in Thoroughbreds in race training." | 2.71 | Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds. ( Lester, GD; Robertson, ID; Smith, RL, 2005) |
| "Rabeprazole is a new proton pump inhibitor with more potent acid suppressive and anti-Helicobacter effects." | 2.70 | Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection. ( Fung, FM; Hu, WH; Hui, CK; Hung, WK; Lai, KC; Lam, SK; Lau, P; Li, KF; Szeto, ML; Tong, TS; Wong, BC; Wong, WM; Yee, YK; Yip, AW; Yuen, MF, 2001) |
| "Omeprazole was better tolerated than misoprostol." | 2.69 | Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. ( Barkun, A; Hawkey, CJ; Karrasch, JA; Swannell, AJ; Szczepañski, L; Walker, DG; Yeomans, ND, 1998) |
| "Omeprazole is an effective agent for gastroduodenal prophylaxis in patients taking NSAIDs." | 2.69 | Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. ( Bardhan, KD; Cullen, D; Eisner, M; Hawkey, CJ; Kogut, DG; Peacock, RA; Thomson, JM, 1998) |
| " Sixty patients received 40 mg of omeprazole twice a day, 1500 mg of amoxicillin three times a day, and 300 mg of rebamipide three times a day (group OAR); the other 60 patients received the same dosage of omeprazole and amoxicillin but no rebamipide for two weeks (group OA)." | 2.69 | Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer. ( Ando, K; Arakawa, T; Harihara, S; Higuchi, K; Ito, H; Kobayashi, K; Kuroki, T; Nebiki, H; Uchida, T, 1998) |
| " The results of this study suggest that omeprazole, employing a once daily dosing schedule, is effective at reducing the severity or eliminating gastric ulcers in Thoroughbreds in active race training." | 2.69 | Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training. ( Holste, J; Nieto, J; Pollmeier, M; Snyder, JR; Thompson, D; Vatistas, NJ, 1999) |
| " At Day 28, 25 of treated horses continued on this dosing regimen while 25 received a half dose (2 mg/kg bwt once daily) and 25 horses were sham-dosed." | 2.69 | Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses. ( Alva, R; Andrews, FM; Bernard, W; Cox, JL; Daurio, CP; Holste, JE; Hughes, FE; Sifferman, RL, 1999) |
| "Rabeprazole is a new PPI with demonstrated efficacy in both the acute and maintenance treatment of erosive GERD." | 2.69 | Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group. ( Beker, JA; Bjaaland, T; Dekkers, C; Finnegan, V; Humphries, TJ; Thjodleifsson, B, 2000) |
| "Twenty-four healthy male volunteers were studied on the 7th day of morning dosing with either placebo or rabeprazole 10, 20 or 40 mg in a crossover fashion." | 2.69 | A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects. ( Blanshard, C; Millson, C; Pounder, RE; Sercombe, J; Williams, MP, 2000) |
| " The optimal dosage and duration of treatment need to be specified." | 2.68 | Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer. ( Fujita, N; Hisano, K; Kobayashi, T; Kurokawa, I; Ochiai, T; Sugiyama, T; Yabana, T; Yachi, A, 1995) |
| "We investigated the eradication and recurrence rate of Helicobacter pylori-infected gastric ulcer patients by combination therapies." | 2.68 | Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients. ( Fukuda, Y; Okui, M; Shimoyama, T; Tonokatsu, Y; Yamamoto, I, 1995) |
| "When healing of gastric ulcers is observed using an electronic endoscope with a magnifying function, five types of regenerated mucosa can be distinguished." | 2.68 | Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function. ( Fukuchi, S; Hashimoto, M; Hoshihara, Y; Iguchi, D; Kimura, T; Sugawara, K; Takemoto, T; Tanaka, T; Yamamoto, T, 1995) |
| "Lansoprazole 30 mg/day was administered to 124 gastric ulcer (GU) patients and 57 duodenal ulcer (DU) patients." | 2.68 | Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication. ( Kato, T; Ogoshi, K; Sakagawa, T, 1995) |
| "Pirenzepine has been reported to inhibit gastrin secretion." | 2.68 | Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients. ( Fukino, Y; Hamada, M; Haruma, K; Inoue, M; Kajiyama, G; Kamiyasu, T; Sumii, K; Sumii, M; Tari, A, 1996) |
| "Cure of HP infection reduces the recurrence of peptic ulcer and of rebleeding from ulcer disease more effectively than does long-term maintenance therapy." | 2.68 | Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. ( Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C, 1996) |
| "pylori infection and the ulcer recurrence rate after 1 year were investigated." | 2.68 | Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients. ( Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Koshiyama, T; Kudo, M; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H, 1996) |
| " Amoxycillin dosing was randomised to either 1 h before or 10 min after food." | 2.67 | Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals. ( Atherton, JC; Hawkey, CK; Hudson, N; Kirk, GE; Spiller, RC, 1994) |
| ", in the dosage used and in a selected group of patients with gastrointestinal bleeding, is similar." | 2.67 | [The treatment of upper digestive hemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole]. ( Blasco Colmenarejo, MM; Cabot Lozano, A; Caneiro Alcubilla, E; García Molinero, MJ; García-Rayo Somoza, M; Herrero Quirós, C; Pérez Flores, R, 1994) |
| "Omeprazole was given once daily." | 2.67 | An open trial on short-term omeprazole therapy for gastric and duodenal ulcers. ( Alvarez, SZ; Espiritu, AC; Perez, JY; Sollano, JD, 1991) |
| " The oral administration of omeprazole has been shown to be effective in both treating horses with gastric ulceration and at preventing re-occurrence whilst the horses are in training, provided that daily dosing is maintained." | 2.44 | Equine gastric ulcer syndrome in adult horses: a review. ( Bell, RJ; Kingston, JK; Mogg, TD, 2007) |
| " Intravenous pantoprazole is especially distinguished in its lack of clinically relevant drug interactions, and it requires no dosage adjustment for patients with renal insufficiency or with mild to moderate hepatic dysfunction." | 2.41 | Potential uses of intravenous proton pump inhibitors to control gastric acid secretion. ( Metz, DC, 2000) |
| "Pantoprazole has similar efficacy to other PPIs in the healing of gastric and duodenal ulcers, as well as erosive esophagitis, and as part of triple-drug regimens for the eradication of Helicobacter pylori from the gastric mucosa." | 2.41 | Pantoprazole: a new proton pump inhibitor. ( Jungnickel, PW, 2000) |
| "Lansoprazole is a proton pump inhibitor that reduces gastric acid secretion in a dose-dependent manner via inhibition of H+/K+-adenosine triphosphatase in gastric parietal cells." | 2.41 | An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole. ( Bown, RL, 2002) |
| "Lansoprazole is a benzimidazole derivative that effectively decreases gastric acid secretion, regardless of the primary stimulus, via inhibition of gastric H+,K(+)-adenosine triphosphatase (ATPase)." | 2.39 | Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. ( Faulds, D; Spencer, CM, 1994) |
| "In gastroesophageal reflux disease in particular, although the optimal degree of acid suppression is not yet defined, the consistently superior performance of proton pump inhibitors demonstrates that increased suppression of acidity is clinically beneficial." | 2.39 | Optimizing acid suppression for treatment of acid-related diseases. ( Cederberg, C; Dent, J; Halter, F; Howden, C; Hunt, RH; Marks, IN; Rune, S; Walt, RP, 1995) |
| "This review provides an updated overview on Helicobacter pylori (HP) trials, focusing on drug dosage and cost:benefit ratio." | 2.39 | The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. ( Treiber, G, 1996) |
| "Pantoprazole is an irreversible proton pump inhibitor which, at the therapeutic dose of 40mg, effectively reduces gastric acid secretion." | 2.39 | Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. ( Fitton, A; Wiseman, L, 1996) |
| "Clarithromycin is useful for treatment of H." | 2.39 | Efficacy of clarithromycin in eradicating Helicobacter pylori. ( Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y, 1996) |
| " Tests of gastric acidity, in particular 24-h acidity studies, have provided considerable insight into normal and abnormal gastric physiology, and have largely determined the dosing regimens for the management of acid-peptic diseases." | 2.38 | Gastric acid secretion and intragastric acidity: measurement in health and disease. ( Fraser, AG; Pounder, RE, 1993) |
| "Lansoprazole, one of PPIs, is a strong antacid and it cures stomach and duodenal ulcers at early stages as well as having antibiotic action towards HP." | 2.38 | [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy]. ( Kawano, S; Murai, M; Tamura, K; Tanaka, M, 1993) |
| "Omeprazole is a powerful inhibitor of gastric acid secretion." | 2.38 | Omeprazole. Overview and opinion. ( Holt, S; Howden, CW, 1991) |
| "Omeprazole is a very potent and long-acting inhibitor of gastric acid secretion." | 2.38 | Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. ( Jansen, JB; Lamers, CB; Meijer, JL, 1989) |
| "Omeprazole has been shown to give significantly higher healing rates than ranitidine or cimetidine in patients with duodenal ulcer and gastric ulcer." | 2.38 | Clinical utility and safety of omeprazole. ( Walan, A, 1989) |
| "Gastric ulcer is associated with weakening of the mucous coating of the stomach and damages to the intestinal lining." | 1.91 | ( Alshehri, MM; Atanda, H; Balogun, TA; Cárdenas-Cárdenas, R; Chenet-Zuta, M; Delgado Wong, H; Olivos-Ramirez, G; Ropón-Palacios, G; Umar, HI; Vilca-Quispe, J, 2023) |
| "Gastric ulcers are a common clinical presentation affecting anyone, regardless of their age or gender." | 1.91 | ( Fang, S; Jing, J; Li, L; Li, R; Liu, T; Liu, W; Wang, C; Yang, C; Yang, S; Zheng, L, 2023) |
| " Although the result of the current study improves, a high dosage of aqueous extracts of plants has more effectiveness than a low dosage of aqueous extracts plants." | 1.91 | Gastro-Protective and Therapeutic Effect of Punica granatum against Stomach Ulcer Caused by Helicobacter Pylori. ( Alamri, ZZ; Faraj, RK; Hussein, MM; M Hussein, A; Mojarradgandoukmolla, S; Muhialdin, AJ; Taha, ZB, 2023) |
| "Gastric ulcer is a common frequent clinical problem affecting all age and gender." | 1.72 | Potential stem cell-Conditioned medium and their derived exosomes versus omeprazole in treatment of experimental model of gastric ulcer. ( Allam, FAFA; Ibrahim, MFG, 2022) |
| "Omeprazole and metformin were found to decrease stomach acidity and ulcer index, restored the histological features and increased mucin levels." | 1.62 | The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway. ( AbdelAziz, EY; Menze, ET; Tadros, MG, 2021) |
| " The aim of this systematic review is to evaluate the effectiveness and safety of Chinese medicine combined with omeprazole for GU." | 1.62 | Effectiveness and safety of Chinese medicine combined with omeprazole in the treatment of gastric ulcer: A protocol for systematic review and meta-analysis. ( Liu, L; Wei, M; Xie, C; Zhu, S, 2021) |
| "Stress induced gastric ulcer is a serious health problem in diabetic patients." | 1.48 | Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats. ( Abd El Motteleb, DM; Elshazly, SM; Ibrahim, IAAE, 2018) |
| "Gastric ulcer was induced in rats with a single dose of ethanol (EtOH)." | 1.46 | Protective effects of orange (Citrus sinensis L.) peel aqueous extract and hesperidin on oxidative stress and peptic ulcer induced by alcohol in rat. ( Grami, D; Marzouki, L; Rtibi, K; Sebai, H; Selmi, S, 2017) |
| " Therefore, the use of singular dosing recommendations that encompass all horse types and management conditions may not be appropriate and dosing recommendations that take into account the diet of the horse may be advantageous." | 1.46 | The effects of dose and diet on the pharmacodynamics of omeprazole in the horse. ( Greer, R; McGowan, CM; Mills, PC; Sykes, BW; Underwood, C, 2017) |
| " Each rat to receive nebivolol and omeprazole was given the agent orally (by gavage) daily for 10 days prior to induction of ulcer by oral dosing with INDO." | 1.43 | Nebivolol prevents indomethacin-induced gastric ulcer in rats. ( El-Ashmawy, NE; El-Bahrawy, HA; Khedr, EG; Selim, HM, 2016) |
| "Pretreatment with omeprazole or MDLA led to an increase in the uptake of Periodic Acid Schiff (PAS) stain in the glandular part of the gastric tissue, raised levels of prostaglandin E2 (PGE2) and superoxide dismutase (SOD), and a reduction in malondialdehyde (MDA) concentrations." | 1.43 | Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Manganese (II) Complex against HCl/Ethanol-Induced Gastric Ulcerations in Rats. ( Adam, H; Al-Obaidi, MM; Ali, HM; Alkotaini, B; Batran, RA; Dhiyaaldeen, SM; El-Ferjani, RM; Hashim, NM; Ibrahim, MY, 2016) |
| "Omeprazole (20 mg/kg) was used as a standard." | 1.42 | Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4. ( El-Naga, RN, 2015) |
| "A new series of novel benzimidazole derivatives containing substituted pyrid-2-yl moiety and polyhydroxy sugar conjugated to the N-benzimidazole moiety has been synthesized and evaluated as orally bioavailable anti-inflammatory agents with anti-ulcerogenic activity." | 1.39 | Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity. ( Biuomy, AR; El-Nezhawy, AO; Hassan, FS; Ismaiel, AK; Omar, HA, 2013) |
| "As the bioavailability of erlotinib is dependent on gastric pH, an increase in gastric pH via the concurrent use of gastric acid suppressive medications (AS) may reduce its bioavailability and efficacy." | 1.39 | An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib. ( Bradbury, PA; Hilton, JF; Seymour, L; Shepherd, FA; Tu, D, 2013) |
| " The CGA is well absorbed orally, and its effects on gastric ulcer have not been previously reported." | 1.39 | Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer. ( de Melo, IL; de Oliveira e Silva, AM; Farsky, SH; Machado, ID; Mancini-Filho, J; Santin, JR; Shimoyama, AT, 2013) |
| "Pre-treatment with arbutin or omeprazole protected the gastric mucosa as seen by reduction in ulcer area and mucosal content, reduced or absence of edema, inflammation and leucocytes infiltration on both models." | 1.38 | Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin. ( Abdelwahab, SI; Abdulla, MA; Ali, HM; Hadi, AH; Salga, MS; Taha, MM, 2012) |
| "Gastric ulcer was induced by administering alcohol (or) acetylsalicylic acid (or) hypothermic restraint stress to rats pretreated with HAEPD (200 mg/kgbwt for 30 day)." | 1.38 | Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats. ( Geetha, A; Megala, J, 2012) |
| "Indomethacin was orally administered to induce an acute gastric injury (3, 10 and 30mg/kg)." | 1.38 | Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury. ( Castañeda-Hernández, G; Chávez-Piña, AE; Jiménez-Andrade, JM; Pineda-Peña, EA, 2012) |
| "pylori eradication prevented gastric cancer to the greatest extent when antibiotics are given at an early point of infection, but that eradication therapy given at a later time point delayed the development of severe dysplastic lesions." | 1.35 | Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. ( Fox, JG; Ge, Z; Lee, CW; Rickman, B; Rogers, AB; Wang, TC, 2008) |
| "Especially patients with severe sepsis or septic shock are prone to develop lesions of the upper gastrointestinal tract with consecutive bleeding." | 1.35 | [Stress ulcer prophylaxis in septic patients. Evidence-based overview]. ( Elke, G; Schädler, D; Scholz, J; Weiler, N; Zick, G, 2008) |
| "Pretreatment with omeprazole did not change the RX-77368 (15 ng)-induced increase in permeability, but quickened the recovery of permeability after the peak." | 1.33 | Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration. ( Itoh, M; Joh, T; Kaneko, H; Kataoka, H; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Sobue, M; Suzuki, H; Takahashi, N; Watanabe, K, 2005) |
| "Pantoprazole is an irreversible proton pump inhibitor that is administered as a racemic mixture clinically." | 1.33 | Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs. ( Cao, H; Hu, ZQ; Ikejima, T; Sun, LX; Wang, MW; Zhao, WH, 2005) |
| "Stress gastric ulcer is a serious complication, but the mechanism involved is not fully clarified." | 1.33 | Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats. ( Chen, L; Geng, B; Ke, Y; Lou, LX; Pan, CS; Qi, YF; Tang, CS; Wang, X; Yu, F; Zhang, J, 2006) |
| " Dose-response studies on gastroprotection in stress and indomethacin-induced ulcer and inhibition of pylorus ligation-induced acid secretion indicate that omeprazole significantly blocks gastric lesions at lower dose (2." | 1.32 | A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. ( Ali, E; Bandyopadhyay, U; Banerjee, RK; Biswas, K; Chattopadhyay, I; Varadaraj, A, 2003) |
| "Optimal timing for daily dosing of athletic horses with an effective OME preparation, in order to suppress gastric squamous ulceration, might be 4-8 h prior to a training session." | 1.32 | Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses. ( Burrow, JA; Church, M; Ludzia, S; Merritt, AM; Sanchez, LC, 2003) |
| "Pretreatment with lansoprazole 90 micromol/kg, given intraduodenally as single dose or once daily by intragastric route for 8 days, significantly prevented ethanol-HCl-induced gastric damage." | 1.32 | Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. ( Blandizzi, C; Colucci, R; Del Tacca, M; Fornai, M; Lazzeri, G; Lubrano, V; Natale, G; Vassalle, C, 2004) |
| "Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output." | 1.32 | Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004) |
| "Ebrotidine is a new H2 receptor antagonist that potentiates the gastric mucosal barrier." | 1.31 | Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine. ( Arroyo, MT; Lanas, A; Sáinz, R, 2000) |
| "Pretreatment with indomethacin did not influence the cytoprotective effect of rabeprazole." | 1.31 | Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide. ( Arakawa, T; Fujiwara, Y; Higuchi, K; Tominaga, K; Watanabe, T, 2000) |
| "We compared the gastric toxic effect of aspirin (ASA) in both normal and diabetic rats, with that of NCX-4016, a derivative of ASA with nitric oxide (NO) releasing moiety." | 1.31 | Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats. ( Fujita, A; Takeuchi, K; Tashima, K; Umeda, M, 2000) |
| "Cumulative ulcer recurrence rate for 12 months, respectively for patients with eradication success and failure, was 2." | 1.31 | [Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up]. ( Bermejo, F; Boixeda, D; Defarges, V; García Plaza, A; Gisbert, JP; Martín de Argila, C; Sanz, JM, 2000) |
| "As chronic use of antiulcer medications might predispose older persons to cobalamin deficiency, we studied participants (> 65 years) in the clinical examination of the Canadian Study of Health and Aging to test the association between the use of an antiulcer medication (histamine-2 blocker or proton pump inhibitor) at baseline with initiation of cobalamin replacement during the 5 year follow-up period." | 1.31 | The association between antiulcer medication and initiation of cobalamin replacement in older persons. ( Mitchell, SL; Rockwood, K, 2001) |
| "Gastric acid is required for recurrence of gastric ulcers caused by IL-1beta, and gastric acid stimulates the inflammatory process in scarred mucosa during ulcer recurrence." | 1.31 | Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta. ( Arakawa, T; Fujiwara, Y; Higuchi, K; Tominaga, K; Watanabe, T, 2001) |
| "1 year after drug therapy the recurrence of CDU is revealed in 16." | 1.31 | [Current principles of the use of laparoscopic surgery in gastroduodenal ulcer]. ( Fedorov, AV; Sazhin, VP, 2001) |
| "Gastric ulcers were induced by a luminal application of acetic acid in male Donryu rats." | 1.31 | Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats. ( Amagase, K; Itoh, S; Nakai, H; Okabe, S; Tsukimi, Y, 2001) |
| "Omeprazole was delivered in bicarbonate suspension through a nasogastric tube." | 1.31 | Omeprozole therapy in pediatric patients after liver and intestinal transplantation. ( Andersen, DA; Bergman, KL; Brown, CR; Davis, CK; Fox, IJ; Horslen, SP; Kaufman, SS; Langnas, AN; Lyden, ER; Olsen, KM; Shaw, BW; Sudan, DL, 2002) |
| "Rabeprazole has a favourable profile with rapid action and good safety." | 1.31 | [Pharma-clinics medication of the month. Rabeprazole (Pariet)]. ( Louis, E, 2002) |
| "Omeprazole, 20 or 40 mg, was administered once daily with water through a nasogastric tube." | 1.30 | Nasogastric omeprazole: effects on gastric pH in critically Ill patients. ( Balaban, DH; Duckworth, CW; Peura, DA, 1997) |
| "Of the 83 smokers, 3 (3." | 1.30 | Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? ( Chan, FK; Chan, LY; Chung, SC; Lee, YT; Leung, WK; Sung, JJ; Yung, MY, 1997) |
| "Omeprazole does increase intragastric pH in bleeding peptic ulcer patients with H." | 1.30 | Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy? ( Chang, FY; Hsieh, YH; Lee, FY; Lee, SD; Lin, HJ; Perng, CL; Tseng, GY, 1999) |
| "Pretreatment with famotidine or omeprazole reduced lesion index, and the protective effects were equivalent to those of 1." | 1.29 | Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats. ( Goto, H; Hamajima, E; Hoshino, H; Ozawa, T; Sugiyama, S; Tsukamoto, Y, 1994) |
| "Gastric ulcers were produced by luminal application of 60% acetic acid (0." | 1.29 | Validity of kissing gastric ulcers induced in rats for screening of antiulcer drugs. ( Okabe, S; Tsukimi, Y, 1994) |
| " Moreover, if omeprazole is administered at a pharmacologically effective dosage for a short period of time, it may not have serious effects on the ultrastructure of human parietal cells." | 1.29 | The effects of omeprazole on the ultrastructure of gastric parietal cells. ( Fujii, T; Kato, S; Naganuma, H; Nakagawa, H; Nakano, K, 1994) |
| "Pretreatment with atropine or ranitidine inhibited the development of stress ulcers, reduced changes in ir-TRH concentrations in the gastric wall and gastric juice, and induced an increase in gastric pH." | 1.29 | The role of thyrotropin-releasing hormone (TRH) in the pathogenesis of water-immersion stress in rats--inhibition of TRH release from the stomach by atropine, ranitidine or omeprazole. ( Furusawa, A; Kaneko, H; Maeda, Y; Mitsuma, T; Morise, K; Nagai, H; Nakada, K; Uchida, K, 1993) |
| "Omeprazole is an inhibitor of gastric H+,K(+)-ATPase." | 1.29 | Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. ( Abe, K; Furukawa, Y; Katano, K; Mizunashi, K, 1993) |
| "Pretreatment with nicardipine, a Ca(2+)-channel blocker (1 mg/kg iv), significantly attenuated the ET-1-induced mucosal damage as well as the decrease in mucosal blood flow." | 1.29 | Gastric ulcer induced by submucosal injection of ET-1: role of potent vasoconstriction and intraluminal acid. ( Fukutomi, H; Goto, K; Kashimura, H; Lazaratos, S; Miyauchi, T; Nakahara, A; Osuga, T; Urushidani, T, 1993) |
| "Omeprazole has a potent antisecretory effect and is a suitable alternative for short-term treatment of refractory acid-related diseases; a relatively low dose (0." | 1.29 | Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity. ( Chiba, H; Ebina, K; Fujii, K; Kato, S; Nakagawa, H, 1996) |
| "Lansoprazole has a cytotoxic action against this organism, the MIC being 2." | 1.29 | Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication. ( Kawano, S; Murakami, M; Saita, H; Tsuji, S, 1996) |
| "3%) had received previous therapy with H2-receptor antagonists and in 33% of these patients it was at an inadequate dose or for an inadequate period of dosing or both." | 1.28 | A drug usage review of omeprazole. ( Kay, EA; McManus, PV; Norris, CM; Petty, D, 1992) |
| " Development of gastric cancer, however, has not been obvious in clinical and experimental studies, but oncongenicity studies indicate an increased risk of gastric cancer with long-term use of proton pump inhibitors in subjects with hyperplastic or other, changes in the gastric mucosa." | 1.28 | [Treatment of gastric ulcers with proton pump inhibitors--long-term treatment]. ( Akimoto, H; Aoki, T; Takayama, S, 1992) |
| "Treatment with omeprazole also failed to bring about healing of the ulceration which, at times, measured up to 10 cm in diameter." | 1.28 | Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration. ( Gail, K; Mihaljevic, L; Stolte, M, 1991) |
| " Chronic administration of hydrocortisone sodium phosphate resulted in a significant delay of ulcer healing induced by acetic acid." | 1.28 | Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat. ( Eastwood, GL; Kuwayama, H; Matsuo, Y, 1991) |
| " Omeprazole, which suppresses acid very effectively, may be problematic in the critically ill, limited by its oral dosage form, acid-labile properties, and potential drug interactions." | 1.28 | Controlling gastric pH: the impact of newer agents on the critically ill patient. ( Earnest, DL, 1990) |
| "Gastric ulcers were induced by the submucosal injection of 20% acetic acid (0." | 1.28 | Effects of NC-1300, a gastric proton pump inhibitor, on healing of acetic acid-induced gastric ulcers in rats. ( Miyake, H; Okabe, S; Yamasaki, S, 1989) |
| "Treatment with omeprazole also gave faster and more pronounced pain relief." | 1.27 | Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors. ( Walan, A, 1986) |
| "In the saline- and the sucralfate-treated groups the gastric ulcer incidence was 83% and 80%, respectively, with a mean of six and seven ulcers per rat." | 1.27 | Insulin-induced gastric ulcers in the rat. ( Axelson, J; Håkanson, R; Hedenbro, JL, 1987) |
| "pretreatment with indomethacin (5 mg/kg, s." | 1.27 | Cytoprotective effects of NC-1300 and omeprazole on Hcl . ethanol-induced gastric lesions in rats. ( Awane, Y; Miyake, H; Okabe, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (8.43) | 18.7374 |
| 1990's | 333 (44.58) | 18.2507 |
| 2000's | 229 (30.66) | 29.6817 |
| 2010's | 89 (11.91) | 24.3611 |
| 2020's | 33 (4.42) | 2.80 |
| Authors | Studies |
|---|---|
| Yum, EK | 1 |
| Kang, SK | 1 |
| Kim, SS | 1 |
| Choi, JK | 1 |
| Cheon, HG | 3 |
| Matsuda, H | 2 |
| Pongpiriyadacha, Y | 1 |
| Morikawa, T | 2 |
| Kishi, A | 1 |
| Kataoka, S | 1 |
| Yoshikawa, M | 2 |
| Donadel, OJ | 1 |
| Guerreiro, E | 1 |
| María, AO | 1 |
| Wendel, G | 1 |
| Enriz, RD | 1 |
| Giordano, OS | 1 |
| Tonn, CE | 1 |
| Li, N | 1 |
| Nagatomo, A | 1 |
| Li, X | 1 |
| Zhang, LY | 2 |
| Yang, F | 1 |
| Shi, WQ | 1 |
| Zhang, P | 1 |
| Li, Y | 2 |
| Yin, SF | 1 |
| El-Nezhawy, AO | 1 |
| Biuomy, AR | 1 |
| Hassan, FS | 1 |
| Ismaiel, AK | 1 |
| Omar, HA | 1 |
| Del Pozo-García, AJ | 1 |
| Valdeés-Lacasa, T | 1 |
| Fresneda-Cuesta, D | 1 |
| Sánchez-Gómez, F | 1 |
| Tamames Gómez, S | 1 |
| Rudra, DS | 1 |
| Pal, U | 1 |
| Chowdhury, N | 1 |
| Maiti, NC | 1 |
| Bagchi, A | 1 |
| Swarnakar, S | 1 |
| Hwang, H | 1 |
| Dong, HJ | 1 |
| Han, J | 1 |
| Cho, S | 1 |
| Kim, Y | 2 |
| Lee, I | 1 |
| Abdel-Kawi, SH | 1 |
| Hashem, KS | 1 |
| Saad, MK | 1 |
| Fekry, G | 1 |
| Abdel-Hameed, EMM | 1 |
| Ibrahim, MFG | 1 |
| Allam, FAFA | 1 |
| Rubab, F | 1 |
| Ijaz, H | 1 |
| Hussain, S | 1 |
| Munir, A | 1 |
| Stuppner, S | 1 |
| Jakschitz, T | 1 |
| Bonn, GK | 1 |
| Ishtiaq, S | 1 |
| Zhang, J | 3 |
| Yin, Y | 1 |
| Xu, Q | 1 |
| Che, X | 1 |
| Yu, C | 1 |
| Ren, Y | 1 |
| Li, D | 1 |
| Zhao, J | 1 |
| Arab, HH | 1 |
| Eid, AH | 1 |
| El-Sheikh, AAK | 1 |
| Arafa, EA | 1 |
| Ashour, AM | 1 |
| Pratt, SL | 2 |
| Bowen, M | 2 |
| Hallowell, GH | 2 |
| Shipman, E | 2 |
| Bailey, J | 2 |
| Redpath, A | 2 |
| Louie, EW | 2 |
| Berryhill, EH | 2 |
| Nieto, J | 3 |
| Wensley, F | 2 |
| Knych, H | 2 |
| Finno, CJ | 2 |
| Morgan, JM | 2 |
| Gao, N | 2 |
| Yan, S | 2 |
| Chen, B | 2 |
| Atanda, H | 1 |
| Balogun, TA | 1 |
| Alshehri, MM | 1 |
| Olivos-Ramirez, G | 1 |
| Vilca-Quispe, J | 1 |
| Chenet-Zuta, M | 1 |
| Cárdenas-Cárdenas, R | 1 |
| Delgado Wong, H | 1 |
| Ropón-Palacios, G | 1 |
| Umar, HI | 1 |
| Li, L | 1 |
| Jing, J | 1 |
| Yang, S | 1 |
| Fang, S | 1 |
| Liu, W | 1 |
| Wang, C | 1 |
| Li, R | 1 |
| Liu, T | 1 |
| Zheng, L | 1 |
| Yang, C | 1 |
| Sundra, T | 1 |
| Kelty, E | 1 |
| Rendle, D | 1 |
| Busechian, S | 1 |
| Conti, MB | 1 |
| Sgorbini, M | 1 |
| Conte, G | 1 |
| Marchesi, MC | 1 |
| Pieramati, C | 1 |
| Zappulla, F | 1 |
| Vitale, V | 1 |
| Rueca, F | 1 |
| Selim, HM | 2 |
| Negm, WA | 1 |
| Hawwal, MF | 1 |
| Hussein, IA | 1 |
| Elekhnawy, E | 1 |
| Ulber, R | 1 |
| Zayed, A | 1 |
| Muhialdin, AJ | 1 |
| Alamri, ZZ | 1 |
| M Hussein, A | 1 |
| Faraj, RK | 1 |
| Taha, ZB | 1 |
| Hussein, MM | 1 |
| Mojarradgandoukmolla, S | 1 |
| Sharma, P | 1 |
| Abdel-Gawad, DRI | 1 |
| Ibrahim, MA | 1 |
| Moawad, UK | 1 |
| Kamel, S | 1 |
| El-Banna, HA | 1 |
| El-Banna, AH | 1 |
| Hassan, WH | 1 |
| El-Ela, FIA | 1 |
| Ebada, SS | 1 |
| Al-Jawabri, NA | 1 |
| Youssef, FS | 1 |
| Albohy, A | 1 |
| Aldalaien, SM | 1 |
| Disi, AM | 1 |
| Proksch, P | 1 |
| Luthersson, N | 1 |
| Bolger, C | 1 |
| Fores, P | 1 |
| Barfoot, C | 1 |
| Nelson, S | 1 |
| Parkin, T | 1 |
| Harris, P | 1 |
| Pagan, JD | 1 |
| Petroski-Rose, L | 1 |
| Mann, A | 1 |
| Hauss, A | 1 |
| Satoh, H | 5 |
| Akiba, Y | 4 |
| Urushidani, T | 2 |
| Xie, L | 1 |
| Guo, YL | 1 |
| Chen, YR | 1 |
| Wang, ZC | 1 |
| Zhang, T | 1 |
| Wang, B | 2 |
| Ricord, M | 1 |
| Andrews, FM | 4 |
| Yñiguez, FJM | 1 |
| Keowen, M | 1 |
| Garza, F | 1 |
| Paul, L | 1 |
| Chapman, A | 1 |
| Banse, HE | 1 |
| Zhang, H | 1 |
| Chen, L | 2 |
| Mi, Z | 1 |
| Xu, Y | 1 |
| Zhao, G | 1 |
| Liu, S | 1 |
| Lei, H | 1 |
| Wang, Z | 1 |
| Niu, J | 1 |
| Cerri, S | 1 |
| Taminiau, B | 1 |
| de Lusancay, AH | 1 |
| Lecoq, L | 1 |
| Amory, H | 1 |
| Daube, G | 1 |
| Cesarini, C | 1 |
| Wise, JC | 1 |
| Hughes, KJ | 1 |
| Edwards, S | 1 |
| Jacobson, GA | 1 |
| Narkowicz, CK | 1 |
| Raidal, SL | 2 |
| AbdelAziz, EY | 1 |
| Tadros, MG | 1 |
| Menze, ET | 1 |
| Damanhuri, NS | 1 |
| Kumolosasi, E | 1 |
| Omar, MS | 1 |
| Razak, AFA | 1 |
| Mansor, AH | 1 |
| Mashaal, K | 1 |
| Perveen, R | 1 |
| Zia, Z | 1 |
| Mahmood, SM | 1 |
| Minhas, K | 1 |
| Ibrahim, S | 1 |
| Hasan Naqvi, SNU | 1 |
| Naeem, H | 1 |
| Xie, C | 1 |
| Liu, L | 1 |
| Zhu, S | 1 |
| Wei, M | 1 |
| da Luz, BB | 1 |
| Maria-Ferreira, D | 1 |
| Dallazen, JL | 1 |
| de Oliveira, AF | 1 |
| Queiroz Telles, JE | 1 |
| Beltrame, OC | 1 |
| Cipriani, TR | 1 |
| de Paula Werner, MF | 1 |
| Zatorski, H | 1 |
| Salaga, M | 1 |
| Zielińska, M | 1 |
| Majchrzak, K | 1 |
| Binienda, A | 1 |
| Kordek, R | 1 |
| Małecka-Panas, E | 1 |
| Fichna, J | 1 |
| Zavoshti, FR | 1 |
| Sykes, BW | 6 |
| Kathawala, K | 1 |
| Song, Y | 1 |
| Garg, S | 1 |
| Page, SW | 1 |
| Underwood, C | 2 |
| Mills, PC | 2 |
| Nielsen, SG | 1 |
| Trope, G | 1 |
| García-Rayado, G | 1 |
| Sostres, C | 1 |
| Lanas, A | 4 |
| Goswami, SK | 1 |
| Rand, AA | 1 |
| Wan, D | 1 |
| Yang, J | 2 |
| Inceoglu, B | 1 |
| Thomas, M | 1 |
| Morisseau, C | 1 |
| Yang, GY | 1 |
| Hammock, BD | 1 |
| Bush, J | 1 |
| van den Boom, R | 1 |
| Franklin, S | 1 |
| Shibukawa, N | 1 |
| Ouchi, S | 1 |
| Wakamatsu, S | 1 |
| Wakahara, Y | 1 |
| Tatsumi, N | 1 |
| Kaneko, A | 1 |
| Selmi, S | 1 |
| Rtibi, K | 1 |
| Grami, D | 1 |
| Sebai, H | 1 |
| Marzouki, L | 1 |
| Nur Azlina, MF | 2 |
| Qodriyah, HMS | 1 |
| Chua, KH | 2 |
| Kamisah, Y | 2 |
| Patel, VB | 1 |
| Patel, AD | 1 |
| Shah, DA | 1 |
| Mason, LV | 1 |
| Moroney, JR | 1 |
| Mason, RJ | 1 |
| Elshazly, SM | 1 |
| Abd El Motteleb, DM | 1 |
| Ibrahim, IAAE | 1 |
| Liang, M | 1 |
| Liwen, Z | 1 |
| Juan, D | 1 |
| Yun, Z | 1 |
| Yanbo, D | 1 |
| Jianping, C | 1 |
| Fang, YF | 1 |
| Xu, WL | 1 |
| Wang, L | 1 |
| Lian, QW | 1 |
| Qiu, LF | 1 |
| Zhou, H | 1 |
| Chen, SJ | 2 |
| He, HB | 1 |
| Li, XQ | 1 |
| Li, XM | 1 |
| He, YM | 1 |
| Qin, HL | 1 |
| Zhang, YF | 1 |
| Xiong, XJ | 1 |
| Wang, JZ | 1 |
| Zou, K | 3 |
| Mishra, V | 2 |
| Agrawal, M | 1 |
| Onasanwo, SA | 1 |
| Madhur, G | 1 |
| Rastogi, P | 1 |
| Pandey, HP | 2 |
| Palit, G | 5 |
| Narender, T | 2 |
| Baananou, S | 1 |
| Bagdonaite, E | 1 |
| Marongiu, B | 1 |
| Piras, A | 1 |
| Porcedda, S | 1 |
| Falconieri, D | 1 |
| Boughattas, N | 1 |
| Shu, MH | 1 |
| Appleton, D | 1 |
| Zandi, K | 1 |
| AbuBakar, S | 1 |
| Yadav, SK | 4 |
| Adhikary, B | 4 |
| Bandyopadhyay, SK | 11 |
| Chattopadhyay, S | 11 |
| Zhang, Q | 1 |
| Huang, N | 1 |
| Wang, J | 2 |
| Luo, H | 1 |
| He, H | 1 |
| Ding, M | 1 |
| Deng, WQ | 1 |
| Singh, VK | 1 |
| Tiwari, S | 1 |
| Khaliq, T | 2 |
| Barthwal, MK | 1 |
| Hilton, JF | 1 |
| Tu, D | 1 |
| Seymour, L | 1 |
| Shepherd, FA | 1 |
| Bradbury, PA | 1 |
| Sykes, KM | 3 |
| Hallowell, GD | 4 |
| Huilgol, SV | 1 |
| Kumar, VH | 1 |
| Nwangwu, S | 1 |
| Ajeigbe, K | 1 |
| Omotoso, D | 1 |
| Josiah, S | 1 |
| Olayanju, A | 1 |
| Bolaji, A | 1 |
| Kubyshkin, VA | 1 |
| Petrov, DIu | 1 |
| Smirnov, AV | 1 |
| Iakubov, AV | 1 |
| Pulatova, NI | 1 |
| Khamraev, AA | 1 |
| Bendas, ER | 1 |
| Abdelbary, AA | 1 |
| Adewoye, EO | 1 |
| Salami, AT | 1 |
| Sykes, K | 1 |
| Higuchi, K | 10 |
| Takeuchi, T | 4 |
| Uedo, N | 1 |
| Takeuchi, Y | 1 |
| Naito, Y | 4 |
| Yagi, N | 1 |
| Tominaga, K | 5 |
| Machida, H | 1 |
| Tamada, T | 1 |
| Morita, Y | 2 |
| Yazumi, S | 1 |
| Yamao, J | 1 |
| Iguchi, M | 1 |
| Azuma, T | 3 |
| Whellan, DJ | 2 |
| Goldstein, JL | 3 |
| Cryer, BL | 1 |
| Eisen, GM | 1 |
| Miller, AB | 1 |
| Scheiman, JM | 2 |
| Fort, JG | 2 |
| Zhang, Y | 1 |
| O'Connor, C | 1 |
| Al-Falah, K | 1 |
| Schachter, J | 1 |
| Sasseville, D | 1 |
| Khoshnood, A | 1 |
| Hakimi, P | 1 |
| Salman-Roghani, H | 1 |
| Reza Mirjalili, M | 1 |
| Lenz, K | 1 |
| Buder, R | 1 |
| Firlinger, F | 1 |
| Lohr, G | 1 |
| Voglmayr, M | 1 |
| Kajiura, S | 1 |
| Hosokawa, A | 1 |
| Ueda, A | 1 |
| Mihara, H | 1 |
| Ando, T | 4 |
| Fujinami, H | 1 |
| Nishikawa, J | 1 |
| Ogawa, K | 1 |
| Minemura, M | 1 |
| Sugiyama, T | 6 |
| Mahmoud-Awny, M | 1 |
| Attia, AS | 1 |
| Abd-Ellah, MF | 1 |
| El-Abhar, HS | 1 |
| Wang, FY | 1 |
| Liu, JM | 1 |
| Luo, HH | 1 |
| Liu, AH | 1 |
| Jiang, Y | 1 |
| Ibrahim, IA | 2 |
| Qodriyah, HM | 1 |
| El-Naga, RN | 1 |
| Majeed, W | 1 |
| Aslam, B | 1 |
| Javed, I | 1 |
| Muhammad, F | 1 |
| Ali, A | 1 |
| Raza, A | 1 |
| Nandy, N | 1 |
| Hanson, JA | 1 |
| Strickland, RG | 1 |
| McCarthy, DM | 1 |
| Mao, S | 1 |
| Yang, G | 1 |
| Li, W | 1 |
| Liang, H | 1 |
| Li, J | 1 |
| Zhang, M | 1 |
| El-Ashmawy, NE | 1 |
| Khedr, EG | 1 |
| El-Bahrawy, HA | 1 |
| Ibrahim, MY | 1 |
| Hashim, NM | 1 |
| Dhiyaaldeen, SM | 1 |
| Al-Obaidi, MM | 1 |
| El-Ferjani, RM | 1 |
| Adam, H | 1 |
| Alkotaini, B | 1 |
| Batran, RA | 1 |
| Ali, HM | 3 |
| Chwiesko, A | 1 |
| Charkiewicz, R | 1 |
| Niklinski, J | 1 |
| Luczaj, W | 1 |
| Skrzydlewska, E | 1 |
| Milewski, R | 1 |
| Baniukiewicz, A | 1 |
| Wroblewski, E | 1 |
| Rosolowski, M | 1 |
| Dabrowski, A | 1 |
| Greer, R | 1 |
| McGowan, CM | 1 |
| Hardy, BT | 1 |
| Gentile-Solomon, J | 1 |
| Solomon, JA | 1 |
| Paxton, BE | 1 |
| Arepally, A | 1 |
| Alley, CL | 1 |
| Kim, CY | 1 |
| McKeage, K | 1 |
| Blick, SK | 1 |
| Croxtall, JD | 1 |
| Lyseng-Williamson, KA | 1 |
| Keating, GM | 1 |
| Skorjanec, S | 1 |
| Dolovski, Z | 1 |
| Kocman, I | 1 |
| Brcic, L | 1 |
| Blagaic Boban, A | 1 |
| Batelja, L | 1 |
| Coric, M | 1 |
| Sever, M | 1 |
| Klicek, R | 1 |
| Berkopic, L | 1 |
| Radic, B | 1 |
| Drmic, D | 1 |
| Kolenc, D | 1 |
| Ilic, S | 1 |
| Cesarec, V | 1 |
| Tonkic, A | 1 |
| Zoricic, I | 1 |
| Mise, S | 1 |
| Staresinic, M | 1 |
| Ivica, M | 1 |
| Lovric Bencic, M | 1 |
| Anic, T | 1 |
| Seiwerth, S | 1 |
| Sikiric, P | 1 |
| Maity, B | 5 |
| Banerjee, D | 7 |
| Pellicano, R | 1 |
| Zhu, L | 1 |
| Cheng, F | 1 |
| Dan, F | 1 |
| Guo, Z | 1 |
| Cai, Z | 1 |
| Ho, KY | 1 |
| Kuan, A | 1 |
| Zaño, F | 1 |
| Goh, KL | 1 |
| Mahachai, V | 2 |
| Kim, DY | 1 |
| Yoon, HM | 1 |
| Nieto, JE | 3 |
| Snyder, JR | 4 |
| Vatistas, NJ | 4 |
| Jones, JH | 1 |
| Cheng, HC | 1 |
| Chang, WL | 1 |
| Yeh, YC | 1 |
| Chen, WY | 1 |
| Tsai, YC | 1 |
| Sheu, BS | 1 |
| Barkun, AN | 1 |
| Kuipers, EJ | 2 |
| Sung, JJ | 7 |
| Karateev, AE | 3 |
| Uspenskiĭ, IuP | 1 |
| Pakhomova, IG | 1 |
| Nasonov, EL | 1 |
| Tan, VP | 1 |
| Wong, BC | 4 |
| Javid, G | 3 |
| Zargar, SA | 2 |
| U-Saif, R | 1 |
| Khan, BA | 3 |
| Yatoo, GN | 2 |
| Shah, AH | 2 |
| Gulzar, GM | 3 |
| Sodhi, JS | 2 |
| Khan, MA | 1 |
| Meyre-Silva, C | 1 |
| Petry, CM | 1 |
| Berté, TE | 1 |
| Becker, RG | 1 |
| Zanatta, F | 1 |
| Delle-Monache, F | 1 |
| Cechinel-Filho, V | 1 |
| Andrade, SF | 1 |
| Molloy, D | 1 |
| Molloy, A | 1 |
| O'Loughlin, C | 1 |
| Falconer, M | 1 |
| Hennessy, M | 1 |
| Doornebal, J | 1 |
| Bijlsma, R | 1 |
| Brouwer, RM | 1 |
| Schmutz, JL | 1 |
| Barbaud, A | 1 |
| Trechot, P | 1 |
| Schaffer, AC | 1 |
| Grad, Y | 1 |
| Ross, JJ | 1 |
| Izzettin, FV | 1 |
| Sancar, M | 1 |
| Okuyan, B | 1 |
| Apikoglu-Rabus, S | 1 |
| Cevikbas, U | 1 |
| Grad, YH | 1 |
| Seifter, JL | 1 |
| Levy, BD | 1 |
| Loscalzo, J | 1 |
| Rezin, GT | 1 |
| Petronilho, FC | 1 |
| Araújo, JH | 1 |
| Gonçalves, CL | 1 |
| Daufenbach, JF | 1 |
| Cardoso, MR | 1 |
| Roesler, R | 1 |
| Schwartsmann, G | 1 |
| Dal-Pizzol, F | 1 |
| Streck, EL | 1 |
| Felga, G | 1 |
| Silva, FM | 1 |
| Barbuti, RC | 1 |
| Navarro-Rodriguez, T | 1 |
| Zaterka, S | 1 |
| Eisig, JN | 1 |
| Yakoob, J | 1 |
| Abid, S | 1 |
| Abbas, Z | 1 |
| Jafri, SN | 1 |
| Chan, WH | 1 |
| Khin, LW | 1 |
| Chung, YF | 1 |
| Goh, YC | 1 |
| Ong, HS | 1 |
| Wong, WK | 1 |
| Yadav, DK | 1 |
| Singh, N | 1 |
| Dev, K | 1 |
| Sharma, R | 1 |
| Sahai, M | 1 |
| Maurya, R | 3 |
| Owens, SL | 1 |
| Parnell, NK | 1 |
| Chand, S | 1 |
| Song, KH | 1 |
| Lee, YC | 1 |
| Fan, DM | 1 |
| Ge, ZZ | 1 |
| Ji, F | 1 |
| Chen, MH | 1 |
| Jung, HC | 2 |
| Bo, J | 1 |
| Lee, SW | 1 |
| Kim, JH | 1 |
| Hassarajani, SA | 1 |
| Narayan, G | 1 |
| Celinski, K | 1 |
| Konturek, PC | 3 |
| Konturek, SJ | 5 |
| Slomka, M | 1 |
| Cichoz-Lach, H | 1 |
| Brzozowski, T | 5 |
| Bielanski, W | 3 |
| Hariprasath, L | 1 |
| Raman, J | 1 |
| Nanjian, R | 1 |
| Taha, MM | 1 |
| Salga, MS | 1 |
| Abdulla, MA | 2 |
| Abdelwahab, SI | 2 |
| Hadi, AH | 1 |
| Qader, SW | 1 |
| Nimir, AR | 1 |
| Al-Bayaty, FH | 1 |
| Zakaria, ZA | 2 |
| Abdul Hisam, EE | 1 |
| Norhafizah, M | 1 |
| Rofiee, MS | 2 |
| Othman, F | 2 |
| Hasiah, AH | 1 |
| Vasudevan, M | 1 |
| Takayama, S | 2 |
| Izuhara, C | 1 |
| Yamada, N | 1 |
| Yamanaka, S | 1 |
| Hashimoto, E | 1 |
| Kaneko, S | 1 |
| Takeuchi, K | 5 |
| Tomita, T | 1 |
| Yamasaki, T | 1 |
| Okugawa, T | 1 |
| Kondo, T | 1 |
| Toyoshima, F | 1 |
| Sakurai, J | 1 |
| Tanaka, J | 2 |
| Morita, T | 1 |
| Oshima, T | 2 |
| Fukui, H | 1 |
| Hori, K | 1 |
| Watari, J | 1 |
| Matsumoto, T | 3 |
| Miwa, H | 1 |
| Endo, Y | 1 |
| Tsuchiya, T | 1 |
| Sato, F | 2 |
| Murase, H | 1 |
| Omura, T | 1 |
| Korosue, K | 1 |
| Nambo, Y | 1 |
| Ishimaru, M | 1 |
| Wakui, Y | 1 |
| Megala, J | 1 |
| Geetha, A | 1 |
| Hashim, H | 1 |
| Mughrabi, FF | 1 |
| Ameen, M | 1 |
| Khaledi, H | 1 |
| El-Shinnawy, NA | 1 |
| Abd-Elmageid, SA | 1 |
| Alshailabi, EM | 1 |
| Niero, R | 3 |
| Dal Molin, MM | 1 |
| Silva, S | 1 |
| Damian, NS | 1 |
| Maia, LO | 1 |
| Delle Monache, F | 1 |
| Cechinel Filho, V | 2 |
| de Andrade, SF | 4 |
| Hisam, EE | 1 |
| Mohtaruddin, N | 1 |
| Hamid, HA | 1 |
| Okamura, Y | 1 |
| Takeno, S | 1 |
| Takahashi, Y | 2 |
| Moroga, T | 1 |
| Yamashita, S | 1 |
| Kawahara, K | 1 |
| Magdy, MA | 1 |
| Hanan, el-A | 1 |
| Nabila, el-M | 1 |
| Pineda-Peña, EA | 1 |
| Jiménez-Andrade, JM | 1 |
| Castañeda-Hernández, G | 1 |
| Chávez-Piña, AE | 1 |
| Shimoyama, AT | 1 |
| Santin, JR | 1 |
| Machado, ID | 1 |
| de Oliveira e Silva, AM | 1 |
| de Melo, IL | 1 |
| Mancini-Filho, J | 1 |
| Farsky, SH | 1 |
| Shcherbynina, MB | 1 |
| Pandian, RS | 1 |
| Anuradha, CV | 1 |
| Viswanathan, P | 1 |
| Zhan, X | 1 |
| Li, Z | 1 |
| Cui, Z | 1 |
| Duan, Y | 1 |
| Nie, S | 1 |
| Liu, J | 1 |
| Xu, G | 1 |
| Malnick, SD | 1 |
| Gottesfeld, F | 1 |
| Walpart, A | 1 |
| Keter, D | 1 |
| Lurie, Y | 1 |
| Beergabel, M | 1 |
| Picot, S | 1 |
| Sapin, G | 1 |
| Michault, A | 1 |
| Faulques, B | 1 |
| Becquart, JP | 1 |
| Simac, C | 1 |
| Amat, C | 1 |
| Ancelin-Malbreil, E | 1 |
| Ishibashi, S | 1 |
| Iwakiri, R | 2 |
| Shimoda, R | 1 |
| Ootani, H | 1 |
| Kawasaki, S | 1 |
| Tadano, J | 1 |
| Kikkawa, A | 1 |
| Ootani, A | 1 |
| Oda, K | 2 |
| Fujise, T | 1 |
| Yoshida, T | 1 |
| Tsunada, S | 1 |
| Sakata, H | 2 |
| Fujimoto, K | 2 |
| Hiraishi, H | 1 |
| Ota, S | 1 |
| Terano, A | 1 |
| Hawkey, CJ | 6 |
| Naesdal, J | 6 |
| Wilson, I | 3 |
| Långström, G | 4 |
| Swannell, AJ | 4 |
| Peacock, RA | 2 |
| Yeomans, ND | 6 |
| Tsuji, S | 4 |
| Wu, XP | 1 |
| He, JR | 1 |
| Wang, CL | 1 |
| Ling, QH | 1 |
| Kobayashi, T | 2 |
| Ohta, Y | 3 |
| Inui, K | 2 |
| Yoshino, J | 3 |
| Nakazawa, S | 6 |
| Vasil'ev, IuV | 1 |
| Kas'ianenko, VI | 1 |
| Minushkin, ON | 1 |
| Zverkov, IV | 1 |
| Aronova, OV | 1 |
| Shuleshova, AG | 1 |
| Spier, S | 1 |
| Pipers, FS | 1 |
| Stanley, S | 1 |
| Aleman, MR | 1 |
| Smith, DC | 1 |
| Weaver, AL | 1 |
| Gitlin, N | 1 |
| Fernández-Fernández, FJ | 1 |
| Murakami, K | 1 |
| Sato, R | 1 |
| Okimoto, T | 1 |
| Nasu, M | 1 |
| Fujioka, T | 1 |
| Kodama, M | 1 |
| Kagawa, J | 1 |
| Sato, S | 1 |
| Abe, H | 1 |
| Arita, T | 1 |
| Gorshkov, VA | 1 |
| Taeron, C | 1 |
| Sun, WH | 1 |
| Tsujii, M | 1 |
| Kawai, N | 1 |
| Kimura, A | 1 |
| Kakiuchi, Y | 1 |
| Yasumaru, S | 1 |
| Komori, M | 1 |
| Murata, H | 1 |
| Sasaki, Y | 1 |
| Kawano, S | 4 |
| Hori, M | 1 |
| Yildizdas, D | 1 |
| Yapicioglu, H | 1 |
| Yilmaz, HL | 1 |
| Chan, FK | 3 |
| Hung, LC | 1 |
| Suen, BY | 1 |
| Wu, JC | 2 |
| Lee, KC | 1 |
| Leung, VK | 2 |
| Hui, AJ | 1 |
| To, KF | 1 |
| Leung, WK | 3 |
| Wong, VW | 1 |
| Chung, SC | 4 |
| Biswas, K | 1 |
| Bandyopadhyay, U | 1 |
| Chattopadhyay, I | 1 |
| Varadaraj, A | 1 |
| Ali, E | 1 |
| Banerjee, RK | 1 |
| Kaviani, MJ | 1 |
| Hashemi, MR | 1 |
| Kazemifar, AR | 1 |
| Roozitalab, S | 1 |
| Mostaghni, AA | 1 |
| Merat, S | 1 |
| Alizadeh-Naini, M | 1 |
| Yarmohammadi, H | 1 |
| Yang, YX | 1 |
| Lewis, JD | 1 |
| Kwiecien, S | 2 |
| Pajdo, R | 2 |
| Drozdowicz, D | 2 |
| Ptak, A | 1 |
| Pawlik, M | 1 |
| Stachura, J | 4 |
| Pawlik, WW | 1 |
| Hahn, EG | 2 |
| Hiramoto, JS | 1 |
| Terdiman, JP | 1 |
| Norton, JA | 1 |
| Aguas, M | 1 |
| Pons, M | 1 |
| Barrera, N | 1 |
| Arboix, A | 1 |
| Eguileor, B | 1 |
| Delás, J | 1 |
| Fedele, E | 1 |
| Malfertheiner, P | 2 |
| Kirchner, T | 1 |
| Kist, M | 1 |
| Leodolter, A | 1 |
| Peitz, U | 3 |
| Strobel, S | 1 |
| Bohuschke, M | 1 |
| Gatz, G | 1 |
| Boixeda, D | 3 |
| Martín De Argila, C | 4 |
| Bermejo, F | 2 |
| López Sanromán, A | 1 |
| Hernández Ranz, F | 1 |
| García Plaza, A | 4 |
| Xia, HH | 1 |
| Lam, SK | 4 |
| Wong, WM | 2 |
| Hu, WH | 3 |
| Lai, KC | 3 |
| Wong, SH | 2 |
| Leung, SY | 1 |
| Yuen, ST | 1 |
| Wright, NA | 1 |
| Tashiro, M | 1 |
| Yoshikawa, I | 1 |
| Kume, K | 1 |
| Narita, R | 1 |
| Sugihara, Y | 1 |
| Otsuki, M | 1 |
| Kamiya, T | 2 |
| Kobayashi, Y | 2 |
| Misu, N | 2 |
| Hirako, M | 2 |
| Adachi, H | 1 |
| Nagao, T | 2 |
| Shikano, M | 1 |
| Matsuhisa, E | 1 |
| Kimura, G | 1 |
| Doucet, MY | 2 |
| Vrins, AA | 1 |
| Dionne, R | 1 |
| Alva, R | 4 |
| Ericsson, G | 1 |
| Orsini, JA | 1 |
| Haddock, M | 1 |
| Stine, L | 1 |
| Sullivan, EK | 1 |
| Rabuffo, TS | 1 |
| Smith, G | 1 |
| Uthaisaengsook, W | 1 |
| Sorba, G | 1 |
| Galli, U | 1 |
| Cena, C | 1 |
| Fruttero, R | 1 |
| Gasco, A | 1 |
| Morini, G | 3 |
| Adami, M | 2 |
| Coruzzi, G | 3 |
| Brenciaglia, MI | 1 |
| Dubini, F | 1 |
| Lau, JY | 2 |
| Yung, MY | 3 |
| Ng, EK | 2 |
| Jensen, DM | 1 |
| Shah, PJ | 1 |
| Gandhi, MS | 1 |
| Shah, MB | 1 |
| Goswami, SS | 1 |
| Santani, D | 1 |
| Romero-Gómez, M | 1 |
| Martínez-Delgado, C | 1 |
| Hergueta, P | 1 |
| Navarro, JM | 1 |
| Garrido-Serrano, A | 1 |
| Santos, O | 1 |
| Montojo, C | 1 |
| Sukhareva, GV | 1 |
| Tsaregorodtseva, TM | 1 |
| Trubitsina, IE | 1 |
| Serova, TI | 1 |
| Goncharenko, LS | 1 |
| Dolgova, NIu | 1 |
| Zarudnaia, SI | 1 |
| Kuz'mina, OS | 1 |
| Lopatina, IN | 1 |
| Manannikov, IV | 1 |
| Melik-Ogandzhanian, NB | 1 |
| Merritt, AM | 1 |
| Sanchez, LC | 2 |
| Burrow, JA | 1 |
| Church, M | 1 |
| Ludzia, S | 1 |
| Lee, SB | 1 |
| Park, SJ | 1 |
| Ryu, JK | 1 |
| Lee, JK | 1 |
| Kim, HJ | 3 |
| Bae, JS | 1 |
| Jung, HS | 1 |
| Park, SM | 1 |
| Farup, PG | 1 |
| O'Conner, MS | 1 |
| Steiner, JM | 1 |
| Roussel, AJ | 1 |
| Williams, DA | 1 |
| Meddings, JB | 1 |
| Pipers, F | 1 |
| Cohen, ND | 1 |
| Ramirez, RO | 1 |
| Roa, CC | 1 |
| Combe, B | 1 |
| Flipo, RM | 1 |
| Natale, G | 2 |
| Lazzeri, G | 1 |
| Lubrano, V | 1 |
| Colucci, R | 1 |
| Vassalle, C | 1 |
| Fornai, M | 1 |
| Blandizzi, C | 2 |
| Del Tacca, M | 2 |
| Gumurdulu, Y | 1 |
| Serin, E | 1 |
| Ozer, B | 1 |
| Kayaselcuk, F | 1 |
| Ozsahin, K | 1 |
| Cosar, AM | 1 |
| Gursoy, M | 1 |
| Gur, G | 1 |
| Yilmaz, U | 1 |
| Boyacioglu, S | 1 |
| Helander, HF | 2 |
| Poorkhalkali, N | 1 |
| Batista, LM | 1 |
| de Almeida, AB | 2 |
| de Pietro Magri, L | 1 |
| Toma, W | 2 |
| Calvo, TR | 1 |
| Vilegas, W | 1 |
| Souza Brito, AR | 1 |
| Asaka, M | 7 |
| Neafsey, P | 1 |
| Mizuki, A | 1 |
| Tatemichi, M | 1 |
| Nishiya, H | 1 |
| Fukui, K | 1 |
| Hayashi, T | 2 |
| Tsukada, N | 1 |
| Nagata, H | 1 |
| Ishii, H | 9 |
| Tanaka, A | 2 |
| Hayashi, Y | 1 |
| Kubo, Y | 1 |
| Watanabe, T | 4 |
| Hamaguchi, M | 1 |
| Shiba, M | 1 |
| Fujiwara, Y | 4 |
| Arakawa, T | 10 |
| Tiesmeier, J | 1 |
| Hinner, H | 1 |
| Kraus, J | 1 |
| Schuppert, F | 1 |
| Kyoi, T | 1 |
| Kitazawa, S | 1 |
| Tajima, K | 1 |
| Zhang, X | 1 |
| Ukai, Y | 1 |
| Lee, SY | 1 |
| Kim, JJ | 1 |
| Lee, JH | 1 |
| Kim, YH | 1 |
| Rhee, PL | 1 |
| Paik, SW | 1 |
| Rhee, JC | 1 |
| Topaloglu, U | 1 |
| Muftuoglu, T | 1 |
| Akturk, Z | 1 |
| Ekinci, H | 1 |
| Peker, O | 1 |
| Unalmiser, S | 1 |
| Masaoka, T | 2 |
| SuzukiKurabayashi, HK | 1 |
| Kamiya, AG | 1 |
| Kotaira, J | 1 |
| Akbulut, S | 1 |
| Yavuz, B | 1 |
| Köseoğlu, T | 1 |
| Gököz, A | 1 |
| Saritaş, U | 1 |
| Joh, T | 5 |
| Takahashi, N | 1 |
| Kaneko, H | 2 |
| Sasaki, M | 1 |
| Kataoka, H | 1 |
| Watanabe, K | 3 |
| Sobue, M | 1 |
| Suzuki, H | 6 |
| Nomura, T | 2 |
| Ohara, H | 1 |
| Itoh, M | 5 |
| Ke, MY | 2 |
| Befrits, R | 1 |
| Sjöstedt, S | 2 |
| Tour, R | 1 |
| Leijonmarck, CE | 1 |
| Hedenborg, L | 1 |
| Backman, M | 1 |
| Huang, B | 3 |
| Amer, F | 1 |
| Christopoulos, NG | 1 |
| Enns, R | 1 |
| Arkkila, PE | 1 |
| Seppälä, K | 1 |
| Kosunen, TU | 1 |
| Sipponen, P | 2 |
| Mäkinen, J | 1 |
| Rautelin, H | 1 |
| Färkkilä, M | 1 |
| Rodríguez, JA | 4 |
| Theoduloz, C | 2 |
| Sánchez, M | 2 |
| Yáñez, T | 2 |
| Razmilic, I | 2 |
| Schmeda-Hirschmann, G | 4 |
| Manes, G | 1 |
| Pieramico, O | 1 |
| Perri, F | 1 |
| Vaira, D | 1 |
| Giardullo, N | 1 |
| Romano, M | 1 |
| Nardone, G | 1 |
| Balzano, A | 1 |
| Dharmani, P | 2 |
| Mishra, PK | 2 |
| Singh Chauhan, V | 1 |
| McClure, SR | 4 |
| White, GW | 3 |
| Sifferman, RL | 4 |
| Bernard, W | 3 |
| Vrins, A | 1 |
| Holste, JE | 5 |
| Fleishman, C | 3 |
| Cramer, LG | 3 |
| Hughes, FE | 2 |
| Ahmed, AF | 1 |
| Constable, PD | 1 |
| Misk, NA | 1 |
| Yamaguchi, Y | 1 |
| Katsumi, N | 1 |
| Tauchi, M | 1 |
| Toki, M | 1 |
| Nakamura, K | 1 |
| Aoki, K | 1 |
| Miura, M | 1 |
| Morozumi, K | 1 |
| Ishida, H | 1 |
| Takahashi, S | 2 |
| García-Altés, A | 1 |
| Rota, R | 1 |
| Barenys, M | 1 |
| Abad, A | 1 |
| Moreno, V | 1 |
| Pons, JM | 1 |
| Piqué, JM | 1 |
| Si, JM | 2 |
| Cao, Q | 1 |
| Wu, JG | 2 |
| Cao, H | 1 |
| Wang, MW | 1 |
| Sun, LX | 1 |
| Ikejima, T | 1 |
| Hu, ZQ | 1 |
| Zhao, WH | 1 |
| Gawrońska-Szklarz, B | 1 |
| Wrześniewska, J | 1 |
| Starzyńska, T | 1 |
| Pawlik, A | 1 |
| Safranow, K | 1 |
| Ferenc, K | 1 |
| Droździk, M | 1 |
| Chauhan, VS | 1 |
| Adeyemi, EO | 1 |
| Bastaki, SA | 1 |
| Chandranath, IS | 1 |
| Hasan, MY | 1 |
| Fahim, M | 1 |
| Adem, A | 1 |
| Akimoto, M | 1 |
| Hashimoto, H | 1 |
| Shigemoto, M | 1 |
| Maeda, A | 1 |
| Yamashita, K | 1 |
| Canbakan, B | 1 |
| Mizrak, D | 1 |
| Keven, K | 1 |
| Kaygusuz, G | 1 |
| Kutlay, S | 1 |
| Sengul, S | 1 |
| Erbay, B | 1 |
| Horvat, D | 1 |
| Vcev, A | 1 |
| Soldo, I | 1 |
| Timarac, J | 1 |
| Dmitrović, B | 1 |
| Misević, T | 1 |
| Ivezić, Z | 1 |
| Kraljik, N | 1 |
| Kato, H | 1 |
| Sugimoto, N | 1 |
| Nagao, Y | 1 |
| Seto, N | 1 |
| Hongo, H | 1 |
| Kajikawa, H | 1 |
| Isozaki, Y | 1 |
| Shimozawa, M | 1 |
| Yoshida, N | 3 |
| Ishizaki, T | 1 |
| Yoshikawa, T | 3 |
| Poonam, D | 1 |
| Vinay, CS | 1 |
| Gautam, P | 1 |
| Bracke, A | 1 |
| Nijsten, T | 1 |
| Vandermaesen, J | 1 |
| Meuleman, L | 1 |
| Lambert, J | 1 |
| Sakai, G | 1 |
| Hibi, T | 3 |
| Güliter, S | 1 |
| Keleş, H | 1 |
| Ozkurt, ZN | 1 |
| Cengiz, DU | 1 |
| Kolukisa, E | 1 |
| Glazunov, VK | 1 |
| Rumiantsev, GV | 1 |
| Buka, GIu | 1 |
| Brikman, AE | 1 |
| Sumishevskiĭ, EV | 1 |
| Kondrat'eva, AB | 1 |
| Lester, GD | 1 |
| Smith, RL | 1 |
| Robertson, ID | 1 |
| Agustí-Escasany, A | 1 |
| Vallano-Ferraz, A | 1 |
| Arisawa, T | 4 |
| Harata, M | 1 |
| Kamiya, Y | 1 |
| Shibata, T | 1 |
| Nagasaka, M | 1 |
| Nakamura, M | 4 |
| Fujita, H | 1 |
| Hasegawa, S | 1 |
| Mizuno, T | 1 |
| Tahara, T | 1 |
| Nakano, H | 1 |
| Stämpfli, H | 1 |
| Oliver, OE | 1 |
| Lou, LX | 1 |
| Geng, B | 1 |
| Yu, F | 1 |
| Pan, CS | 1 |
| Qi, YF | 1 |
| Ke, Y | 1 |
| Wang, X | 1 |
| Tang, CS | 1 |
| Ye, BD | 1 |
| Cheon, JH | 1 |
| Choi, KD | 1 |
| Kim, SG | 3 |
| Kim, JS | 1 |
| Song, IS | 1 |
| Hsieh, JS | 1 |
| Howng, SL | 1 |
| Huang, TJ | 1 |
| Wang, JY | 2 |
| Chen, FM | 1 |
| Hamaishi, K | 1 |
| Kojima, R | 2 |
| Ito, M | 6 |
| Malairajan, P | 1 |
| Gopalakrishnan, G | 1 |
| Narasimhan, S | 1 |
| Veni, KJ | 1 |
| Kavimani, S | 1 |
| Qian, Y | 1 |
| Zhu, YF | 1 |
| Sun, KK | 1 |
| Deng, YY | 1 |
| Chen, K | 1 |
| Wang, LJ | 1 |
| Liu, WL | 1 |
| Bell, RJ | 1 |
| Mogg, TD | 1 |
| Kingston, JK | 1 |
| Levin, B | 1 |
| Sacks, R | 1 |
| McKeever, JM | 1 |
| McKeever, KH | 1 |
| Albeirci, JM | 1 |
| Gordon, ME | 1 |
| Manso Filho, HC | 1 |
| Lemos, M | 2 |
| de Barros, MP | 1 |
| Sousa, JP | 1 |
| da Silva Filho, AA | 1 |
| Bastos, JK | 1 |
| White, G | 1 |
| Sifferman, R | 1 |
| Murray, MJ | 3 |
| Comunello, E | 2 |
| Noldin, VF | 2 |
| Filho, VC | 1 |
| Diukov, IV | 1 |
| Deng, C | 1 |
| Luo, WS | 1 |
| Li, GX | 1 |
| Koussoulas, V | 1 |
| Vassiliou, S | 1 |
| Spyridaki, E | 1 |
| Demonakou, M | 1 |
| Vaki, I | 1 |
| Barbatzas, C | 1 |
| Giamarellou, H | 1 |
| Giamarellos-Bourboulis, EJ | 1 |
| Berenguer, B | 2 |
| Trabadela, C | 1 |
| Sánchez-Fidalgo, S | 1 |
| Quílez, A | 1 |
| Miño, P | 1 |
| De la Puerta, R | 1 |
| Martín-Calero, MJ | 1 |
| Ishikawa, T | 1 |
| Kokura, S | 1 |
| Bauri, AK | 2 |
| Guha, RK | 1 |
| Aydinli, B | 1 |
| Yildirgan, MI | 1 |
| Oztürk, G | 1 |
| Atamanalap, SS | 1 |
| Polat, KY | 1 |
| Başoğlu, M | 1 |
| Gündoğdu, C | 1 |
| Süleyman, H | 2 |
| Kiziltunç, A | 1 |
| Gürsan, N | 1 |
| Oren, D | 1 |
| Bandivdeker, AH | 1 |
| Javsicas, LH | 1 |
| Desai, JC | 1 |
| Sanyal, SM | 1 |
| Goo, T | 1 |
| Benson, AA | 1 |
| Bodian, CA | 1 |
| Miller, KM | 1 |
| Cohen, LB | 1 |
| Aisenberg, J | 1 |
| Monache, FD | 1 |
| Hashiguchi, M | 1 |
| Yamauchi, N | 1 |
| Uchikura, T | 1 |
| Mochizuki, M | 1 |
| Bauters, TG | 1 |
| Verlooy, J | 1 |
| Robays, H | 1 |
| Laureys, G | 1 |
| Jonaitis, L | 1 |
| Kiudelis, G | 1 |
| Kupcinskas, L | 1 |
| Bhattacharya, S | 1 |
| Lee, CW | 1 |
| Rickman, B | 1 |
| Rogers, AB | 1 |
| Ge, Z | 1 |
| Wang, TC | 1 |
| Fox, JG | 1 |
| Elke, G | 1 |
| Schädler, D | 1 |
| Zick, G | 1 |
| Scholz, J | 1 |
| Weiler, N | 1 |
| Misiewicz, JJ | 2 |
| Radecki, T | 1 |
| Bodemar, G | 1 |
| Walan, A | 9 |
| Mattsson, H | 1 |
| Andersson, K | 1 |
| Larsson, H | 1 |
| Yamamoto, O | 1 |
| Okada, Y | 1 |
| Okabe, S | 16 |
| Schepp, W | 4 |
| Hamajima, E | 1 |
| Sugiyama, S | 2 |
| Hoshino, H | 2 |
| Goto, H | 7 |
| Tsukamoto, Y | 7 |
| Ozawa, T | 2 |
| Spencer, CM | 1 |
| Faulds, D | 2 |
| Schmassmann, A | 3 |
| Tarnawski, A | 4 |
| Peskar, BM | 1 |
| Varga, L | 2 |
| Flogerzi, B | 2 |
| Halter, F | 4 |
| Villanueva, C | 1 |
| Balanzó, J | 2 |
| Torras, X | 1 |
| Sáinz, S | 1 |
| Soriano, G | 1 |
| González, D | 1 |
| Vilardell, F | 2 |
| Swain, P | 1 |
| Grandi, D | 1 |
| Arcari, ML | 1 |
| Bertaccini, G | 3 |
| Onodera, S | 1 |
| Shibata, M | 1 |
| Tanaka, M | 5 |
| Inaba, N | 1 |
| Yamaura, T | 1 |
| Ohnishi, H | 1 |
| Folwaczny, C | 1 |
| Higashi, T | 1 |
| Mukuda, T | 1 |
| Imaizumi, T | 1 |
| Tatsumi, T | 1 |
| Miura, N | 1 |
| Miyajima, K | 1 |
| Fukuda, M | 2 |
| Noguchi, M | 1 |
| Hisano, K | 1 |
| Ochiai, T | 1 |
| Fujita, N | 2 |
| Yabana, T | 1 |
| Kurokawa, I | 1 |
| Yachi, A | 1 |
| Katoh, M | 1 |
| Kudoh, M | 1 |
| Kagaya, H | 4 |
| Katagiri, M | 3 |
| Takeda, H | 4 |
| Furuta, T | 3 |
| Futami, H | 3 |
| Arai, H | 3 |
| Hanai, H | 3 |
| Kaneko, E | 5 |
| Takimoto, T | 2 |
| Ido, K | 2 |
| Taniguchi, Y | 2 |
| Satoh, K | 2 |
| Saifuku, K | 2 |
| Kihira, K | 3 |
| Yoshida, Y | 4 |
| Kimura, K | 3 |
| Nakata, H | 1 |
| Itoh, H | 1 |
| Nishioka, S | 1 |
| Shimoyama, T | 4 |
| Munakata, A | 2 |
| Mizuki, I | 1 |
| Akagi, T | 1 |
| Fukuda, S | 2 |
| Ohkawa, K | 1 |
| Aisawa, T | 1 |
| Sakata, Y | 1 |
| Fukushi, M | 1 |
| Fukuda, Y | 2 |
| Yamamoto, I | 1 |
| Okui, M | 1 |
| Tonokatsu, Y | 1 |
| Otani, Y | 1 |
| Kitajima, M | 1 |
| Sugiyama, M | 1 |
| Watanabe, Y | 1 |
| Aoki, T | 2 |
| Sakaguchi, M | 2 |
| Ashida, K | 4 |
| Umegaki, E | 1 |
| Miyoshi, H | 1 |
| Katsu, K | 2 |
| Okai, T | 2 |
| Sawabu, N | 2 |
| Songür, Y | 1 |
| Motoo, Y | 2 |
| Watanabe, H | 3 |
| Obara, K | 1 |
| Kuwana, T | 1 |
| Ishihata, R | 1 |
| Kondo, Y | 1 |
| Ejiri, Y | 1 |
| Yokogi, K | 1 |
| Okubo, Y | 1 |
| Ajima, H | 1 |
| Mukai, S | 1 |
| Kasukawa, R | 1 |
| Hase, S | 5 |
| Niwa, Y | 2 |
| Hayakawa, T | 1 |
| Yoshikane, H | 2 |
| Komuro, Y | 2 |
| Ishii, K | 1 |
| Miyake, Y | 1 |
| Tanabe, S | 2 |
| Oida, M | 1 |
| Saigenji, K | 2 |
| Fujino, MA | 1 |
| Morozumi, A | 1 |
| Kobayashi, K | 7 |
| Ueda, F | 1 |
| Suzuki, Y | 6 |
| Uchida, N | 1 |
| Tachikawa, H | 1 |
| Sano, S | 1 |
| Ohtsuka, H | 1 |
| Yamamoto, Y | 1 |
| Fukuda, T | 3 |
| Shimizu, Y | 1 |
| Ohtani, K | 1 |
| Tamada, F | 1 |
| Hirohata, S | 1 |
| Honsako, Y | 1 |
| Kumada, H | 1 |
| Kashio, Y | 1 |
| Konishi, M | 1 |
| Fujio, Y | 1 |
| Yamamoto, T | 4 |
| Miura, J | 1 |
| Miyamoto, M | 1 |
| Hashimoto, M | 2 |
| Hoshihara, Y | 3 |
| Tanaka, T | 2 |
| Kimura, T | 2 |
| Iguchi, D | 2 |
| Sugawara, K | 2 |
| Fukuchi, S | 2 |
| Takemoto, T | 4 |
| Asaki, S | 2 |
| Sato, A | 1 |
| Sakurada, H | 1 |
| Takeda, T | 1 |
| Hongo, M | 1 |
| Toyota, T | 1 |
| Takiuchi, H | 1 |
| Egashira, Y | 1 |
| Ito, G | 1 |
| Nakagawara, M | 1 |
| Watanabe, F | 1 |
| Ooi, S | 1 |
| Nawano, M | 1 |
| Hoshino, E | 1 |
| Umeda, N | 1 |
| Sano, J | 1 |
| Miki, K | 1 |
| Yahagi, N | 1 |
| Oka, M | 1 |
| Kimura, M | 1 |
| Miyashita, H | 1 |
| Mine, T | 3 |
| Yasuda, H | 1 |
| Akimoto, K | 1 |
| Katoaka, A | 1 |
| Mashima, H | 1 |
| Tajima, A | 1 |
| Fukujin, H | 1 |
| Tsuchida, T | 3 |
| Takano, T | 1 |
| Nagasawa, J | 1 |
| Ohashi, T | 1 |
| Sakata, J | 1 |
| Haraguchi, Y | 1 |
| Eto, T | 1 |
| Aoyama, N | 1 |
| Kinoshita, Y | 2 |
| Misaki, F | 1 |
| Himeno, S | 1 |
| Kasuga, M | 1 |
| Chiba, T | 1 |
| Ogoshi, K | 1 |
| Kato, T | 4 |
| Sakagawa, T | 1 |
| Roberts, SJ | 1 |
| Bateman, DN | 1 |
| Eriksson, S | 5 |
| Rikner, L | 1 |
| Carlsson, R | 1 |
| Ponce, J | 1 |
| Nos, P | 1 |
| Avner, DL | 1 |
| Movva, R | 1 |
| Nelson, KJ | 1 |
| McFarland, M | 1 |
| Berry, W | 1 |
| Erfling, W | 1 |
| Kori, Y | 1 |
| Choné, L | 1 |
| Fléjou, JF | 1 |
| Grignon, Y | 1 |
| Bigard, MA | 3 |
| Labenz, J | 8 |
| Stolte, M | 8 |
| Blum, AL | 3 |
| Jorias, I | 1 |
| Leverkus, F | 2 |
| Sollböhmer, M | 1 |
| Bertrams, J | 2 |
| Börsch, G | 7 |
| Kohli, Y | 2 |
| Ito, S | 2 |
| Hirai, M | 1 |
| Andersson, T | 1 |
| Hässle, A | 1 |
| Hotz, J | 1 |
| Plein, K | 1 |
| Schönekäs, H | 1 |
| Rose, K | 1 |
| Park, KN | 2 |
| Hahm, JS | 1 |
| Michel, P | 2 |
| Duhamel, C | 1 |
| Bazin, B | 1 |
| Raoul, JL | 1 |
| Person, B | 1 |
| Legoux, JL | 1 |
| Sallerin, V | 1 |
| Colin, R | 2 |
| Witzel, L | 4 |
| Gütz, H | 1 |
| Hüttemann, W | 4 |
| Hudson, N | 2 |
| Brydon, WG | 1 |
| Eastwood, MA | 1 |
| Ferguson, A | 1 |
| Palmer, KR | 1 |
| Santos, AM | 2 |
| Hanke, S | 1 |
| Douglass, TG | 1 |
| Sarfeh, IJ | 2 |
| Agrawal, NM | 3 |
| Ottervanger, JP | 1 |
| Stricker, BH | 1 |
| Kappelle, JW | 1 |
| Claas, FH | 1 |
| Harris, A | 1 |
| Ling, TK | 1 |
| Li, MK | 1 |
| Cheng, AF | 1 |
| Li, AK | 1 |
| Rakic, S | 1 |
| Pesko, P | 1 |
| Dunjic, M | 1 |
| Gerzic, Z | 1 |
| Adamek, RJ | 3 |
| Freitag, M | 2 |
| Opferkuch, W | 3 |
| Rühl, GH | 3 |
| Wegener, M | 3 |
| Segami, T | 3 |
| Tsukahara, T | 1 |
| Inaguma, K | 1 |
| Rantala, A | 1 |
| Ovaska, J | 1 |
| Hunt, RH | 3 |
| Cederberg, C | 1 |
| Dent, J | 2 |
| Howden, C | 1 |
| Marks, IN | 2 |
| Rune, S | 1 |
| Walt, RP | 1 |
| Atherton, JC | 1 |
| Kirk, GE | 1 |
| Hawkey, CK | 1 |
| Spiller, RC | 2 |
| Tsukimi, Y | 3 |
| Maruoka, A | 1 |
| Chijiiwa, Y | 1 |
| Nawata, H | 1 |
| Szymanski, C | 1 |
| Pfaffenbach, B | 1 |
| Ricken, D | 1 |
| Sheptulin, AA | 1 |
| Florent, C | 1 |
| Koyama, T | 1 |
| Ohyama, T | 1 |
| Mizuguchi, M | 1 |
| Tokunaga, O | 1 |
| Gherardi, G | 1 |
| Marveggio, C | 1 |
| Nishida, A | 1 |
| Takinami, Y | 1 |
| Yuki, H | 1 |
| Kobayashi, A | 1 |
| Akuzawa, S | 1 |
| Kamato, T | 1 |
| Ito, H | 2 |
| Yamano, M | 1 |
| Nagakura, Y | 1 |
| Miyata, K | 1 |
| Alarcón de la Lastra, C | 3 |
| Martín, MJ | 3 |
| La Casa, C | 1 |
| Motilva, V | 2 |
| Ishihara, K | 1 |
| Ichikawa, T | 1 |
| Ohara, S | 1 |
| Hotta, K | 1 |
| Iwasaki, A | 1 |
| Miyazawa, K | 2 |
| Kawamura, Y | 1 |
| Sakai, Y | 1 |
| Tashiro, Y | 1 |
| Ito, K | 1 |
| Arakawa, Y | 1 |
| Matsuo, Y | 2 |
| Giraud, V | 1 |
| Sée, J | 1 |
| Biour, M | 1 |
| Pras, V | 1 |
| Grangé, JD | 1 |
| Bodin, F | 1 |
| Kato, S | 4 |
| Fujii, T | 1 |
| Nakano, K | 1 |
| Naganuma, H | 1 |
| Nakagawa, H | 2 |
| Pérez Flores, R | 1 |
| García Molinero, MJ | 1 |
| Herrero Quirós, C | 1 |
| Blasco Colmenarejo, MM | 1 |
| Caneiro Alcubilla, E | 1 |
| García-Rayo Somoza, M | 1 |
| Cabot Lozano, A | 1 |
| Krappweis, J | 1 |
| Petereit, G | 1 |
| Schentke, KU | 1 |
| Kirch, W | 1 |
| Karita, M | 1 |
| Morshed, MG | 1 |
| Ouchi, K | 1 |
| Okita, K | 1 |
| Sørensen, HT | 1 |
| Rasmussen, HH | 1 |
| Balslev, I | 1 |
| Boesby, S | 2 |
| Boné, J | 1 |
| Kruse, A | 1 |
| Rasmussen, SN | 1 |
| Bardhan, KD | 7 |
| Ahlberg, J | 1 |
| Hislop, WS | 2 |
| Lindholmer, C | 1 |
| Long, RG | 1 |
| Morgan, AG | 1 |
| Smith, PM | 2 |
| Stig, R | 1 |
| Wormsley, KG | 1 |
| al-Assi, MT | 1 |
| Genta, RM | 1 |
| Graham, DY | 2 |
| Gerber, HA | 1 |
| Sanner, M | 1 |
| Matsukura, H | 1 |
| Masuda, M | 1 |
| Kawaguchi, K | 1 |
| Uchida, A | 1 |
| Kamishiro, T | 1 |
| Uchida, K | 1 |
| Mitsuma, T | 1 |
| Morise, K | 1 |
| Nagai, H | 3 |
| Furusawa, A | 1 |
| Nakada, K | 1 |
| Maeda, Y | 1 |
| Netchvolodoff, CV | 1 |
| Pounder, RE | 2 |
| Fraser, AG | 1 |
| Arens, MJ | 1 |
| Mizunashi, K | 1 |
| Furukawa, Y | 1 |
| Katano, K | 1 |
| Abe, K | 1 |
| Kasano, T | 1 |
| Bader, JP | 2 |
| Delchier, JC | 1 |
| Rehner, M | 3 |
| Brunner, G | 7 |
| Harke, U | 2 |
| Lemaire, M | 2 |
| Bommelaer, G | 1 |
| Rambaud, JC | 1 |
| Dupas, JL | 1 |
| Verwaerd, JC | 1 |
| Seifert, E | 1 |
| Lazaratos, S | 1 |
| Kashimura, H | 1 |
| Nakahara, A | 1 |
| Fukutomi, H | 1 |
| Osuga, T | 1 |
| Miyauchi, T | 1 |
| Goto, K | 1 |
| Yamaguchi, T | 1 |
| Aihara, K | 1 |
| Yamada, S | 1 |
| Narita, S | 1 |
| Kogi, K | 1 |
| Imoto, I | 1 |
| Suzuki, S | 1 |
| Lesur, G | 1 |
| Paupard, T | 1 |
| Turner, L | 1 |
| Bergemer, AM | 1 |
| Parlier, H | 1 |
| Dupuy, P | 1 |
| Shi, GY | 1 |
| Sakaki, N | 3 |
| Tamura, K | 1 |
| Murai, M | 1 |
| Kimura, S | 1 |
| Uchida, T | 2 |
| Takagi, K | 1 |
| Inoue, K | 1 |
| Bour, B | 1 |
| Pariente, EA | 1 |
| Hamelin, B | 1 |
| Garcia, E | 1 |
| Raedsch, R | 1 |
| Imai, S | 3 |
| Koike, K | 1 |
| Ahmed, W | 1 |
| Dallera, F | 1 |
| Gendarini, A | 1 |
| Scanzi, G | 1 |
| Horie, S | 1 |
| Yano, S | 1 |
| Protzer, U | 1 |
| Holtermüller, KH | 1 |
| Oshitani, N | 1 |
| Yamada, T | 1 |
| Arnold, R | 3 |
| Hennig, U | 1 |
| Fuchs, W | 1 |
| Gonthier, R | 1 |
| Bouchou, K | 1 |
| Guy, C | 1 |
| Cathebras, P | 1 |
| Rousset, H | 1 |
| González Carro, P | 2 |
| Toro, H | 1 |
| Li, H | 1 |
| Tillenburg, B | 2 |
| Köhl, H | 1 |
| Becker, T | 1 |
| Diehl, HG | 1 |
| Grosso, C | 1 |
| Rossi, A | 1 |
| Gambitta, P | 1 |
| Bini, M | 1 |
| Zanasi, G | 1 |
| Pirone, Z | 1 |
| Arcidiacono, R | 1 |
| Tanoue, K | 1 |
| Artal, A | 1 |
| Blás, JM | 1 |
| Arroyo, MT | 2 |
| Lopez-Zaborras, J | 1 |
| Sáinz, R | 2 |
| Treiber, G | 2 |
| Bertoni, G | 1 |
| Sassatelli, R | 1 |
| Nigrisoli, E | 1 |
| Tansini, P | 1 |
| Bianchi, G | 1 |
| Della Casa, G | 1 |
| Bagni, A | 1 |
| Bedogni, G | 1 |
| Davis, S | 1 |
| Blomgren, K | 1 |
| Alván, G | 1 |
| Tari, A | 1 |
| Hamada, M | 1 |
| Kamiyasu, T | 1 |
| Fukino, Y | 1 |
| Sumii, M | 1 |
| Haruma, K | 1 |
| Sumii, K | 1 |
| Inoue, M | 1 |
| Kajiyama, G | 2 |
| Costable, JM | 1 |
| McKinley, MJ | 1 |
| van der Hulst, RW | 2 |
| Keller, JJ | 1 |
| Rauws, EA | 1 |
| Tytgat, GN | 2 |
| Nozue, C | 1 |
| Amagase, K | 2 |
| Yamamoto, H | 1 |
| Jaspersen, D | 1 |
| Keerl, R | 1 |
| Weber, R | 1 |
| Huppmann, A | 1 |
| Hammar, CH | 1 |
| Draf, W | 1 |
| Santander, C | 2 |
| Grávalos, RG | 1 |
| Gómez-Cedenilla, A | 1 |
| Cantero, J | 1 |
| Pajares, JM | 2 |
| Ebina, K | 1 |
| Fujii, K | 1 |
| Chiba, H | 1 |
| Oda, M | 2 |
| Inoue, J | 1 |
| Ito, T | 1 |
| Tsuchiya, M | 1 |
| Bayerdörffer, E | 4 |
| Miehlke, S | 2 |
| Lehn, N | 3 |
| Mannes, GA | 2 |
| Höchter, W | 2 |
| Weingart, J | 2 |
| Klann, H | 2 |
| Sommer, A | 2 |
| Heldwein, W | 1 |
| Hatz, R | 2 |
| Simon, T | 2 |
| Bolle, KH | 2 |
| Bästlein, E | 2 |
| Meining, A | 3 |
| Ruckdeschel, G | 1 |
| van Rensburg, CJ | 2 |
| Louw, JA | 1 |
| Girdwood, AH | 1 |
| Simjee, AE | 1 |
| Bulgakov, SA | 1 |
| Lee, M | 1 |
| Kallal, SM | 1 |
| Feldman, M | 1 |
| Fitton, A | 1 |
| Wiseman, L | 1 |
| Kato, M | 3 |
| Kudo, M | 3 |
| Sukegawa, M | 2 |
| Koshiyama, T | 1 |
| Nishikawa, K | 3 |
| Hokari, K | 3 |
| Wada, K | 2 |
| Kamisaki, Y | 2 |
| Kitano, M | 2 |
| Kishimoto, Y | 2 |
| Nakamoto, K | 2 |
| Itoh, T | 2 |
| Valenzuela, JE | 1 |
| Kogut, DG | 2 |
| McCullough, AJ | 1 |
| Colón Pagán, JR | 1 |
| Shah, U | 1 |
| Whipple, J | 1 |
| Gilde, LR | 1 |
| Simon, TJ | 1 |
| Murakami, M | 1 |
| Saita, H | 2 |
| Moreno, JA | 1 |
| Carpintero, P | 1 |
| Hermida, C | 1 |
| Lara, S | 1 |
| García Grávalos, R | 1 |
| Reynaert, H | 1 |
| Fernandes, E | 1 |
| Bourgain, C | 1 |
| Smekens, L | 1 |
| Devis, G | 1 |
| Rubin, CE | 1 |
| Moshkowitz, M | 1 |
| Konikoff, FM | 1 |
| Peled, Y | 1 |
| Brill, S | 1 |
| Hallak, A | 1 |
| Tiomny, E | 1 |
| Santo, M | 1 |
| Bujanover, Y | 1 |
| Gilat, T | 1 |
| Balaban, DH | 1 |
| Duckworth, CW | 1 |
| Peura, DA | 1 |
| Baba, S | 2 |
| Suzuki, T | 2 |
| Nonaka, Y | 1 |
| Hirano, M | 1 |
| Miyazawa, I | 1 |
| Ishikawa, F | 1 |
| Kakiuchi, T | 1 |
| Caselli, M | 2 |
| Trevisani, L | 2 |
| Tursi, A | 2 |
| Sartori, S | 2 |
| Ruina, M | 2 |
| Luzzi, I | 1 |
| Gaudenzi, P | 1 |
| Alvisi, V | 2 |
| Gasbarrini, G | 2 |
| Ardizzone, S | 1 |
| Bianchi Porro, G | 6 |
| La Corte, R | 1 |
| Bajocchi, G | 1 |
| Trotta, F | 1 |
| Lerang, F | 1 |
| Moum, B | 1 |
| Haug, JB | 1 |
| Tolås, P | 1 |
| Breder, O | 1 |
| Aubert, E | 1 |
| Høie, O | 1 |
| Søberg, T | 1 |
| Flaaten, B | 1 |
| Farup, P | 1 |
| Berge, T | 1 |
| Axon, AT | 1 |
| O'Moráin, CA | 1 |
| Crowe, JP | 2 |
| Beattie, AD | 1 |
| Thompson, RP | 1 |
| Hollanders, FD | 1 |
| Baron, JH | 1 |
| Lynch, DA | 1 |
| Dixon, MF | 1 |
| Tompkins, DS | 1 |
| Birrell, H | 1 |
| Gillon, KR | 1 |
| Kung, NN | 1 |
| Yuen, NW | 1 |
| Ng, PW | 1 |
| Wong, KC | 1 |
| Chung, EC | 1 |
| Lim, BH | 1 |
| Choi, CH | 1 |
| Li, TH | 1 |
| Ma, HC | 1 |
| Kwok, SP | 1 |
| Lee, YT | 1 |
| Chan, LY | 1 |
| Khuroo, MS | 1 |
| Yattoo, GN | 1 |
| Shah, AA | 1 |
| Sodi, JS | 1 |
| Schaffalitzky de Muckadell, OB | 1 |
| Havelund, T | 2 |
| Harling, H | 1 |
| Snel, P | 2 |
| Vreeburg, EM | 1 |
| Fernström, P | 2 |
| Hasselgren, G | 2 |
| Lind, T | 2 |
| Lundell, L | 1 |
| Aadland, E | 1 |
| Efskind, P | 1 |
| Falk, A | 1 |
| Hyltander, A | 1 |
| Söderlund, C | 1 |
| Berstad, A | 1 |
| Leusing, C | 1 |
| Hizawa, K | 1 |
| Satou, H | 1 |
| Aoyagi, K | 2 |
| Eguchi, K | 1 |
| Fujishima, M | 2 |
| Arroyo Villarino, MT | 1 |
| Lanas Arbeloa, A | 2 |
| Esteva Díaz, F | 1 |
| Ortego Fernández de Retana, J | 1 |
| Sainz Samitier, R | 1 |
| Gupta, VK | 1 |
| Dhar, A | 1 |
| Srinivasan, S | 1 |
| Rattan, A | 1 |
| Sharma, MP | 1 |
| Munkel, L | 1 |
| French, L | 1 |
| Skála, I | 1 |
| Marecková, O | 1 |
| Vítko, S | 1 |
| Matl, I | 1 |
| Lácha, J | 1 |
| Kobler, E | 1 |
| Werth, B | 1 |
| Wüst, W | 1 |
| Reinhart, WH | 1 |
| La Casa, M | 1 |
| López, A | 1 |
| Krishnamurthy, S | 1 |
| Dayal, Y | 1 |
| Evangelista, S | 2 |
| Maconi, G | 2 |
| Lazzaroni, M | 5 |
| Sangaletti, O | 1 |
| Bargiggia, S | 2 |
| Vago, L | 1 |
| Haven, ML | 1 |
| Eichorn, ES | 1 |
| Zhang, D | 1 |
| Eagleson, J | 1 |
| Hickey, GJ | 1 |
| Bobrzyński, A | 1 |
| Gedliczka, O | 1 |
| Konturek, S | 1 |
| Budzyński, A | 1 |
| Gabryelewicz, A | 2 |
| Laszewicz, W | 1 |
| Dzieniszewski, J | 1 |
| Ciok, J | 1 |
| Marlicz, K | 1 |
| Bielecki, D | 1 |
| Popiela, T | 1 |
| Legutko, J | 1 |
| Knapik, Z | 1 |
| Poniewierka, E | 1 |
| Kawasaki, H | 1 |
| Cammarota, G | 2 |
| Cannizzaro, O | 2 |
| Papa, A | 2 |
| Cuoco, L | 1 |
| Cianci, R | 2 |
| Fedeli, P | 1 |
| Fedeli, G | 1 |
| Suzuki, M | 4 |
| Mori, M | 3 |
| Miyayama, A | 1 |
| Iwai, N | 1 |
| Tsunematsu, N | 1 |
| Oonuki, M | 1 |
| Huber, F | 1 |
| Fischer, G | 1 |
| Nagasawa, Y | 1 |
| Tatsuta, M | 2 |
| Iishi, H | 2 |
| Ishiguro, S | 1 |
| Karrasch, JA | 1 |
| Szczepañski, L | 1 |
| Walker, DG | 1 |
| Barkun, A | 1 |
| Tulassay, Z | 2 |
| Juhász, L | 1 |
| Rácz, I | 1 |
| Howard, JM | 1 |
| Boixeda de Miquel, D | 2 |
| Kusuhara, H | 1 |
| Hirayama, F | 1 |
| Matsuyuki, H | 1 |
| Hisadome, M | 1 |
| Ikeda, Y | 1 |
| Shindo, K | 1 |
| Machida, M | 1 |
| Fukumura, M | 1 |
| Koide, K | 1 |
| Yamazaki, R | 1 |
| Glaser, J | 1 |
| Hein, J | 1 |
| Daikeler, R | 1 |
| Weithofer, G | 1 |
| Vieth, M | 1 |
| Schmidt, M | 1 |
| Suzuki, J | 2 |
| Kobayasi, I | 2 |
| Fujita, T | 2 |
| Serrano Aulló, MT | 1 |
| Carnicer, J | 1 |
| Kovacs, TO | 1 |
| Campbell, D | 1 |
| Haber, M | 1 |
| Rose, P | 1 |
| Jennings, DE | 1 |
| Richter, J | 1 |
| Koizumi, W | 1 |
| Hibi, K | 1 |
| Imaizumi, H | 1 |
| Ohida, M | 1 |
| Okabe, H | 1 |
| Okayasu, I | 1 |
| Cloud, ML | 1 |
| Enas, N | 1 |
| Humphries, TJ | 3 |
| Bassion, S | 1 |
| Takashima, M | 1 |
| Kajimura, M | 1 |
| Felder, LR | 1 |
| Barkin, JS | 1 |
| Woo, TW | 1 |
| Chang, MS | 2 |
| Chung, YK | 2 |
| Kim, KB | 2 |
| Sohn, SK | 2 |
| Choi, WS | 2 |
| Sakaguchi, AA | 1 |
| Miura, S | 1 |
| Wayman, J | 1 |
| Hayes, N | 1 |
| Griffin, SM | 1 |
| Inalöz, SS | 1 |
| Goral, V | 1 |
| Sari, I | 1 |
| Perego, M | 1 |
| Fiocca, R | 1 |
| Solcia, E | 1 |
| Franceschi, M | 1 |
| Cesana, B | 1 |
| Spinzi, GC | 1 |
| Bierti, L | 1 |
| Bortoli, A | 1 |
| Colombo, E | 1 |
| Fertitta, AM | 1 |
| Lanzi, GL | 1 |
| Venturelli, R | 1 |
| Minoli, G | 1 |
| Lambert, JR | 1 |
| Carvalho, AF | 1 |
| Fiorelli, LA | 1 |
| Jorge, VN | 1 |
| Da Silva, CM | 1 |
| De Nucci, G | 1 |
| Ferraz, JG | 1 |
| Pedrazzoli, J | 1 |
| Manzionna, G | 1 |
| Petrillo, M | 2 |
| Cullen, D | 1 |
| Eisner, M | 1 |
| Thomson, JM | 1 |
| Morton, D | 1 |
| Slater, DN | 1 |
| Perry, MJ | 1 |
| Cherian, P | 1 |
| Jones, RB | 1 |
| Brookes, A | 1 |
| Thompson, M | 2 |
| Morris, P | 2 |
| McCaldin, B | 1 |
| Smith, BB | 1 |
| Dekkers, CP | 1 |
| Beker, JA | 2 |
| Thjodleifsson, B | 2 |
| Bell, NE | 1 |
| Lamouliatte, H | 1 |
| Cayla, R | 1 |
| Zerbib, F | 1 |
| Forestier, S | 1 |
| de Mascarel, A | 1 |
| Joubert-Collin, M | 1 |
| Mégraud, F | 1 |
| Katelaris, PH | 1 |
| Nebiki, H | 1 |
| Ando, K | 1 |
| Harihara, S | 1 |
| Kuroki, T | 1 |
| Ishihara, M | 2 |
| Legaz Huidobro, ML | 1 |
| Pérez Roldán, F | 1 |
| Ruíz Carrillo, F | 1 |
| Pedraza Martín, C | 1 |
| Sáez Bravo, JM | 1 |
| Langman, MJ | 1 |
| Andou, T | 1 |
| Hara, M | 2 |
| Fujinami, T | 1 |
| Tanaka, S | 1 |
| Kaunitz, JD | 1 |
| Kishikawa, H | 1 |
| Kitahora, T | 2 |
| Nagahashi, S | 2 |
| Peddicord, TE | 1 |
| Olsen, KM | 2 |
| Collier, DS | 1 |
| Keto, Y | 3 |
| Nilsson, F | 1 |
| Walder, M | 1 |
| Grimaz, S | 1 |
| Damiani, D | 1 |
| Brosolo, P | 1 |
| Skert, C | 1 |
| Geromin, A | 1 |
| de Pretis, G | 1 |
| Lad, R | 1 |
| Armstrong, D | 2 |
| Makovec, F | 1 |
| Revel, L | 1 |
| Letari, O | 1 |
| Mennuni, L | 1 |
| Impicciatore, M | 2 |
| Gisbert, JP | 2 |
| Armuzzi, A | 1 |
| Gasbarrini, A | 1 |
| Addolorato, G | 1 |
| Gasbarrini, GB | 1 |
| Matsumoto, J | 1 |
| Shiota, K | 1 |
| Kitajima, S | 1 |
| Goto, M | 1 |
| Imaizumi, M | 1 |
| Arima, T | 1 |
| Madridejos Mora, R | 1 |
| Takeyama, Y | 1 |
| Matsui, T | 1 |
| Yao, T | 2 |
| Motomura, A | 1 |
| Arita, M | 1 |
| Okada, M | 1 |
| Tanaka, K | 1 |
| Imamura, T | 1 |
| Hatakeyama, S | 1 |
| Diete, U | 1 |
| Gil, J | 1 |
| Misiuna, P | 1 |
| O'Morain, C | 1 |
| Stasiewicz, J | 1 |
| Treichel, H | 1 |
| Ujszászy, L | 1 |
| Unge, P | 1 |
| Zanten, SJ | 1 |
| Zeijlon, L | 1 |
| Dojyo, M | 1 |
| Yamazaki, Y | 1 |
| Miyaji, H | 1 |
| Ito, Y | 1 |
| Suto, H | 1 |
| Kuriyama, M | 1 |
| Raskin, JB | 1 |
| Vitaux, J | 1 |
| Roseau, G | 1 |
| Cockayne, SE | 1 |
| Glet, RJ | 1 |
| Gawkrodger, DJ | 1 |
| McDonagh, AJ | 1 |
| Huang, J | 1 |
| Lu, X | 1 |
| Kromer, W | 2 |
| Horbach, S | 1 |
| Lühmann, R | 1 |
| Lehmann, FS | 1 |
| Beglinger, C | 1 |
| Sasakii, M | 1 |
| Yokoyama, Y | 3 |
| Seno, K | 1 |
| Tsuchida, K | 1 |
| Kurokawa, T | 1 |
| Gschwantler, M | 1 |
| Dragosics, B | 1 |
| Schütze, K | 1 |
| Wurzer, H | 1 |
| Hirschl, AM | 1 |
| Pasching, E | 1 |
| Wimmer, M | 1 |
| Klimpfinger, M | 1 |
| Oberhuber, G | 1 |
| Brandstätter, G | 1 |
| Hentschel, E | 1 |
| Weiss, W | 1 |
| Ohtsuka, T | 1 |
| Yamakage, A | 1 |
| Yamazaki, S | 1 |
| Axon, A | 1 |
| Melnichouk, S | 1 |
| Friendship, RM | 2 |
| Dewey, CE | 2 |
| Bildfell, R | 1 |
| Lin, HJ | 1 |
| Tseng, GY | 1 |
| Hsieh, YH | 1 |
| Perng, CL | 1 |
| Lee, FY | 1 |
| Chang, FY | 1 |
| Lee, SD | 1 |
| Hirasaki, S | 1 |
| Koide, N | 1 |
| Ogawa, H | 1 |
| Tsuji, T | 1 |
| Sou, Y | 1 |
| Yoshinaga, T | 1 |
| Matsukawa, Y | 1 |
| Sekikawa, A | 1 |
| Nakazawa, T | 1 |
| Shio, S | 1 |
| Kohigashi, K | 1 |
| Lamers, CB | 6 |
| Bustamante, M | 1 |
| Stollman, N | 1 |
| Moreira Vicente, V | 1 |
| Nielsen, I | 1 |
| Tassinari, D | 1 |
| Panzini, I | 1 |
| Abbasciano, V | 1 |
| de Mestier, P | 1 |
| Plue, RE | 1 |
| Wall, HG | 1 |
| Daurio, C | 1 |
| Attebery, DK | 1 |
| Cox, JL | 3 |
| Wallace, DH | 1 |
| Thompson, D | 2 |
| Pollmeier, M | 1 |
| Holste, J | 1 |
| MacAllister, CG | 1 |
| Ericcson, GF | 1 |
| Daurio, CP | 1 |
| Backe, KW | 1 |
| Sha, W | 1 |
| Nie, Y | 1 |
| Wu, H | 1 |
| She, Q | 1 |
| Dai, S | 1 |
| Jia, L | 1 |
| Yu, W | 1 |
| Mo, HK | 1 |
| Lee, BH | 1 |
| Choi, J | 1 |
| Ooie, T | 1 |
| Saikawa, T | 1 |
| Ono, H | 1 |
| Seike, M | 1 |
| Sakata, T | 1 |
| Dorta, G | 1 |
| Nicolet, M | 1 |
| Vouillamoz, D | 1 |
| Margalith, D | 1 |
| Saraga, E | 1 |
| Bouzourene, H | 1 |
| Häcki, WH | 1 |
| Vernet Vernet, M | 1 |
| Roca Figueras, G | 1 |
| Jovell Fernández, E | 1 |
| Iglesias Rodríguez, M | 1 |
| Ureña Tapia, MM | 1 |
| Roca Fusalba, A | 1 |
| Dekkers, C | 1 |
| Bjaaland, T | 1 |
| Finnegan, V | 1 |
| Tanaka, Y | 1 |
| Kassai, K | 1 |
| Kondo, M | 1 |
| Campbell, DR | 2 |
| Safdi, MA | 1 |
| Lukasik, NL | 2 |
| Haber, MM | 2 |
| Pardi, DS | 1 |
| Williams, MP | 1 |
| Blanshard, C | 1 |
| Millson, C | 1 |
| Sercombe, J | 1 |
| Zullo, A | 1 |
| Rinaldi, V | 1 |
| Winn, S | 1 |
| Meddi, P | 1 |
| Lionetti, R | 1 |
| Hassan, C | 1 |
| Ripani, C | 1 |
| Tomaselli, G | 1 |
| Attili, AF | 1 |
| Johnson, D | 1 |
| Perdomo, C | 2 |
| Barth, J | 2 |
| Jokubaitis, L | 1 |
| Hurenkamp, GJ | 1 |
| Van Der Ende, A | 1 |
| Grundmeijer, HG | 1 |
| Hui, WM | 2 |
| Gomollón, F | 1 |
| Valdepérez, J | 1 |
| Garuz, R | 1 |
| Fuentes, J | 1 |
| Barrera, F | 1 |
| Malo, J | 1 |
| Tirado, M | 1 |
| Simón, MA | 1 |
| Cattoli, G | 1 |
| Bart, A | 1 |
| Klaver, PS | 1 |
| Robijn, RJ | 1 |
| Beumer, HJ | 1 |
| van Vugt, R | 1 |
| Pot, RG | 1 |
| van der Gaag, I | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Kusters, JG | 1 |
| Imbesi, V | 1 |
| Montrone, F | 1 |
| Santagada, T | 1 |
| Tashima, K | 1 |
| Fujita, A | 1 |
| Umeda, M | 1 |
| Defarges, V | 1 |
| Sanz, JM | 1 |
| Metz, DC | 1 |
| Reubi, JC | 1 |
| Kawamura, T | 1 |
| Miyaji, C | 1 |
| Toyabe, S | 1 |
| Abo, T | 1 |
| Egan, LJ | 1 |
| Murray, JA | 1 |
| Ohtsubo, K | 1 |
| Sakai, J | 1 |
| Kawashima, A | 1 |
| Harasawa, S | 1 |
| Nakamura, T | 3 |
| Ogawa, N | 2 |
| Muto, Y | 1 |
| van den Wollenberg, L | 1 |
| Sloet van Oldruitenborgh-Oosterbaan, MM | 1 |
| Jungnickel, PW | 1 |
| Lee, SS | 1 |
| Lim, H | 1 |
| Lee, DH | 1 |
| Melnichouk, SI | 1 |
| Hiruma-Lima, CA | 1 |
| Gracioso, JD | 1 |
| de Paula, AC | 1 |
| Brasil, DD | 1 |
| Muller, AH | 1 |
| Brito, AR | 1 |
| Garcia, N | 1 |
| Calvet, X | 1 |
| Gené, E | 1 |
| Campo, R | 1 |
| Brullet, E | 1 |
| Sener-Muratoğlu, G | 1 |
| Paskaloğlu, K | 1 |
| Arbak, S | 1 |
| Hürdağ, C | 1 |
| Ayanoğlu-Dülger, G | 1 |
| Lanza, F | 1 |
| Niecestro, R | 1 |
| Mitchell, SL | 1 |
| Rockwood, K | 1 |
| Ogawa, Y | 1 |
| Kunikata, T | 1 |
| Bardou, M | 1 |
| Murav'ev, IuV | 1 |
| Sazhin, VP | 1 |
| Fedorov, AV | 1 |
| Maev, IV | 1 |
| V'iuchnova, ES | 1 |
| Lebedev, EG | 1 |
| Dicheva, DT | 1 |
| Ovsiannikova, EV | 1 |
| Antonenko, OM | 1 |
| Shchekina, MI | 1 |
| Wongkusoltham, P | 1 |
| Vilaichone, RK | 1 |
| Kullavanijaya, P | 1 |
| Phaosawadi, K | 1 |
| Saito, M | 1 |
| Miyagishima, T | 1 |
| Ishizuka, J | 1 |
| Komatsu, Y | 1 |
| Mizushima, T | 1 |
| Hige, S | 1 |
| Masoodi, I | 1 |
| Nakai, H | 1 |
| Itoh, S | 1 |
| Herszényi, L | 1 |
| Ebata, M | 2 |
| Ikeda, S | 1 |
| Tamamuro, T | 1 |
| Hamashima, C | 1 |
| Vichev, E | 1 |
| Krŭstev, N | 1 |
| Krŭstev, D | 1 |
| Baeva, N | 1 |
| Kiselova, A | 1 |
| Ianev, N | 1 |
| Yee, YK | 1 |
| Hung, WK | 1 |
| Yip, AW | 1 |
| Szeto, ML | 1 |
| Li, KF | 1 |
| Lau, P | 1 |
| Fung, FM | 1 |
| Tong, TS | 1 |
| Yuen, MF | 1 |
| Hui, CK | 1 |
| Demirezer, LO | 1 |
| Büyükokuroglu, ME | 1 |
| Akcay, MF | 1 |
| Gepdiremen, A | 1 |
| Banoglu, ZN | 1 |
| Göçer, F | 1 |
| Udd, M | 1 |
| Miettinen, P | 1 |
| Palmu, A | 1 |
| Heikkinen, M | 1 |
| Janatuinen, E | 1 |
| Pasanen, P | 1 |
| Tarvainen, R | 1 |
| Kairaluoma, MV | 1 |
| Lohman, M | 1 |
| Mustonen, H | 1 |
| Julkunen, R | 1 |
| Carswell, CI | 1 |
| Goa, KL | 1 |
| Collis, C | 1 |
| Tran, TT | 1 |
| Quandalle, P | 1 |
| Kaufman, SS | 1 |
| Lyden, ER | 1 |
| Brown, CR | 1 |
| Davis, CK | 1 |
| Andersen, DA | 1 |
| Bergman, KL | 1 |
| Horslen, SP | 1 |
| Sudan, DL | 1 |
| Fox, IJ | 1 |
| Shaw, BW | 1 |
| Langnas, AN | 1 |
| Yeomans, N | 1 |
| Hawkey, C | 1 |
| Wiklund, I | 1 |
| Miyazawa, M | 1 |
| Suzuki, K | 1 |
| Louis, E | 1 |
| Bustamante, C | 1 |
| Astudillo, L | 2 |
| Adachi, K | 1 |
| Suetsugu, H | 1 |
| Moriyama, N | 1 |
| Kazumori, H | 1 |
| Kawamura, A | 1 |
| Fujishiro, H | 1 |
| Sato, H | 1 |
| Okuyama, T | 1 |
| Ishihara, S | 1 |
| Watanabe, M | 1 |
| Chandranath, SI | 1 |
| Bastaki, SM | 1 |
| Singh, J | 1 |
| Bown, RL | 1 |
| Esaki, M | 1 |
| Kuwano, Y | 1 |
| Shimizu, M | 1 |
| Zlabek, JA | 1 |
| Anderson, CG | 1 |
| Mizokami, Y | 1 |
| Shiraishi, T | 1 |
| Otsubo, T | 1 |
| Nakamura, H | 1 |
| Narushima, K | 1 |
| Matsuoka, T | 1 |
| Tomita, K | 1 |
| Gonzalez, FG | 1 |
| Di Stasi, LC | 1 |
| Moreno, FJ | 1 |
| Vakhrushev, IaM | 1 |
| Muravtseva, OV | 1 |
| Norris, CM | 1 |
| McManus, PV | 1 |
| Petty, D | 1 |
| Kay, EA | 1 |
| Akimoto, H | 1 |
| Okuda, S | 1 |
| Takase, S | 1 |
| Takada, A | 1 |
| Karasawa, H | 1 |
| Miwa, T | 1 |
| Yamao, K | 1 |
| Yamachika, H | 1 |
| Wakabayashi, T | 1 |
| McQuaid, KR | 1 |
| Isenberg, JI | 1 |
| Perroni, GB | 1 |
| De Matteis, G | 1 |
| Pellizzeri, F | 1 |
| Cassone, A | 1 |
| Malara, F | 1 |
| Barradell, LB | 1 |
| McTavish, D | 2 |
| Asai, J | 1 |
| Bergmann, JF | 1 |
| Chassany, O | 1 |
| Simoneau, G | 1 |
| Segrestaa, JM | 1 |
| Caulin, C | 1 |
| Bell, GD | 1 |
| Powell, KU | 1 |
| Burridge, SM | 1 |
| Spencer, G | 1 |
| Bolton, G | 1 |
| Purser, K | 1 |
| Brooks, S | 1 |
| Prosser, S | 1 |
| Harrison, G | 1 |
| Gant, PW | 1 |
| Johlin, FC | 1 |
| Labrecque, DR | 1 |
| Neil, GA | 1 |
| Lajoie, C | 1 |
| Larner, AJ | 1 |
| Lendrum, R | 1 |
| Kuroiwa, M | 2 |
| Ohara, A | 1 |
| Hellström, PM | 1 |
| Tsuneoka, K | 1 |
| Hinchliffe, RF | 1 |
| Daly, MJ | 1 |
| Carroll, NJ | 1 |
| Rubin, W | 1 |
| Vallot, T | 1 |
| Galmiche, JP | 1 |
| Gouilloud-Celle, S | 1 |
| Mignon, M | 1 |
| Segawa, K | 2 |
| Koop, H | 2 |
| Buckley, MM | 1 |
| Heel, RC | 1 |
| Gail, K | 1 |
| Mihaljevic, L | 1 |
| Garlicki, J | 1 |
| Majka, J | 1 |
| Nauert, C | 1 |
| Akimoto, Y | 2 |
| Yamasaki, S | 2 |
| Kuwahara, K | 1 |
| Jenkins, CC | 1 |
| DeNovo, RC | 1 |
| Patton, CS | 1 |
| Bright, RM | 1 |
| Rohrbach, BW | 1 |
| Ohashi, S | 1 |
| Mizutani, K | 1 |
| Kuwayama, H | 1 |
| Eastwood, GL | 1 |
| Sollano, JD | 1 |
| Espiritu, AC | 1 |
| Alvarez, SZ | 1 |
| Perez, JY | 1 |
| Inatomi, N | 1 |
| Nagaya, H | 1 |
| Takami, K | 1 |
| Shino, A | 1 |
| Chen, BW | 1 |
| Cho, CH | 2 |
| Luk, CT | 1 |
| Marinos, Y | 1 |
| Honson, K | 1 |
| Muramatsu, M | 1 |
| Isobe, Y | 1 |
| Arai, I | 1 |
| Hirose-Kijima, H | 1 |
| Usuki-Ito, C | 1 |
| Aihara, H | 1 |
| Otomo, S | 1 |
| Earnest, DL | 1 |
| Gönne, S | 1 |
| Riedel, R | 1 |
| Postius, S | 1 |
| Piper, DW | 2 |
| Shearman, DJ | 1 |
| Maton, PN | 1 |
| Holt, S | 1 |
| Howden, CW | 1 |
| Hirose, H | 1 |
| Savarino, V | 2 |
| Mela, GS | 2 |
| Celle, G | 2 |
| Kubo, K | 1 |
| Kaneko, T | 1 |
| Nohara, A | 1 |
| Keshavarzian, A | 1 |
| Haydek, JM | 1 |
| Zepeda, DO | 1 |
| Stinneford, JG | 1 |
| Fields, JZ | 1 |
| Chang, J | 1 |
| Yasue, N | 1 |
| Iwai, A | 1 |
| Matsusako, K | 1 |
| Endoh, K | 1 |
| Kawai, T | 1 |
| Tarui, S | 1 |
| Gunion, MW | 1 |
| Kauffman, GL | 1 |
| Taché, Y | 1 |
| Plas, J | 1 |
| Gloria, VI | 1 |
| Domingo, EO | 1 |
| Makalinao, AU | 1 |
| Zano, FM | 1 |
| Rasco, ET | 1 |
| Sy, CT | 1 |
| Sun, HS | 1 |
| Choi, KW | 1 |
| Yoon, CM | 1 |
| Min, YI | 1 |
| Lee, SI | 1 |
| Chung, JM | 1 |
| Yang, US | 1 |
| Creutzfeldt, W | 4 |
| Lamberts, R | 3 |
| Stöckmann, F | 2 |
| Meijer, JL | 1 |
| Jansen, JB | 1 |
| Chelvam, P | 1 |
| Wong, EC | 1 |
| Osada, T | 1 |
| Kawabe, Y | 1 |
| Chen, SP | 1 |
| Mai, CR | 1 |
| Classen, M | 4 |
| Rutgersson, K | 1 |
| Bate, CM | 1 |
| Wilkinson, SP | 1 |
| Bradby, GV | 1 |
| Bateson, MC | 1 |
| Willoughby, CP | 1 |
| Peers, EM | 1 |
| Richardson, PD | 1 |
| Lauritsen, K | 2 |
| de Bruijne, JW | 1 |
| Bium, AL | 1 |
| Miyake, H | 3 |
| Bank, S | 1 |
| Chiavarini, M | 1 |
| Barocelli, E | 1 |
| Bordi, F | 1 |
| Haga, K | 1 |
| Asano, K | 1 |
| Osuga, K | 1 |
| Maruyama, Y | 1 |
| Duchateau, A | 1 |
| Thiefin, G | 1 |
| Varin-Bischoff, S | 1 |
| Zeitoun, P | 1 |
| Cisternino, M | 1 |
| Francavilla, A | 1 |
| Gallazzi, M | 1 |
| Ingrosso, M | 1 |
| Labò, G | 1 |
| Rinetti, M | 1 |
| Sivelli, R | 1 |
| Tomassetti, P | 1 |
| Berglindh, T | 1 |
| Sachs, G | 1 |
| McArthur, KE | 1 |
| Jensen, RT | 1 |
| Gardner, JD | 1 |
| Elander, B | 1 |
| Fellenius, E | 1 |
| Leth, R | 1 |
| Olbe, L | 1 |
| Wallmark, B | 1 |
| Müller, P | 2 |
| Dammann, HG | 4 |
| Simon, B | 4 |
| McColl, KE | 1 |
| Kolbasa, KP | 1 |
| Lancaster, C | 1 |
| Olafsson, AS | 1 |
| Gilbertson, SK | 1 |
| Robert, A | 1 |
| Namba, S | 1 |
| Skov Olsen, P | 1 |
| Therkelsen, K | 1 |
| Poulsen, SS | 1 |
| Ghelardoni, M | 1 |
| Meli, A | 1 |
| Pestellini, V | 1 |
| Viti, G | 1 |
| Rune, SJ | 1 |
| Wulff, HR | 1 |
| Olsen, JH | 1 |
| Laursen, LS | 1 |
| Astrup, L | 1 |
| Bendtsen, F | 1 |
| Linde, J | 1 |
| Bytzer, P | 1 |
| Axelson, J | 1 |
| Håkanson, R | 1 |
| Hedenbro, JL | 1 |
| Inauen, W | 1 |
| Wyss, PA | 1 |
| Kayser, S | 1 |
| Baumgartner, A | 1 |
| Schürer-Maly, CC | 1 |
| Koelz, HR | 1 |
| Jacubaschke, U | 1 |
| Maas, S | 1 |
| Imada, J | 1 |
| Ogle, CW | 1 |
| Matsuda, K | 1 |
| Awane, Y | 1 |
| MacLellan, DG | 1 |
| Shulkes, A | 1 |
| Hardy, KJ | 1 |
| Domschke, W | 2 |
| Londong, W | 2 |
| Scholten, T | 1 |
| Berger, J | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Different Omeprazole Dosing on Gastric pH in Non- Variceal Upper Gastrointestinal Bleeding: A Randomized Prospective Study[NCT03980496] | Phase 4 | 50 participants (Actual) | Interventional | 2010-09-09 | Completed | ||
| Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection[NCT03124199] | Phase 3 | 40 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Intravenous Infusion of High Dose Omeprazole Versus Regular Dose Omeprazole on Recurrent Bleeding After Endoscopic Treatment of Bleeding Peptic Ulcers[NCT00519519] | Phase 3 | 126 participants (Actual) | Interventional | 2004-07-31 | Completed | ||
| Melanole, a Nigella Sativa (Black Seed) Extract for the Treatment of Gastroesophageal Reflux Disease[NCT02587910] | Phase 2/Phase 3 | 170 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
| The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin[NCT00281047] | Phase 2/Phase 3 | 138 participants | Interventional | 2006-01-31 | Recruiting | ||
| Comparison of High Dose Infusion and Low Dose Bolus Intravenous Omeprazole for Treatment of Bleeding Ulcer With Adherent Clot[NCT02536989] | Phase 4 | 40 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Comparing the Efficacy and Impact on Gastrointestinal Microbiome of Reverse Hybrid Therapy and Bismuth Quadruple Therapy in Helicobacter Pylori Eradication[NCT02547038] | 352 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment[NCT02978157] | 102 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial[NCT02541864] | 330 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012] | 51 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection - a Randomized Controlled Trial (REHYTRI Study)[NCT02359435] | 440 participants (Actual) | Interventional | 2012-10-31 | Completed | |||
| European Registry on the Management of Helicobacter Pylori Infection[NCT02328131] | 10,000 participants (Anticipated) | Observational | 2013-06-30 | Recruiting | |||
| A Randomized, Blinded, Placebo-Controlled Study of the Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on Gastroduodenal Healing[NCT00778193] | Phase 4 | 125 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| Correlation Between Peri-implantitis and Assumptions of Medications: a Retrospective Study[NCT04783974] | 270 participants (Actual) | Observational | 2021-02-15 | Completed | |||
| Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention[NCT00413309] | 30 participants (Anticipated) | Interventional | 2006-04-30 | Completed | |||
| Effects of Esomeprazole Magnesium on Gastric Free Radical Production and Total Antioxidant Capacity in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs[NCT00443963] | Phase 4 | 0 participants (Actual) | Interventional | 2006-12-31 | Withdrawn (stopped due to The study was not approved by the Human Studies Subcommittee.) | ||
| Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers[NCT00284908] | Phase 1 | 32 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| Assessment of the Healing Rate of Erosive or Ulcerative Esophagitis After Two and Four Weeks of Treatment With S-Tenatoprazole-Na (STU-Na) 15 mg, 30 mg, 60 mg, 90 mg and Esomeprazole 40 mg. A Multicenter, Randomized, Double-Blind, Parallel Group Study.[NCT00282555] | Phase 2 | 450 participants | Interventional | 2006-02-28 | Suspended | ||
| Phase 4, Prospective, Randomized and Comparative Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice[NCT01273441] | Phase 4 | 338 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percentage of patients that has comply with treatment, considered as intake of more than 90% of study drugs in patients who attended the post-treatment visit. (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 100 |
Percentage of Participants with H.Pylori Infection Eradication confirmed with urea breath test at least 4 weeks after the end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 61 |
Patients with side effects present during treatment and in the 4 weeks after end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| with diarrhea | with metallic taste | headache | nausea | abdominal pain | |
| Rifaximin | 13 | 9 | 5 | 5 | 1 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (Number of Participants With Complete Eradication of Helicobacter Pylori) (NCT02547038)
Timeframe: sixth week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 169 |
| (Panto+Amox+Clar+Metr)+(Panto+Amox) | 170 |
Number of participants with negative H pylori status in follow-up tests as a measure of successful eradication (NCT02978157)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo | 36 |
| Esomeprazole+Bismuth+Tetra+Levo | 49 |
Repeated endoscopy with rapid urease test, histological examination and culture or urea breath tests are conducted to assess H. pylori status. (NCT02541864)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 154 |
| Hybrid Therapy | 154 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo+Tetra | 13 |
| Esomeprazole+Amox+Levo | 21 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02359435)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Reverse Hybrid Therapy | 206 |
| Standard Triple Therapy | 191 |
99 reviews available for omeprazole and Stomach Ulcer
| Article | Year |
|---|---|
Over 30 Years of Omeprazole.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Gastroesophageal Reflux; Humans; Omeprazole; P | 2023 |
Over 30 Years of Omeprazole.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Gastroesophageal Reflux; Humans; Omeprazole; P | 2023 |
Therapeutics for Equine Gastric Ulcer Syndrome.
Topics: Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Proton Pump Inhibitors; Stomach Ulce | 2017 |
Therapeutics for Equine Gastric Ulcer Syndrome.
Topics: Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Proton Pump Inhibitors; Stomach Ulce | 2017 |
Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Omepr | 2017 |
Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Omepr | 2017 |
Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis.
Topics: Animals; Anti-Ulcer Agents; Bias; Confidence Intervals; Female; Horse Diseases; Horses; Male; Odds R | 2019 |
Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis.
Topics: Animals; Anti-Ulcer Agents; Bias; Confidence Intervals; Female; Horse Diseases; Horses; Male; Odds R | 2019 |
[Endoscopic hemostasis in the treatment of the gastroduodenal ulcer bleeding].
Topics: Administration, Intravenous; Comparative Effectiveness Research; Duodenal Ulcer; Hemostasis, Endosco | 2013 |
[Endoscopic hemostasis in the treatment of the gastroduodenal ulcer bleeding].
Topics: Administration, Intravenous; Comparative Effectiveness Research; Duodenal Ulcer; Hemostasis, Endosco | 2013 |
Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature.
Topics: Aged; Carcinoid Tumor; Endoscopy, Digestive System; Humans; Male; Omeprazole; Proton Pump Inhibitors | 2016 |
Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature.
Topics: Aged; Carcinoid Tumor; Endoscopy, Digestive System; Humans; Male; Omeprazole; Proton Pump Inhibitors | 2016 |
Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Esomeprazole; Gastroesophageal Reflux; Helicobacter Infect | 2008 |
Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Esomeprazole; Gastroesophageal Reflux; Helicobacter Infect | 2008 |
[Proton pump inhibitors, a family of drugs in continuous expansion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett E | 2000 |
[Proton pump inhibitors, a family of drugs in continuous expansion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett E | 2000 |
Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Duodenal | 2013 |
Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Duodenal | 2013 |
[Treatment of NSAID-associated gastric ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
[Treatment of NSAID-associated gastric ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
[Prevention and treatment of gastro-duodenal ulcers in elderly--from theory-based toward evidence-based].
Topics: Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Evidence-Based Medicine; Humans; Misoprostol; | 2002 |
[Prevention and treatment of gastro-duodenal ulcers in elderly--from theory-based toward evidence-based].
Topics: Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Evidence-Based Medicine; Humans; Misoprostol; | 2002 |
Prevention and treatment of stress ulcers in critically ill patients.
Topics: Aged; Anti-Ulcer Agents; Cimetidine; Critical Illness; Female; Gastric Mucosa; Gastrointestinal Hemo | 2003 |
Prevention and treatment of stress ulcers in critically ill patients.
Topics: Aged; Anti-Ulcer Agents; Cimetidine; Critical Illness; Female; Gastric Mucosa; Gastrointestinal Hemo | 2003 |
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; D | 2003 |
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; D | 2003 |
[What treatments can reduce the digestive complications of NSAIDs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Gastrointestinal Diseases; Histamine H2 Ant | 2003 |
[What treatments can reduce the digestive complications of NSAIDs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Gastrointestinal Diseases; Histamine H2 Ant | 2003 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; | 2004 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; | 2004 |
Protein pump inhibitors go over the counter.
Topics: Administration, Intravaginal; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Aryl Hydro | 2004 |
Protein pump inhibitors go over the counter.
Topics: Administration, Intravaginal; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Aryl Hydro | 2004 |
Cost-effectiveness of a 'score and scope' strategy for the management of dyspepsia.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cost-Benefit Analysis; Decision Trees; Diagn | 2005 |
Cost-effectiveness of a 'score and scope' strategy for the management of dyspepsia.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cost-Benefit Analysis; Decision Trees; Diagn | 2005 |
[Quality of ulcer healing and rebamipide].
Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination | 2005 |
[Quality of ulcer healing and rebamipide].
Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination | 2005 |
Equine gastric ulcer syndrome in adult horses: a review.
Topics: Animal Husbandry; Animals; Anti-Ulcer Agents; Gastric Mucosa; Horse Diseases; Horses; Omeprazole; Ph | 2007 |
Equine gastric ulcer syndrome in adult horses: a review.
Topics: Animal Husbandry; Animals; Anti-Ulcer Agents; Gastric Mucosa; Horse Diseases; Horses; Omeprazole; Ph | 2007 |
Medical management of peptic ulcer.
Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omep | 1984 |
Medical management of peptic ulcer.
Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omep | 1984 |
Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Humans; Lansoprazole; Omeprazol | 1994 |
Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Humans; Lansoprazole; Omeprazol | 1994 |
What should be done when initial endoscopic therapy for bleeding peptic ulcer fails?
Topics: Animals; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer; Hemostasis, Endoscopic; Humans | 1995 |
What should be done when initial endoscopic therapy for bleeding peptic ulcer fails?
Topics: Animals; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer; Hemostasis, Endoscopic; Humans | 1995 |
Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Topics: Adult; Cimetidine; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Male; M | 1995 |
Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Topics: Adult; Cimetidine; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Male; M | 1995 |
[Lansoprazol].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Controlled Clinical Trials as Topic; Duo | 1995 |
[Lansoprazol].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Controlled Clinical Trials as Topic; Duo | 1995 |
Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Prevalence | 1995 |
Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Prevalence | 1995 |
Optimizing acid suppression for treatment of acid-related diseases.
Topics: Duodenal Ulcer; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Omeprazole; | 1995 |
Optimizing acid suppression for treatment of acid-related diseases.
Topics: Duodenal Ulcer; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Omeprazole; | 1995 |
[New antisecretory drugs in the treatment of ulcer].
Topics: Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Stomach Ulcer | 1994 |
[New antisecretory drugs in the treatment of ulcer].
Topics: Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Stomach Ulcer | 1994 |
Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Gastritis; Gastroesophag | 1993 |
Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Gastritis; Gastroesophag | 1993 |
Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Drug Therapy, Combination; Gastric Acid; Gastric Mucosa; Gastrins; Helicobacter Infecti | 1994 |
Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Drug Therapy, Combination; Gastric Acid; Gastric Mucosa; Gastrins; Helicobacter Infecti | 1994 |
Refractory peptic lesions. Therapeutic strategies for ulcers and reflux esophagitis that resist standard regimens.
Topics: Anti-Ulcer Agents; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Drug Therapy, Com | 1993 |
Refractory peptic lesions. Therapeutic strategies for ulcers and reflux esophagitis that resist standard regimens.
Topics: Anti-Ulcer Agents; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Drug Therapy, Com | 1993 |
Gastric acid secretion and intragastric acidity: measurement in health and disease.
Topics: Duodenal Ulcer; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Helico | 1993 |
Gastric acid secretion and intragastric acidity: measurement in health and disease.
Topics: Duodenal Ulcer; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Helico | 1993 |
Acid pump blockers: what are their current therapeutic roles?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Gastroesophageal Reflux; | 1993 |
Acid pump blockers: what are their current therapeutic roles?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Gastroesophageal Reflux; | 1993 |
Clinical efficacy of pantoprazole compared with ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; | 1994 |
Clinical efficacy of pantoprazole compared with ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; | 1994 |
A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Double-Blind Metho | 1994 |
A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Double-Blind Metho | 1994 |
[Lansoprazole--profile of a new proton pump inhibitor].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug A | 1994 |
[Lansoprazole--profile of a new proton pump inhibitor].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug A | 1994 |
[Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Helicobacter Infections; Helicobacter pylori; Humans; Lanso | 1993 |
[Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Helicobacter Infections; Helicobacter pylori; Humans; Lanso | 1993 |
[Omeprazole. Its pharmacology and therapeutic efficacy].
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Stomach Ulcer; Zollinger-Ellison Syndrome | 1993 |
[Omeprazole. Its pharmacology and therapeutic efficacy].
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Stomach Ulcer; Zollinger-Ellison Syndrome | 1993 |
Is there any acid peptic disease that is refractory to proton pump inhibitors?
Topics: Clinical Trials as Topic; Drug Resistance; Duodenal Ulcer; Gastric Acid; Gastroesophageal Reflux; Hu | 1993 |
Is there any acid peptic disease that is refractory to proton pump inhibitors?
Topics: Clinical Trials as Topic; Drug Resistance; Duodenal Ulcer; Gastric Acid; Gastroesophageal Reflux; Hu | 1993 |
Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment?
Topics: Animals; Anti-Ulcer Agents; Epidermal Growth Factor; ErbB Receptors; Fibroblast Growth Factors; Gast | 1995 |
Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment?
Topics: Animals; Anti-Ulcer Agents; Epidermal Growth Factor; ErbB Receptors; Fibroblast Growth Factors; Gast | 1995 |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benef | 1996 |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benef | 1996 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; | 1996 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; | 1996 |
[Treatment of Helicobacter pylori infection].
Topics: Adolescent; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, | 1996 |
[Treatment of Helicobacter pylori infection].
Topics: Adolescent; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, | 1996 |
[Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Topics: Animals; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Rats; Re | 1995 |
[Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Topics: Animals; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Rats; Re | 1995 |
Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastroes | 1996 |
Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastroes | 1996 |
Efficacy of clarithromycin in eradicating Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibito | 1996 |
Efficacy of clarithromycin in eradicating Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibito | 1996 |
Prevention of NSAID-gastropathy.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer | 1996 |
Prevention of NSAID-gastropathy.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer | 1996 |
Therapy of NSAIDs-induced gastropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Histamine H2 Antagonists | 1996 |
Therapy of NSAIDs-induced gastropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Histamine H2 Antagonists | 1996 |
Suppression of gastric acidity in horses.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Horse Diseases; | 1997 |
Suppression of gastric acidity in horses.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Horse Diseases; | 1997 |
[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials a | 1998 |
[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials a | 1998 |
Pantoprazole--a third proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Enzyme I | 1997 |
Pantoprazole--a third proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Enzyme I | 1997 |
The impact of Helicobacter pylori eradication on peptic ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer | 1998 |
The impact of Helicobacter pylori eradication on peptic ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer | 1998 |
Proton pump inhibitors.
Topics: Anti-Ulcer Agents; Drug Therapy, Combination; Enzyme Inhibitors; Gastroesophageal Reflux; H(+)-K(+)- | 1998 |
Proton pump inhibitors.
Topics: Anti-Ulcer Agents; Drug Therapy, Combination; Enzyme Inhibitors; Gastroesophageal Reflux; H(+)-K(+)- | 1998 |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, | 1999 |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, | 1999 |
Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Gastric Juic | 1999 |
Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Gastric Juic | 1999 |
[Omeprazole and gastric protection].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Helicobacter I | 1999 |
[Omeprazole and gastric protection].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Helicobacter I | 1999 |
Gastrointestinal effects of nonsteroidal anti-inflammatory therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Cyclooxygenase | 1999 |
Gastrointestinal effects of nonsteroidal anti-inflammatory therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Cyclooxygenase | 1999 |
[Mechanism of proton pump inhibitors in the treatment of Holicobacter pylori-associated ulcers].
Topics: Anti-Ulcer Agents; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inh | 1997 |
[Mechanism of proton pump inhibitors in the treatment of Holicobacter pylori-associated ulcers].
Topics: Anti-Ulcer Agents; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inh | 1997 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationsh | 1999 |
[Present position in the prevention and therapy of NSAID-induced ulcers].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer | 1999 |
[Present position in the prevention and therapy of NSAID-induced ulcers].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer | 1999 |
Benign gastric ulcer associated with Canidida infection in a healthy adult.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alanine; Anti-Infective Agents; Anti-Ulcer Agents; Candidia | 1999 |
Benign gastric ulcer associated with Canidida infection in a healthy adult.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alanine; Anti-Infective Agents; Anti-Ulcer Agents; Candidia | 1999 |
[25 years of gastric acid blockers].
Topics: Anti-Ulcer Agents; Cimetidine; Dyspepsia; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; | 1999 |
[25 years of gastric acid blockers].
Topics: Anti-Ulcer Agents; Cimetidine; Dyspepsia; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; | 1999 |
The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Humans; | 2000 |
The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Humans; | 2000 |
[Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Topics: Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Esophageal Diseases; Esophagitis; Gastritis; | 1999 |
[Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Topics: Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Esophageal Diseases; Esophagitis; Gastritis; | 1999 |
The benefit/risk profile of rabeprazole, a new proton-pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Controlled Clinical Trials as Topic; Duoden | 2000 |
The benefit/risk profile of rabeprazole, a new proton-pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Controlled Clinical Trials as Topic; Duoden | 2000 |
Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastric Acid; Gastric Ac | 2000 |
Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastric Acid; Gastric Ac | 2000 |
New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitors.
Topics: Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gastric Acid; Genotype; H(+)-K(+)-Exchanging ATPa | 2000 |
New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitors.
Topics: Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gastric Acid; Genotype; H(+)-K(+)-Exchanging ATPa | 2000 |
[Gastric ulceration in horses: etiology, diagnosis, and therapy: a review].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antacids; Anti-Ulcer Agents; Dose-Response Relatio | 2000 |
[Gastric ulceration in horses: etiology, diagnosis, and therapy: a review].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antacids; Anti-Ulcer Agents; Dose-Response Relatio | 2000 |
Pantoprazole: a new proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic | 2000 |
Pantoprazole: a new proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic | 2000 |
Efficacy of rabeprazole once daily for acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Anti-Ulcer Agents; Benzimidazole | 2001 |
Efficacy of rabeprazole once daily for acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Anti-Ulcer Agents; Benzimidazole | 2001 |
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child | 2001 |
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child | 2001 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double | 2001 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double | 2001 |
[Comparative study of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; C | 2001 |
[Comparative study of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; C | 2001 |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 2001 |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 2001 |
Rabeprazole: an update of its use in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimida | 2001 |
Rabeprazole: an update of its use in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimida | 2001 |
An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Digestive System Diseases; Duodenal Ulcer; Dyspepsia; Enzym | 2002 |
An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Digestive System Diseases; Duodenal Ulcer; Dyspepsia; Enzym | 2002 |
Medical therapy of peptic ulcer disease.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Diet; Duodenal Ulcer; Histamine H2 Antag | 1992 |
Medical therapy of peptic ulcer disease.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Diet; Duodenal Ulcer; Histamine H2 Antag | 1992 |
[The medical therapy of peptic ulcer. The state of the art].
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Stoma | 1992 |
[The medical therapy of peptic ulcer. The state of the art].
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Stoma | 1992 |
Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Duodenal Ulcer; | 1992 |
Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Duodenal Ulcer; | 1992 |
[High demands on drug administration and pharmacological principles applied in ulcer diseases].
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Hista | 1991 |
[High demands on drug administration and pharmacological principles applied in ulcer diseases].
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Hista | 1991 |
Medical treatment of peptic ulcer disease.
Topics: Antacids; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Prostaglandins | 1991 |
Medical treatment of peptic ulcer disease.
Topics: Antacids; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Prostaglandins | 1991 |
[Intragastric pH modifications induced by antisecretory treatments].
Topics: Duodenal Ulcer; Esophagitis; Gastric Acidity Determination; Gastroesophageal Reflux; Histamine H2 An | 1991 |
[Intragastric pH modifications induced by antisecretory treatments].
Topics: Duodenal Ulcer; Esophagitis; Gastric Acidity Determination; Gastroesophageal Reflux; Histamine H2 An | 1991 |
[New developments in drug therapy: omeprazole].
Topics: Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Ranitidine; Smoking; Stomach Ulcer | 1991 |
[New developments in drug therapy: omeprazole].
Topics: Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Ranitidine; Smoking; Stomach Ulcer | 1991 |
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
Topics: Animals; Duodenal Ulcer; Esophagitis, Peptic; Gastrointestinal Diseases; Histamine H2 Antagonists; H | 1991 |
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
Topics: Animals; Duodenal Ulcer; Esophagitis, Peptic; Gastrointestinal Diseases; Histamine H2 Antagonists; H | 1991 |
Omeprazole.
Topics: Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Humans; Omeprazole; Stomach Ulcer; Zollinger-Ellison S | 1991 |
Omeprazole.
Topics: Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Humans; Omeprazole; Stomach Ulcer; Zollinger-Ellison S | 1991 |
Omeprazole. Overview and opinion.
Topics: Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Omeprazole; Stomach Ulce | 1991 |
Omeprazole. Overview and opinion.
Topics: Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Omeprazole; Stomach Ulce | 1991 |
[Ulcer disease--drug treatment and its limitations].
Topics: Campylobacter Infections; Duodenal Ulcer; Humans; Long-Term Care; Omeprazole; Organometallic Compoun | 1990 |
[Ulcer disease--drug treatment and its limitations].
Topics: Campylobacter Infections; Duodenal Ulcer; Humans; Long-Term Care; Omeprazole; Organometallic Compoun | 1990 |
Clinical experience with omeprazole: assessment of efficacy and safety.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulcer; Stomach Ulcer; Zollinger-Elli | 1989 |
Clinical experience with omeprazole: assessment of efficacy and safety.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulcer; Stomach Ulcer; Zollinger-Elli | 1989 |
The clinical utility and safety of omeprazole.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Multicenter Studies as Topic; | 1989 |
The clinical utility and safety of omeprazole.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Multicenter Studies as Topic; | 1989 |
Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Topics: Drug Administration Schedule; Duodenal Ulcer; Gastric Acid; Histamine H2 Antagonists; Humans; Omepra | 1989 |
Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Topics: Drug Administration Schedule; Duodenal Ulcer; Gastric Acid; Histamine H2 Antagonists; Humans; Omepra | 1989 |
Clinical utility and safety of omeprazole.
Topics: Animals; Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulcer; Stomach Ulcer; Zolli | 1989 |
Clinical utility and safety of omeprazole.
Topics: Animals; Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulcer; Stomach Ulcer; Zolli | 1989 |
Omeprazole in the acute treatment of gastric ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Wound Healing | 1989 |
Omeprazole in the acute treatment of gastric ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Wound Healing | 1989 |
Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
Topics: Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Therapeutic Equivalency | 1989 |
Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
Topics: Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Therapeutic Equivalency | 1989 |
Is there a need for strong gastric acid inhibition in clinical practice?
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Esophagitis, Peptic; Gastric Acid; Humans; Omeprazo | 1989 |
Is there a need for strong gastric acid inhibition in clinical practice?
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Esophagitis, Peptic; Gastric Acid; Humans; Omeprazo | 1989 |
Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
Topics: Drug Administration Schedule; Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Stomach Ulcer | 1989 |
Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
Topics: Drug Administration Schedule; Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Stomach Ulcer | 1989 |
H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Stomach Ulcer | 1989 |
H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Stomach Ulcer | 1989 |
[Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Aspi | 1986 |
[Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Aspi | 1986 |
Emerging strategies in ulcer therapy: pumps and receptors.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Pariet | 1985 |
Emerging strategies in ulcer therapy: pumps and receptors.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Pariet | 1985 |
Omeprazole.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Humans; Omeprazole; Sto | 1988 |
Omeprazole.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Humans; Omeprazole; Sto | 1988 |
Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Enprostil; Gastric Juice; Gastrins; Humans; | 1988 |
Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Enprostil; Gastric Juice; Gastrins; Humans; | 1988 |
235 trials available for omeprazole and Stomach Ulcer
| Article | Year |
|---|---|
Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea.
Topics: Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Prevalence; Stomach Ulcer | 2022 |
Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea.
Topics: Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Prevalence; Stomach Ulcer | 2022 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial.
Topics: Animals; Anti-Ulcer Agents; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Powders; S | 2023 |
A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial.
Topics: Animals; Anti-Ulcer Agents; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Powders; S | 2023 |
Effect of Changing Diet on Gastric Ulceration in Exercising Horses and Ponies After Cessation of Omeprazole Treatment.
Topics: Animals; Gastroscopy; Horse Diseases; Horses; Omeprazole; Physical Conditioning, Animal; Stomach Ulc | 2019 |
Effect of Changing Diet on Gastric Ulceration in Exercising Horses and Ponies After Cessation of Omeprazole Treatment.
Topics: Animals; Gastroscopy; Horse Diseases; Horses; Omeprazole; Physical Conditioning, Animal; Stomach Ulc | 2019 |
Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Omeprazole; Phenylbutazone | 2021 |
Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Omeprazole; Phenylbutazone | 2021 |
Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses | 2021 |
Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses | 2021 |
Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse.
Topics: Animals; Anti-Ulcer Agents; Delayed-Action Preparations; Dosage Forms; Female; Gastric Acidity Deter | 2017 |
Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse.
Topics: Animals; Anti-Ulcer Agents; Delayed-Action Preparations; Dosage Forms; Female; Gastric Acidity Deter | 2017 |
Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores.
Topics: Animals; Anti-Ulcer Agents; Dosage Forms; Gastric Acidity Determination; Horse Diseases; Horses; Hyd | 2017 |
Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores.
Topics: Animals; Anti-Ulcer Agents; Dosage Forms; Gastric Acidity Determination; Horse Diseases; Horses; Hyd | 2017 |
Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
Topics: Aloe; Animals; Female; Gels; Horse Diseases; Horses; Male; Omeprazole; Phytotherapy; Stomach Ulcer | 2018 |
Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
Topics: Aloe; Animals; Female; Gels; Horse Diseases; Horses; Male; Omeprazole; Phytotherapy; Stomach Ulcer | 2018 |
A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; | 2014 |
A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; | 2014 |
A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; | 2015 |
A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; | 2015 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; | 2015 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; | 2015 |
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind | 2014 |
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind | 2014 |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial.
Topics: Amoxicillin; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infection | 2014 |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial.
Topics: Amoxicillin; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infection | 2014 |
Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study.
Topics: Animals; Anti-Ulcer Agents; Female; Horse Diseases; Horses; Male; Omeprazole; Single-Blind Method; S | 2014 |
Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study.
Topics: Animals; Anti-Ulcer Agents; Female; Horse Diseases; Horses; Male; Omeprazole; Single-Blind Method; S | 2014 |
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Topics: Adolescent; Adult; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Dou | 2016 |
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Topics: Adolescent; Adult; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Dou | 2016 |
Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
Topics: Adult; Aged; Aged, 80 and over; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Adm | 2016 |
Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
Topics: Adult; Aged; Aged, 80 and over; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Adm | 2016 |
Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Dru | 2009 |
Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Dru | 2009 |
Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
Topics: Aged; Aged, 80 and over; Comorbidity; Confidence Intervals; Dose-Response Relationship, Drug; Drug A | 2009 |
Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
Topics: Aged; Aged, 80 and over; Comorbidity; Confidence Intervals; Dose-Response Relationship, Drug; Drug A | 2009 |
[Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Therapy, Combination; Female; | 2009 |
[Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Therapy, Combination; Female; | 2009 |
Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Drug Administratio | 2009 |
Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Drug Administratio | 2009 |
Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, | 2010 |
Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, | 2010 |
Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
Topics: Acute Disease; Anti-Ulcer Agents; Female; Gastroscopy; Hemostasis, Surgical; Humans; Infusions, Intr | 2011 |
Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
Topics: Acute Disease; Anti-Ulcer Agents; Female; Gastroscopy; Hemostasis, Surgical; Humans; Infusions, Intr | 2011 |
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2011 |
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2011 |
Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric | 2011 |
Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric | 2011 |
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric | 2012 |
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric | 2012 |
Efficacy of omeprazole paste in the prevention of gastric ulcers in 2 years old Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Stomach Ulcer | 2012 |
Efficacy of omeprazole paste in the prevention of gastric ulcers in 2 years old Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Stomach Ulcer | 2012 |
Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Horse Diseases; Horses; Ointments; Omeprazole; Physi | 2002 |
Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Horse Diseases; Horses; Ointments; Omeprazole; Physi | 2002 |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2002 |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2002 |
Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole.
Topics: Anti-Ulcer Agents; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newb | 2002 |
Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole.
Topics: Anti-Ulcer Agents; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newb | 2002 |
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; | 2002 |
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; | 2002 |
Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-Blind Me | 2003 |
Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-Blind Me | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Be | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Be | 2003 |
The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Female; Follow-Up Studies | 2003 |
The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Female; Follow-Up Studies | 2003 |
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clavulanic Acids; Double-Blin | 2003 |
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clavulanic Acids; Double-Blin | 2003 |
[Therapeutic effect of gastrozolum in stomach ulcers].
Topics: Administration, Oral; Adolescent; Adult; Aged; Dosage Forms; Drug Administration Schedule; Enzyme In | 2003 |
[Therapeutic effect of gastrozolum in stomach ulcers].
Topics: Administration, Oral; Adolescent; Adult; Aged; Dosage Forms; Drug Administration Schedule; Enzyme In | 2003 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Fe | 2003 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Fe | 2003 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; | 2004 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; | 2004 |
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Female; Humans; Male; Omeprazole; Pro | 2004 |
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Female; Humans; Male; Omeprazole; Pro | 2004 |
[Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Enzyme I | 2004 |
[Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Enzyme I | 2004 |
[The effect of rabeprazole on gastric pH in patients with gastric ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Meth | 2004 |
[The effect of rabeprazole on gastric pH in patients with gastric ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Meth | 2004 |
Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy, | 2004 |
Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy, | 2004 |
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2004 |
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2004 |
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agent | 2005 |
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agent | 2005 |
Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy.
Topics: Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 2005 |
Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy.
Topics: Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 2005 |
Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Di | 2005 |
Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Di | 2005 |
Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Di | 2005 |
Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Di | 2005 |
Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer.
Topics: Abomasum; Administration, Oral; Animal Nutritional Physiological Phenomena; Animals; Animals, Newbor | 2005 |
Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer.
Topics: Abomasum; Administration, Oral; Animal Nutritional Physiological Phenomena; Animals; Animals, Newbor | 2005 |
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Topics: Aged; Anti-Ulcer Agents; Cost-Benefit Analysis; Endoscopy, Gastrointestinal; Famotidine; Female; Gas | 2005 |
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Topics: Aged; Anti-Ulcer Agents; Cost-Benefit Analysis; Endoscopy, Gastrointestinal; Famotidine; Female; Gas | 2005 |
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 2005 |
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 2005 |
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Sc | 2005 |
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Sc | 2005 |
A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Be | 2005 |
A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Be | 2005 |
Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses | 2005 |
Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses | 2005 |
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
Topics: Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Hum | 2006 |
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
Topics: Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Hum | 2006 |
Effect of omeprazole on markers of performance in gastric ulcer-free standardbred horses.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Cross-Over Studies; Exercise Test; Female; Horses; | 2006 |
Effect of omeprazole on markers of performance in gastric ulcer-free standardbred horses.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Cross-Over Studies; Exercise Test; Female; Horses; | 2006 |
Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration.
Topics: Animals; Anti-Ulcer Agents; Female; Horse Diseases; Horses; Male; Omeprazole; Physical Conditioning, | 2007 |
Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration.
Topics: Animals; Anti-Ulcer Agents; Female; Horse Diseases; Horses; Male; Omeprazole; Physical Conditioning, | 2007 |
[Factors affecting efficacy of proton pump inhibitors in NAID-induced gastric ulcers].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Humans; Male; Middle Aged; Omepr | 2007 |
[Factors affecting efficacy of proton pump inhibitors in NAID-induced gastric ulcers].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Humans; Male; Middle Aged; Omepr | 2007 |
[Morphological observation on gastric mucosa membrane of patients with gastric ulcer treated with combined use of Qifang Weitong Powder and omeprazole].
Topics: Adult; Anti-Ulcer Agents; Biopsy, Needle; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; | 2007 |
[Morphological observation on gastric mucosa membrane of patients with gastric ulcer treated with combined use of Qifang Weitong Powder and omeprazole].
Topics: Adult; Anti-Ulcer Agents; Biopsy, Needle; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; | 2007 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; | 2007 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; | 2007 |
Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylas | 2008 |
Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylas | 2008 |
Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Dy | 2008 |
Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Dy | 2008 |
Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Dose-Response Relationship, Drug; Duoden | 1984 |
Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Dose-Response Relationship, Drug; Duoden | 1984 |
Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
Topics: Adult; Aged; Anti-Ulcer Agents; Confidence Intervals; Drug Therapy, Combination; Duodenal Ulcer; End | 1995 |
Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
Topics: Adult; Aged; Anti-Ulcer Agents; Confidence Intervals; Drug Therapy, Combination; Duodenal Ulcer; End | 1995 |
[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Topics: Aluminum Hydroxide; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; | 1995 |
[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Topics: Aluminum Hydroxide; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; | 1995 |
Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Famotidine; Female; Fibroblast Growth Fa | 1995 |
Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Famotidine; Female; Fibroblast Growth Fa | 1995 |
Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; | 1995 |
Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; | 1995 |
Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Drug Administration | 1995 |
Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Drug Administration | 1995 |
Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Jui | 1995 |
Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Jui | 1995 |
Efficacy of lansoprazole in eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidaz | 1995 |
Efficacy of lansoprazole in eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidaz | 1995 |
Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Anti | 1995 |
Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Anti | 1995 |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; D | 1995 |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; D | 1995 |
Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Amoxicillin; Anti-Bacterial Agents; Anti- | 1995 |
Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Amoxicillin; Anti-Bacterial Agents; Anti- | 1995 |
Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Female; Gastric | 1995 |
Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Female; Gastric | 1995 |
Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Famot | 1995 |
Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Famot | 1995 |
Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Famotidi | 1995 |
Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Famotidi | 1995 |
Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gas | 1995 |
Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gas | 1995 |
Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Gastric Mucosa; Gastroscopy; Histamine H | 1995 |
Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Gastric Mucosa; Gastroscopy; Histamine H | 1995 |
Effects of lansoprazole on gastric ulcer healing and mucin content.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Femal | 1995 |
Effects of lansoprazole on gastric ulcer healing and mucin content.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Femal | 1995 |
Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal | 1995 |
Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal | 1995 |
Quantitative analysis of the gastric ulcer healing process using video endoscopic pseudocolor imaging systems.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Epithelium; Female; Hemoglobins; | 1995 |
Quantitative analysis of the gastric ulcer healing process using video endoscopic pseudocolor imaging systems.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Epithelium; Female; Hemoglobins; | 1995 |
Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastric | 1995 |
Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastric | 1995 |
Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Atrophy; Duodenal Ulcer; Gastric Mucosa; | 1995 |
Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Atrophy; Duodenal Ulcer; Gastric Mucosa; | 1995 |
Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Drug Administration Schedule; Duo | 1995 |
Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Drug Administration Schedule; Duo | 1995 |
The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antibodi | 1995 |
The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antibodi | 1995 |
Effect of lansoprazole on peptic ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Female; Helicobacter Inf | 1995 |
Effect of lansoprazole on peptic ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Female; Helicobacter Inf | 1995 |
Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Cimetidine; Female; G | 1995 |
Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Cimetidine; Female; G | 1995 |
Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Helicobacter Infections; | 1995 |
Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Helicobacter Infections; | 1995 |
Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Admini | 1995 |
Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Admini | 1995 |
[Clinical significance of clearing Helicobacter pylori in the treatment of peptic ulcer].
Topics: Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Recurrence; Stoma | 1995 |
[Clinical significance of clearing Helicobacter pylori in the treatment of peptic ulcer].
Topics: Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Recurrence; Stoma | 1995 |
Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duode | 1995 |
Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duode | 1995 |
Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulce | 1995 |
Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulce | 1995 |
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Ad | 1995 |
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Ad | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1994 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1994 |
[Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-B | 1994 |
[Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-B | 1994 |
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 | 1995 |
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 | 1995 |
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.
Topics: Adult; Amoxicillin; Drug Synergism; Drug Therapy, Combination; Female; Helicobacter Infections; Heli | 1995 |
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.
Topics: Adult; Amoxicillin; Drug Synergism; Drug Therapy, Combination; Female; Helicobacter Infections; Heli | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Carb | 1994 |
Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Carb | 1994 |
Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals.
Topics: Adolescent; Adult; Aged; Amoxicillin; Drug Administration Schedule; Duodenal Ulcer; Eating; Female; | 1994 |
Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals.
Topics: Adolescent; Adult; Aged; Amoxicillin; Drug Administration Schedule; Duodenal Ulcer; Eating; Female; | 1994 |
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Clinical Trials as Topic; Drug Therapy, Combination; | 1994 |
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Clinical Trials as Topic; Drug Therapy, Combination; | 1994 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
Serum gastrin levels following administration of omeprazole alone or in combination with pirenzepine.
Topics: Drug Therapy, Combination; Duodenal Ulcer; Gastrins; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; | 1994 |
Serum gastrin levels following administration of omeprazole alone or in combination with pirenzepine.
Topics: Drug Therapy, Combination; Duodenal Ulcer; Gastrins; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; | 1994 |
[The treatment of upper digestive hemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole].
Topics: Chi-Square Distribution; Duodenal Ulcer; Female; Humans; Infusions, Intravenous; Male; Middle Aged; | 1994 |
[The treatment of upper digestive hemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole].
Topics: Chi-Square Distribution; Duodenal Ulcer; Female; Humans; Infusions, Intravenous; Male; Middle Aged; | 1994 |
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Topics: Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastr | 1994 |
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Topics: Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastr | 1994 |
Effect of omeprazole and sucralfate on prepyloric gastric ulcer. A double blind comparative trial and one year follow up.
Topics: Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; | 1994 |
Effect of omeprazole and sucralfate on prepyloric gastric ulcer. A double blind comparative trial and one year follow up.
Topics: Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; | 1994 |
Rapid healing of gastric ulcers with lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agen | 1994 |
Rapid healing of gastric ulcers with lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agen | 1994 |
Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1994 |
Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1994 |
Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infecti | 1994 |
Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infecti | 1994 |
Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enterochromaffin Cells; Eso | 1994 |
Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enterochromaffin Cells; Eso | 1994 |
Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Doubl | 1994 |
Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Doubl | 1994 |
Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Drug Administration | 1994 |
Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Drug Administration | 1994 |
Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Duodenal Ulcer; Epi | 1993 |
Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Duodenal Ulcer; Epi | 1993 |
An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug A | 1993 |
An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug A | 1993 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug The | 1996 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug The | 1996 |
Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.
Topics: Adult; Anti-Ulcer Agents; Chi-Square Distribution; Female; Gastroscopy; Hemostasis, Endoscopic; Huma | 1995 |
Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.
Topics: Adult; Anti-Ulcer Agents; Chi-Square Distribution; Female; Gastroscopy; Hemostasis, Endoscopic; Huma | 1995 |
Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acidity Determination; Humans; Hydrogen-Io | 1995 |
Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acidity Determination; Humans; Hydrogen-Io | 1995 |
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Duodenal Ulcer; Dy | 1996 |
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Duodenal Ulcer; Dy | 1996 |
Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Gas | 1996 |
Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Gas | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 1996 |
Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Autoradiography; Binding Sites; Biopsy; | 1995 |
Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Autoradiography; Binding Sites; Biopsy; | 1995 |
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Bismuth; Drug Administration Schedule; Drug The | 1996 |
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Bismuth; Drug Administration Schedule; Drug The | 1996 |
A trial of lansoprazole in refractory gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Anti-Ulcer Agents; Drug Resistanc | 1996 |
A trial of lansoprazole in refractory gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Anti-Ulcer Agents; Drug Resistanc | 1996 |
Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Ulcer | 1996 |
Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Ulcer | 1996 |
Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study.
Topics: Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Omeprazole; Pain; Patient Co | 1996 |
Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study.
Topics: Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Omeprazole; Pain; Patient Co | 1996 |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Dr | 1996 |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Dr | 1996 |
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer A | 1996 |
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer A | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A | 1997 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A | 1997 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromyci | 1997 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromyci | 1997 |
Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Female; Follow-Up Studies; Helicobacter | 1997 |
Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Female; Follow-Up Studies; Helicobacter | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Adm | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Adm | 1997 |
A comparison of omeprazole and placebo for bleeding peptic ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Fe | 1997 |
A comparison of omeprazole and placebo for bleeding peptic ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Fe | 1997 |
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.
Topics: Aged; Anti-Ulcer Agents; Blood Transfusion; Double-Blind Method; Duodenal Ulcer; Female; Hemostasis, | 1997 |
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.
Topics: Aged; Anti-Ulcer Agents; Blood Transfusion; Double-Blind Method; Duodenal Ulcer; Female; Hemostasis, | 1997 |
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.
Topics: Aged; Anti-Ulcer Agents; Blood Transfusion; Double-Blind Method; Duodenal Ulcer; Female; Hemostasis, | 1997 |
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.
Topics: Aged; Anti-Ulcer Agents; Blood Transfusion; Double-Blind Method; Duodenal Ulcer; Female; Hemostasis, | 1997 |
Does profound acid inhibition improve haemostasis in peptic ulcer bleeding?
Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Hemostasis, Endoscopic; Humans; Infusions, Intraveno | 1997 |
Does profound acid inhibition improve haemostasis in peptic ulcer bleeding?
Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Hemostasis, Endoscopic; Humans; Infusions, Intraveno | 1997 |
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal Ulcer; Female; Humans; Hydrogen-Ion Conc | 1997 |
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal Ulcer; Female; Humans; Hydrogen-Ion Conc | 1997 |
Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Muc | 1997 |
Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Muc | 1997 |
Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug | 1997 |
Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug | 1997 |
Treatment of bleeding peptic ulcers with omeprazole.
Topics: Anti-Ulcer Agents; Blood Transfusion; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Follow-Up S | 1997 |
Treatment of bleeding peptic ulcers with omeprazole.
Topics: Anti-Ulcer Agents; Blood Transfusion; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Follow-Up S | 1997 |
Prophylaxis of acute gastroduodenal bleeding after renal transplantation.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; | 1997 |
Prophylaxis of acute gastroduodenal bleeding after renal transplantation.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; | 1997 |
Parietal cell protrusions in gastric ulcer disease.
Topics: Chronic Disease; Double-Blind Method; Endoscopy, Digestive System; Gastric Mucosa; Gastritis; Helico | 1997 |
Parietal cell protrusions in gastric ulcer disease.
Topics: Chronic Disease; Double-Blind Method; Endoscopy, Digestive System; Gastric Mucosa; Gastritis; Helico | 1997 |
Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastroscopy; H | 1997 |
Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastroscopy; H | 1997 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; H | 1997 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; H | 1997 |
Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Synergis | 1997 |
Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Synergis | 1997 |
Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Dru | 1998 |
Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Dru | 1998 |
Prevention of gastric ulcer recurrence with tetraprenylacetone.
Topics: Adult; Aged; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Female; Gastric Mucosa; Helic | 1998 |
Prevention of gastric ulcer recurrence with tetraprenylacetone.
Topics: Adult; Aged; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Female; Gastric Mucosa; Helic | 1998 |
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-B | 1998 |
Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Cell Count; Double-Blind Method; | 1998 |
Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Cell Count; Double-Blind Method; | 1998 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Heli | 1998 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Heli | 1998 |
Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Dose-Respo | 1998 |
Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Dose-Respo | 1998 |
A comparison of omeprazole and placebo for bleeding peptic ulcer.
Topics: Anti-Ulcer Agents; Double-Blind Method; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Stomach Ulcer; | 1998 |
A comparison of omeprazole and placebo for bleeding peptic ulcer.
Topics: Anti-Ulcer Agents; Double-Blind Method; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Stomach Ulcer; | 1998 |
Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter | 1997 |
Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter | 1997 |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 1998 |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 1998 |
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up S | 1998 |
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up S | 1998 |
Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duode | 1998 |
Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duode | 1998 |
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agen | 1998 |
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agen | 1998 |
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; | 1998 |
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; | 1998 |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin | 1998 |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin | 1998 |
Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Ulcer Agents; Diterpenes; | 1998 |
Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Ulcer Agents; Diterpenes; | 1998 |
Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Topics: Adult; Aged; Alanine; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1998 |
Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Topics: Adult; Aged; Alanine; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1998 |
Omeprazole in the treatment of ulcers induced by NSAIDs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agen | 1998 |
Omeprazole in the treatment of ulcers induced by NSAIDs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agen | 1998 |
Effects of trimebutine maleate on gastric motility in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Drug Therapy, Combination; Enz | 1998 |
Effects of trimebutine maleate on gastric motility in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Drug Therapy, Combination; Enz | 1998 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration S | 1999 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration S | 1999 |
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer | 1999 |
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer | 1999 |
[Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
Topics: Anti-Ulcer Agents; Cimetidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Huma | 1999 |
[Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
Topics: Anti-Ulcer Agents; Cimetidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Huma | 1999 |
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Female; Helicobacter Infections; Helicobacter p | 1999 |
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Female; Helicobacter Infections; Helicobacter p | 1999 |
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicob | 1999 |
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicob | 1999 |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resis | 1999 |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resis | 1999 |
Evaluation of lansoprazole (an H+/K+-ATPase inhibitor) and azithromycin (an antibiotic) for control of gastric ulceration in swine during periods of feed deprivation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animal Feed; Animals; Anti-Bacterial Agents; Anti-Ulcer Age | 1999 |
Evaluation of lansoprazole (an H+/K+-ATPase inhibitor) and azithromycin (an antibiotic) for control of gastric ulceration in swine during periods of feed deprivation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animal Feed; Animals; Anti-Bacterial Agents; Anti-Ulcer Age | 1999 |
Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.
Topics: Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Duodenal | 2000 |
Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.
Topics: Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Duodenal | 2000 |
Safety of omeprazole paste in foals and mature horses.
Topics: Administration, Oral; Animals; Animals, Newborn; Enzyme Inhibitors; Female; Horse Diseases; Horses; | 1999 |
Safety of omeprazole paste in foals and mature horses.
Topics: Administration, Oral; Animals; Animals, Newborn; Enzyme Inhibitors; Female; Horse Diseases; Horses; | 1999 |
Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training.
Topics: Administration, Oral; Animals; Double-Blind Method; Enzyme Inhibitors; Female; Gastroscopy; Horse Di | 1999 |
Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training.
Topics: Administration, Oral; Animals; Double-Blind Method; Enzyme Inhibitors; Female; Gastroscopy; Horse Di | 1999 |
Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial.
Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Breeding; Double-Blind Method; Enzyme | 1999 |
Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial.
Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Breeding; Double-Blind Method; Enzyme | 1999 |
Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Female; Florida; Gastroscopy; Horse Diseases; Hors | 1999 |
Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Female; Florida; Gastroscopy; Horse Diseases; Hors | 1999 |
Clinical trial to determine the effect of omeprazole given once or twice daily on gastric ulceration.
Topics: Administration, Oral; Animals; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; | 1999 |
Clinical trial to determine the effect of omeprazole given once or twice daily on gastric ulceration.
Topics: Administration, Oral; Animals; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; | 1999 |
Effect of intragastric pH on control of peptic ulcer bleeding.
Topics: Adolescent; Adult; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Female; Gastric Aci | 2000 |
Effect of intragastric pH on control of peptic ulcer bleeding.
Topics: Adolescent; Adult; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Female; Gastric Aci | 2000 |
The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cross-Over Studies; Diclofenac; D | 2000 |
The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cross-Over Studies; Diclofenac; D | 2000 |
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Respon | 2000 |
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Respon | 2000 |
Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti- | 2000 |
Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti- | 2000 |
A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studie | 2000 |
A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studie | 2000 |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitricho | 2000 |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitricho | 2000 |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 2000 |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benef | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benef | 2000 |
Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti- | 2000 |
Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti- | 2000 |
Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug | 2000 |
Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug | 2000 |
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Female; Histamine | 2000 |
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Female; Histamine | 2000 |
The use of omeprazole to alleviate stomach ulcers in swine during periods of feed withdrawal.
Topics: Animal Feed; Animals; Anti-Ulcer Agents; Fasting; Gastric Acid; Omeprazole; Stomach Ulcer; Swine; Sw | 2000 |
The use of omeprazole to alleviate stomach ulcers in swine during periods of feed withdrawal.
Topics: Animal Feed; Animals; Anti-Ulcer Agents; Fasting; Gastric Acid; Omeprazole; Stomach Ulcer; Swine; Sw | 2000 |
Limited usefulness of a seven-day twice-a-day quadruple therapy.
Topics: Adult; Aged; Amoxicillin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administratio | 2000 |
Limited usefulness of a seven-day twice-a-day quadruple therapy.
Topics: Adult; Aged; Amoxicillin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administratio | 2000 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl | 2001 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl | 2001 |
Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.
Topics: Anti-Ulcer Agents; Chi-Square Distribution; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Ga | 2001 |
Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.
Topics: Anti-Ulcer Agents; Chi-Square Distribution; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Ga | 2001 |
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2001 |
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2001 |
Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study.
Topics: Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Ome | 2001 |
Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study.
Topics: Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Ome | 2001 |
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A | 2002 |
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A | 2002 |
[Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; C | 2002 |
[Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; C | 2002 |
Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Ster | 2001 |
Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Ster | 2001 |
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Biopsy; | 2002 |
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Biopsy; | 2002 |
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Gastric | 2001 |
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Gastric | 2001 |
Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans.
Topics: Aged; Anti-Ulcer Agents; Endoscopy; Famotidine; Female; Fibroblast Growth Factor 2; Humans; Male; Mi | 2002 |
Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans.
Topics: Aged; Anti-Ulcer Agents; Endoscopy; Famotidine; Female; Fibroblast Growth Factor 2; Humans; Male; Mi | 2002 |
[Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adolescent; Adult; Aged; Anti-Ul | 1992 |
[Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adolescent; Adult; Aged; Anti-Ul | 1992 |
Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Duodenal Ulcer; | 1992 |
Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Duodenal Ulcer; | 1992 |
Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Analysis of Variance; Anti-Ulcer Agents; Aspirin; Do | 1992 |
Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Analysis of Variance; Anti-Ulcer Agents; Aspirin; Do | 1992 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Dr | 1992 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Dr | 1992 |
Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Topics: Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Mid | 1991 |
Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Topics: Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Mid | 1991 |
Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Time | 1991 |
Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Time | 1991 |
An open trial on short-term omeprazole therapy for gastric and duodenal ulcers.
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Duodenal Ulcer; Duodenoscopy; Female; Gastroscopy; | 1991 |
An open trial on short-term omeprazole therapy for gastric and duodenal ulcers.
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Duodenal Ulcer; Duodenoscopy; Female; Gastroscopy; | 1991 |
Omeprazole.
Topics: Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Humans; Omeprazole; Stomach Ulcer; Zollinger-Ellison S | 1991 |
Omeprazole.
Topics: Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Humans; Omeprazole; Stomach Ulcer; Zollinger-Ellison S | 1991 |
Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Topics: Aged; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Multicenter Studies as | 1990 |
Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Topics: Aged; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Multicenter Studies as | 1990 |
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.
Topics: Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Randomized C | 1990 |
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.
Topics: Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Randomized C | 1990 |
Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.
Topics: Cimetidine; Double-Blind Method; Humans; Omeprazole; Random Allocation; Stomach Ulcer | 1990 |
Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.
Topics: Cimetidine; Double-Blind Method; Humans; Omeprazole; Random Allocation; Stomach Ulcer | 1990 |
Clinical experience with omeprazole: assessment of efficacy and safety.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulcer; Stomach Ulcer; Zollinger-Elli | 1989 |
Clinical experience with omeprazole: assessment of efficacy and safety.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulcer; Stomach Ulcer; Zollinger-Elli | 1989 |
Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Stomach | 1989 |
Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Stomach | 1989 |
Evaluation of omeprazole as a treatment for gastric and prepyloric ulcer in Korean patients.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Middle Aged; Omeprazole; Stomach Ulcer | 1989 |
Evaluation of omeprazole as a treatment for gastric and prepyloric ulcer in Korean patients.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Middle Aged; Omeprazole; Stomach Ulcer | 1989 |
Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group.
Topics: Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1989 |
Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group.
Topics: Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1989 |
Omeprazole and cimetidine in treating ulcers of the body of the stomach.
Topics: Cimetidine; Humans; Omeprazole; Stomach Ulcer | 1989 |
Omeprazole and cimetidine in treating ulcers of the body of the stomach.
Topics: Cimetidine; Humans; Omeprazole; Stomach Ulcer | 1989 |
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Follow-Up Studies; Gastric Acid; Gast | 1989 |
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Follow-Up Studies; Gastric Acid; Gast | 1989 |
The clinical utility and safety of omeprazole.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Multicenter Studies as Topic; | 1989 |
The clinical utility and safety of omeprazole.
Topics: Duodenal Ulcer; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Multicenter Studies as Topic; | 1989 |
Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Topics: Adult; Aged; Drug Evaluation; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle | 1989 |
Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Topics: Adult; Aged; Drug Evaluation; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle | 1989 |
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Topics: Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up | 1989 |
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Topics: Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up | 1989 |
New drug effective.
Topics: Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
New drug effective.
Topics: Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Follow-U | 1989 |
Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Follow-U | 1989 |
Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.
Topics: Cimetidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Omeprazole; Randomized Controlle | 1989 |
Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.
Topics: Cimetidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Omeprazole; Randomized Controlle | 1989 |
Omeprazole in the treatment of prepyloric ulcer: review of the results of the Danish Omeprazole Study Group.
Topics: Adult; Cimetidine; Denmark; Double-Blind Method; Follow-Up Studies; Gastric Acid; Humans; Middle Age | 1989 |
Omeprazole in the treatment of prepyloric ulcer: review of the results of the Danish Omeprazole Study Group.
Topics: Adult; Cimetidine; Denmark; Double-Blind Method; Follow-Up Studies; Gastric Acid; Humans; Middle Age | 1989 |
Omeprazole in the acute treatment of gastric ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Wound Healing | 1989 |
Omeprazole in the acute treatment of gastric ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Wound Healing | 1989 |
[Therapeutic achlorhydria: for which diseases, when and for how long?].
Topics: Achlorhydria; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Hi | 1988 |
[Therapeutic achlorhydria: for which diseases, when and for how long?].
Topics: Achlorhydria; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Hi | 1988 |
[The Italian pilot experience with omeprazole. Preliminary pharmacologic and clinical results].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Duodenal Ulcer; Female; Gastric Acid; Humans | 1987 |
[The Italian pilot experience with omeprazole. Preliminary pharmacologic and clinical results].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Duodenal Ulcer; Female; Gastric Acid; Humans | 1987 |
Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
Topics: Adenosine Triphosphatases; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulc | 1986 |
Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
Topics: Adenosine Triphosphatases; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulc | 1986 |
Omeprazole.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Humans; Omeprazole; Sto | 1988 |
Omeprazole.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Humans; Omeprazole; Sto | 1988 |
[Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Topics: Adult; Alprostadil; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Clinical Trials as Topic; Double-Bli | 1986 |
[Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Topics: Adult; Alprostadil; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Clinical Trials as Topic; Double-Bli | 1986 |
[Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
Topics: Adult; Alprostadil; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspiri | 1987 |
[Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
Topics: Adult; Alprostadil; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspiri | 1987 |
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; H | 1988 |
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; H | 1988 |
[Short-term therapy of stomach ulcer with single daily doses of omeprazole].
Topics: Adult; Aged; Benzimidazoles; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle | 1985 |
[Short-term therapy of stomach ulcer with single daily doses of omeprazole].
Topics: Adult; Aged; Benzimidazoles; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle | 1985 |
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study].
Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Femal | 1985 |
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study].
Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Femal | 1985 |
Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulcer | 1985 |
Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulcer | 1985 |
420 other studies available for omeprazole and Stomach Ulcer
| Article | Year |
|---|---|
Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.
Topics: Animals; Anti-Ulcer Agents; Enzyme Inhibitors; Ethanol; Gastric Acid; Molecular Structure; Proton Pu | 1999 |
Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.
Topics: Animals; Anti-Ulcer Agents; Enzyme Inhibitors; Ethanol; Gastric Acid; Molecular Structure; Proton Pu | 1999 |
Protective effects of steroid saponins from Paris polyphylla var. yunnanensis on ethanol- or indomethacin-induced gastric mucosal lesions in rats: structural requirement for activity and mode of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Carbohydrate Sequence; Ethanol; | 2003 |
Protective effects of steroid saponins from Paris polyphylla var. yunnanensis on ethanol- or indomethacin-induced gastric mucosal lesions in rats: structural requirement for activity and mode of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Carbohydrate Sequence; Ethanol; | 2003 |
Gastric cytoprotective activity of ilicic aldehyde: structure-activity relationships.
Topics: Animals; Anti-Ulcer Agents; Gastrointestinal Tract; Male; Rats; Rats, Wistar; Sesquiterpenes; Stomac | 2005 |
Gastric cytoprotective activity of ilicic aldehyde: structure-activity relationships.
Topics: Animals; Anti-Ulcer Agents; Gastrointestinal Tract; Male; Rats; Rats, Wistar; Sesquiterpenes; Stomac | 2005 |
Triterpene saponins with gastroprotective effects from tea seed (the seeds of Camellia sinensis).
Topics: Animals; Camellia sinensis; Plants, Medicinal; Rats; Saponins; Seeds; Stomach Ulcer; Structure-Activ | 2006 |
Triterpene saponins with gastroprotective effects from tea seed (the seeds of Camellia sinensis).
Topics: Animals; Camellia sinensis; Plants, Medicinal; Rats; Saponins; Seeds; Stomach Ulcer; Structure-Activ | 2006 |
Synthesis and antigastric ulcer activity of novel 5-isoproyl-3,8-dimethylazulene derivatives.
Topics: Animals; Anti-Ulcer Agents; Azulenes; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Mic | 2011 |
Synthesis and antigastric ulcer activity of novel 5-isoproyl-3,8-dimethylazulene derivatives.
Topics: Animals; Anti-Ulcer Agents; Azulenes; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Mic | 2011 |
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Benzimidazoles; Carrageenan; Drug Design; Edem | 2013 |
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Benzimidazoles; Carrageenan; Drug Design; Edem | 2013 |
Perforation of a decubitus gastric ulcer during intragastric balloon retrieval after surreptitious withdrawal of omeprazole.
Topics: Abdominal Pain; Gastric Balloon; Humans; Male; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer; Yo | 2022 |
Perforation of a decubitus gastric ulcer during intragastric balloon retrieval after surreptitious withdrawal of omeprazole.
Topics: Abdominal Pain; Gastric Balloon; Humans; Male; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer; Yo | 2022 |
Omeprazole prevents stress induced gastric ulcer by direct inhibition of MMP-2/TIMP-3 interactions.
Topics: Animals; Matrix Metalloproteinase 2; Omeprazole; Rats; Stomach Ulcer; Tissue Inhibitor of Metallopro | 2022 |
Omeprazole prevents stress induced gastric ulcer by direct inhibition of MMP-2/TIMP-3 interactions.
Topics: Animals; Matrix Metalloproteinase 2; Omeprazole; Rats; Stomach Ulcer; Tissue Inhibitor of Metallopro | 2022 |
The ameliorative effects of cinnamon oil against ethanol-induced gastric ulcer in rats by regulating oxidative stress and promoting angiogenesis.
Topics: Animals; Antioxidants; Body Weight; Cinnamomum zeylanicum; Ethanol; Omeprazole; Oxidative Stress; Ra | 2022 |
The ameliorative effects of cinnamon oil against ethanol-induced gastric ulcer in rats by regulating oxidative stress and promoting angiogenesis.
Topics: Animals; Antioxidants; Body Weight; Cinnamomum zeylanicum; Ethanol; Omeprazole; Oxidative Stress; Ra | 2022 |
Potential stem cell-Conditioned medium and their derived exosomes versus omeprazole in treatment of experimental model of gastric ulcer.
Topics: Animals; Culture Media, Conditioned; Exosomes; Gastric Mucosa; Models, Theoretical; Omeprazole; Rats | 2022 |
Potential stem cell-Conditioned medium and their derived exosomes versus omeprazole in treatment of experimental model of gastric ulcer.
Topics: Animals; Culture Media, Conditioned; Exosomes; Gastric Mucosa; Models, Theoretical; Omeprazole; Rats | 2022 |
Gastroprotective effects of Caragana ambigua stocks on ethanol-induced gastric ulcer in rats supported by LC-MS/MS characterization of formononetin and biochanin A.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Caragana; Chloroform; Chromatography, Liquid; Ethanol; Gas | 2022 |
Gastroprotective effects of Caragana ambigua stocks on ethanol-induced gastric ulcer in rats supported by LC-MS/MS characterization of formononetin and biochanin A.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Caragana; Chloroform; Chromatography, Liquid; Ethanol; Gas | 2022 |
Integrated serum pharmacochemistry and investigation of the anti-gastric ulcer effect of Zuojin pill in rats induced by ethanol.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Drugs, Chinese Herbal; Ethanol; Gastric Mucosa; Male; Omep | 2022 |
Integrated serum pharmacochemistry and investigation of the anti-gastric ulcer effect of Zuojin pill in rats induced by ethanol.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Drugs, Chinese Herbal; Ethanol; Gastric Mucosa; Male; Omep | 2022 |
Irbesartan reprofiling for the amelioration of ethanol-induced gastric mucosal injury in rats: Role of inflammation, apoptosis, and autophagy.
Topics: AMP-Activated Protein Kinases; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents; | 2022 |
Irbesartan reprofiling for the amelioration of ethanol-induced gastric mucosal injury in rats: Role of inflammation, apoptosis, and autophagy.
Topics: AMP-Activated Protein Kinases; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents; | 2022 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Effects of lansoprazole and omeprazole Combined With Antimicrobial Agents on Gastric Juice pH and Inflammatory Factors in Elderly Patients With Hp Positive Gastric Ulcer.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Ga | 2023 |
Topics: Helicobacter Infections; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Omepra | 2023 |
Topics: Helicobacter Infections; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Omepra | 2023 |
Topics: Animals; Ethanol; Omeprazole; Polysaccharides; Rats; Stomach Ulcer | 2023 |
Topics: Animals; Ethanol; Omeprazole; Polysaccharides; Rats; Stomach Ulcer | 2023 |
Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
Topics: Animals; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Retrospective Studies; Stomac | 2024 |
Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
Topics: Animals; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Retrospective Studies; Stomac | 2024 |
Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis.
Topics: Animals; Ethanol; Gastric Mucosa; Glutathione; Inflammation; Male; Mice; NF-kappa B; NLR Family, Pyr | 2023 |
Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis.
Topics: Animals; Ethanol; Gastric Mucosa; Glutathione; Inflammation; Male; Mice; NF-kappa B; NLR Family, Pyr | 2023 |
Gastro-Protective and Therapeutic Effect of Punica granatum against Stomach Ulcer Caused by Helicobacter Pylori.
Topics: Amoxicillin; Animals; Helicobacter Infections; Helicobacter pylori; Omeprazole; Pomegranate; Rats; S | 2023 |
Gastro-Protective and Therapeutic Effect of Punica granatum against Stomach Ulcer Caused by Helicobacter Pylori.
Topics: Amoxicillin; Animals; Helicobacter Infections; Helicobacter pylori; Omeprazole; Pomegranate; Rats; S | 2023 |
Effectiveness of natural biomaterials in the protection and healing of experimentally induced gastric mucosa Ulcer in rats.
Topics: Amygdalin; Animals; Anti-Ulcer Agents; Ethanol; Gastric Mucosa; Histamine; Omeprazole; Plant Extract | 2023 |
Effectiveness of natural biomaterials in the protection and healing of experimentally induced gastric mucosa Ulcer in rats.
Topics: Amygdalin; Animals; Anti-Ulcer Agents; Ethanol; Gastric Mucosa; Histamine; Omeprazole; Plant Extract | 2023 |
In vivo antiulcer activity, phytochemical exploration, and molecular modelling of the polyphenolic-rich fraction of Crepis sancta extract.
Topics: Animals; Anti-Ulcer Agents; Crepis; Gastric Mucosa; Male; Omeprazole; Phytochemicals; Phytotherapy; | 2020 |
In vivo antiulcer activity, phytochemical exploration, and molecular modelling of the polyphenolic-rich fraction of Crepis sancta extract.
Topics: Animals; Anti-Ulcer Agents; Crepis; Gastric Mucosa; Male; Omeprazole; Phytochemicals; Phytotherapy; | 2020 |
Omeprazole Reduces Calcium Digestibility in Thoroughbred Horses.
Topics: Animals; Calcium, Dietary; Diet; Horse Diseases; Horses; Omeprazole; Proton Pump Inhibitors; Stomach | 2020 |
Omeprazole Reduces Calcium Digestibility in Thoroughbred Horses.
Topics: Animals; Calcium, Dietary; Diet; Horse Diseases; Horses; Omeprazole; Proton Pump Inhibitors; Stomach | 2020 |
Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Disease Models, Animal; Gastric Emptyin | 2020 |
Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Disease Models, Animal; Gastric Emptyin | 2020 |
A potential drug combination of omeprazole and patchouli alcohol significantly normalizes oxidative stress and inflammatory responses against gastric ulcer in ethanol-induced rat model.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Apoptosis; Cell Line; Cytokines; | 2020 |
A potential drug combination of omeprazole and patchouli alcohol significantly normalizes oxidative stress and inflammatory responses against gastric ulcer in ethanol-induced rat model.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Apoptosis; Cell Line; Cytokines; | 2020 |
Extraction, purification, and determination of the gastroprotective activity of glucomannan from Bletilla striata.
Topics: Animals; Antioxidants; Catalase; Cell Line; Epithelial Cells; Ethanol; Gastric Mucosa; Gastrointesti | 2020 |
Extraction, purification, and determination of the gastroprotective activity of glucomannan from Bletilla striata.
Topics: Animals; Antioxidants; Catalase; Cell Line; Epithelial Cells; Ethanol; Gastric Mucosa; Gastrointesti | 2020 |
Effect of oral administration of omeprazole on the microbiota of the gastric glandular mucosa and feces of healthy horses.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Feces; Gastric Mucosa; Horse Diseases; Horses; Mi | 2020 |
Effect of oral administration of omeprazole on the microbiota of the gastric glandular mucosa and feces of healthy horses.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Feces; Gastric Mucosa; Horse Diseases; Horses; Mi | 2020 |
The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Indomethacin; Male; Metformin; N | 2021 |
The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Indomethacin; Male; Metformin; N | 2021 |
The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Su | 2021 |
The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Su | 2021 |
Histopathological effects on stomach, liver and kidney associated with Cedrus deodara root oil in ulcer induced rats (Wistar strain).
Topics: Animals; Anti-Ulcer Agents; Cedrus; Ethanol; Kidney; Liver; Medicine, Ayurvedic; Omeprazole; Plant O | 2020 |
Histopathological effects on stomach, liver and kidney associated with Cedrus deodara root oil in ulcer induced rats (Wistar strain).
Topics: Animals; Anti-Ulcer Agents; Cedrus; Ethanol; Kidney; Liver; Medicine, Ayurvedic; Omeprazole; Plant O | 2020 |
Effectiveness and safety of Chinese medicine combined with omeprazole in the treatment of gastric ulcer: A protocol for systematic review and meta-analysis.
Topics: Combined Modality Therapy; Humans; Medicine, Chinese Traditional; Meta-Analysis as Topic; Omeprazole | 2021 |
Effectiveness and safety of Chinese medicine combined with omeprazole in the treatment of gastric ulcer: A protocol for systematic review and meta-analysis.
Topics: Combined Modality Therapy; Humans; Medicine, Chinese Traditional; Meta-Analysis as Topic; Omeprazole | 2021 |
Effectiveness of the polyphenols-rich Sedum dendroideum infusion on gastric ulcer healing in rats: Roles of protective endogenous factors and antioxidant and anti-inflammatory mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Female; | 2021 |
Effectiveness of the polyphenols-rich Sedum dendroideum infusion on gastric ulcer healing in rats: Roles of protective endogenous factors and antioxidant and anti-inflammatory mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Female; | 2021 |
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
Topics: Administration, Oral; Animals; Catalase; Diclofenac; Disease Models, Animal; Ethanol; Male; Mice; Om | 2021 |
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
Topics: Administration, Oral; Animals; Catalase; Diclofenac; Disease Models, Animal; Ethanol; Male; Mice; Om | 2021 |
Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apoptosis; Diclofenac; Dose-Res | 2017 |
Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apoptosis; Diclofenac; Dose-Res | 2017 |
A Rare Case of Gastric Ulcer Penetrating the Pancreas that was Successfully Managed by Conservative Therapy.
Topics: Anti-Ulcer Agents; Conservative Treatment; Female; Humans; Middle Aged; Omeprazole; Pancreas; Rare D | 2017 |
A Rare Case of Gastric Ulcer Penetrating the Pancreas that was Successfully Managed by Conservative Therapy.
Topics: Anti-Ulcer Agents; Conservative Treatment; Female; Humans; Middle Aged; Omeprazole; Pancreas; Rare D | 2017 |
Protective effects of orange (Citrus sinensis L.) peel aqueous extract and hesperidin on oxidative stress and peptic ulcer induced by alcohol in rat.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Catalase; Citrus sinensis; Cyclooxygenase 2; Ethanol; Frui | 2017 |
Protective effects of orange (Citrus sinensis L.) peel aqueous extract and hesperidin on oxidative stress and peptic ulcer induced by alcohol in rat.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Catalase; Citrus sinensis; Cyclooxygenase 2; Ethanol; Frui | 2017 |
Comparison between tocotrienol and omeprazole on gastric growth factors in stress-exposed rats.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Fibroblast Growth Factor 2; Gastri | 2017 |
Comparison between tocotrienol and omeprazole on gastric growth factors in stress-exposed rats.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Fibroblast Growth Factor 2; Gastri | 2017 |
Stability Indicating Liquid Chromatographic Method for Simultaneous Determination of Aspirin and Omeprazole.
Topics: Aspirin; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Drug Co | 2018 |
Stability Indicating Liquid Chromatographic Method for Simultaneous Determination of Aspirin and Omeprazole.
Topics: Aspirin; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Drug Co | 2018 |
Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Cyclooxygenase 2; Diabetes Mellitus, | 2018 |
Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Cyclooxygenase 2; Diabetes Mellitus, | 2018 |
A rare case report of fungal esophagitis combined with giant gastric ulcer in an immunocompetent patient.
Topics: Aged; Anti-Ulcer Agents; Antifungal Agents; Endoscopy, Gastrointestinal; Esophagitis; Fluconazole; H | 2019 |
A rare case report of fungal esophagitis combined with giant gastric ulcer in an immunocompetent patient.
Topics: Aged; Anti-Ulcer Agents; Antifungal Agents; Endoscopy, Gastrointestinal; Esophagitis; Fluconazole; H | 2019 |
Effect of Hydrotalcite on Indometacin-Induced Gastric Injury in Rats.
Topics: Aluminum Hydroxide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygena | 2019 |
Effect of Hydrotalcite on Indometacin-Induced Gastric Injury in Rats.
Topics: Aluminum Hydroxide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygena | 2019 |
[Therapeutic effect of total triterpenoids of Chaenomeles speciosa combined with omeprazole on gastric ulcer induced by indomethacin in rats].
Topics: Animals; Cytokines; Gastric Mucosa; Indomethacin; Omeprazole; Phytochemicals; Random Allocation; Rat | 2019 |
[Therapeutic effect of total triterpenoids of Chaenomeles speciosa combined with omeprazole on gastric ulcer induced by indomethacin in rats].
Topics: Animals; Cytokines; Gastric Mucosa; Indomethacin; Omeprazole; Phytochemicals; Random Allocation; Rat | 2019 |
Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Ethanol; Female; Fruit; Gastric Acid; G | 2013 |
Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Ethanol; Female; Fruit; Gastric Acid; G | 2013 |
Extraction of the volatile oil from Carum carvi of Tunisia and Lithuania by supercritical carbon dioxide: chemical composition and antiulcerogenic activity.
Topics: Animals; Anti-Ulcer Agents; Apiaceae; Carbon Dioxide; Drug Evaluation, Preclinical; Male; Oils, Vola | 2013 |
Extraction of the volatile oil from Carum carvi of Tunisia and Lithuania by supercritical carbon dioxide: chemical composition and antiulcerogenic activity.
Topics: Animals; Anti-Ulcer Agents; Apiaceae; Carbon Dioxide; Drug Evaluation, Preclinical; Male; Oils, Vola | 2013 |
Anti-inflammatory, gastroprotective and anti-ulcerogenic effects of red algae Gracilaria changii (Gracilariales, Rhodophyta) extract.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Betamethasone; Cell Line, Tumor; Chlorophyll; | 2013 |
Anti-inflammatory, gastroprotective and anti-ulcerogenic effects of red algae Gracilaria changii (Gracilariales, Rhodophyta) extract.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Betamethasone; Cell Line, Tumor; Chlorophyll; | 2013 |
Inhibition of TNF-α, and NF-κB and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catechols; Disease Models, Anim | 2013 |
Inhibition of TNF-α, and NF-κB and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catechols; Disease Models, Anim | 2013 |
The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Pro | 2013 |
The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Pro | 2013 |
Anti-secretory and cyto-protective effects of peganine hydrochloride isolated from the seeds of Peganum harmala on gastric ulcers.
Topics: Alcohols; Alkaloids; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Cold Temperature; Disease Mo | 2013 |
Anti-secretory and cyto-protective effects of peganine hydrochloride isolated from the seeds of Peganum harmala on gastric ulcers.
Topics: Alcohols; Alkaloids; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Cold Temperature; Disease Mo | 2013 |
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III | 2013 |
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III | 2013 |
Evaluation of antiulcerogenic potential of antioxidant α-tocopherol in pylorus-ligated albino rats.
Topics: alpha-Tocopherol; Animals; Anti-Ulcer Agents; Antioxidants; Female; Gastric Acid; Gastric Acidity De | 2014 |
Evaluation of antiulcerogenic potential of antioxidant α-tocopherol in pylorus-ligated albino rats.
Topics: alpha-Tocopherol; Animals; Anti-Ulcer Agents; Antioxidants; Female; Gastric Acid; Gastric Acidity De | 2014 |
Acid buffering effects of aqueous leaf extract of Ocimum gratissimum L. in the rabbit stomach.
Topics: Animals; Anti-Ulcer Agents; Buffers; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Male; | 2013 |
Acid buffering effects of aqueous leaf extract of Ocimum gratissimum L. in the rabbit stomach.
Topics: Animals; Anti-Ulcer Agents; Buffers; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Male; | 2013 |
[Effect of schemes second line quadruple therapy on interactions of some protective factors in gastric mucosal tissue in experimental ulcer].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Models, Animal; Drug Therapy | 2013 |
[Effect of schemes second line quadruple therapy on interactions of some protective factors in gastric mucosal tissue in experimental ulcer].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Models, Animal; Drug Therapy | 2013 |
Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.
Topics: Animals; Anti-Ulcer Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Disease M | 2014 |
Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.
Topics: Animals; Anti-Ulcer Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Disease M | 2014 |
Anti-ulcerogenic mechanism of magnesium in indomethacin induced gastric ulcer in rats.
Topics: Animals; Anti-Ulcer Agents; Cytoprotection; Disease Models, Animal; Gastric Mucosa; Indomethacin; Ma | 2013 |
Anti-ulcerogenic mechanism of magnesium in indomethacin induced gastric ulcer in rats.
Topics: Animals; Anti-Ulcer Agents; Cytoprotection; Disease Models, Animal; Gastric Mucosa; Indomethacin; Ma | 2013 |
Comparison of the effect of two doses of omeprazole on the squamous gastric mucosa in thoroughbred racehorses.
Topics: Animals; Anti-Ulcer Agents; Breeding; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Hors | 2014 |
Comparison of the effect of two doses of omeprazole on the squamous gastric mucosa in thoroughbred racehorses.
Topics: Animals; Anti-Ulcer Agents; Breeding; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Hors | 2014 |
Occupational allergic contact dermatitis caused by omeprazole in a horse breeder.
Topics: Adult; Animals; Cross Reactions; Dermatitis, Allergic Contact; Dermatitis, Occupational; Female; Hor | 2014 |
Occupational allergic contact dermatitis caused by omeprazole in a horse breeder.
Topics: Adult; Animals; Cross Reactions; Dermatitis, Allergic Contact; Dermatitis, Occupational; Female; Hor | 2014 |
Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Female; Gastric Acid; Gastric Acidity Determination; | 2015 |
Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Female; Gastric Acid; Gastric Acidity Determination; | 2015 |
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Topics: Adenocarcinoma; Adenoma; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastroscopy; Humans; Male; | 2015 |
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Topics: Adenocarcinoma; Adenoma; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastroscopy; Humans; Male; | 2015 |
Mangiferin Mitigates Gastric Ulcer in Ischemia/ Reperfused Rats: Involvement of PPAR-γ, NF-κB and Nrf2/HO-1 Signaling Pathways.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Gene Expression Regulation; Heme | 2015 |
Mangiferin Mitigates Gastric Ulcer in Ischemia/ Reperfused Rats: Involvement of PPAR-γ, NF-κB and Nrf2/HO-1 Signaling Pathways.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Gene Expression Regulation; Heme | 2015 |
Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Catalase; Clostridium butyricum; Cold Temperature; Disease Mo | 2015 |
Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Catalase; Clostridium butyricum; Cold Temperature; Disease Mo | 2015 |
Preventive Effects of Tocotrienol on Stress-Induced Gastric Mucosal Lesions and Its Relation to Oxidative and Inflammatory Biomarkers.
Topics: Animals; Antioxidants; Biomarkers; Gastric Mucosa; Inflammation; Interleukin-1beta; Lipid Peroxidati | 2015 |
Preventive Effects of Tocotrienol on Stress-Induced Gastric Mucosal Lesions and Its Relation to Oxidative and Inflammatory Biomarkers.
Topics: Animals; Antioxidants; Biomarkers; Gastric Mucosa; Inflammation; Interleukin-1beta; Lipid Peroxidati | 2015 |
Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4.
Topics: Acetophenones; Animals; Caspase 3; Cytoprotection; Ethanol; Gastric Juice; Hydrogen-Ion Concentratio | 2015 |
Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4.
Topics: Acetophenones; Animals; Caspase 3; Cytoprotection; Ethanol; Gastric Juice; Hydrogen-Ion Concentratio | 2015 |
Histopathological evaluation of gastro protective effect of Berberis vulgaris (Zereshk) seeds against aspirin induced ulcer in albino mice.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Berberis; Cell Proliferatio | 2015 |
Histopathological evaluation of gastro protective effect of Berberis vulgaris (Zereshk) seeds against aspirin induced ulcer in albino mice.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Berberis; Cell Proliferatio | 2015 |
Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Chemokine CC | 2016 |
Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Chemokine CC | 2016 |
Nebivolol prevents indomethacin-induced gastric ulcer in rats.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Dinoprostone; Glutathione; Humans; Indomethacin; Male; | 2016 |
Nebivolol prevents indomethacin-induced gastric ulcer in rats.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Dinoprostone; Glutathione; Humans; Indomethacin; Male; | 2016 |
Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Manganese (II) Complex against HCl/Ethanol-Induced Gastric Ulcerations in Rats.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Female; Gastric Mucosa; Kidney; Liver; Male; Manganese; Omepraz | 2016 |
Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Manganese (II) Complex against HCl/Ethanol-Induced Gastric Ulcerations in Rats.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Female; Gastric Mucosa; Kidney; Liver; Male; Manganese; Omepraz | 2016 |
The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Diet; Dose-Response Relationship, Drug; Gastric Acid | 2017 |
The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Diet; Dose-Response Relationship, Drug; Gastric Acid | 2017 |
Multiple gastric erosions diagnosed by means of capsule endoscopy in a dog.
Topics: Animals; Anti-Ulcer Agents; Capsule Endoscopes; Dog Diseases; Dogs; Female; Omeprazole; Stomach Ulce | 2016 |
Multiple gastric erosions diagnosed by means of capsule endoscopy in a dog.
Topics: Animals; Anti-Ulcer Agents; Capsule Endoscopes; Dog Diseases; Dogs; Female; Omeprazole; Stomach Ulce | 2016 |
Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model.
Topics: Angiography; Animals; Anti-Ulcer Agents; Arteries; Biomarkers; Cytoprotection; Down-Regulation; Embo | 2016 |
Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model.
Topics: Angiography; Animals; Anti-Ulcer Agents; Arteries; Biomarkers; Cytoprotection; Down-Regulation; Embo | 2016 |
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.
Topics: Adrenal Cortex Hormones; Animals; Anti-Ulcer Agents; Atropine; Cutaneous Fistula; Disease Models, An | 2009 |
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.
Topics: Adrenal Cortex Hormones; Animals; Anti-Ulcer Agents; Atropine; Cutaneous Fistula; Disease Models, An | 2009 |
Myristica malabarica heals stomach ulceration by increasing prostaglandin synthesis and angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; D | 2008 |
Myristica malabarica heals stomach ulceration by increasing prostaglandin synthesis and angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; D | 2008 |
Regulation of arginase/nitric oxide synthesis axis via cytokine balance contributes to the healing action of malabaricone B against indomethacin-induced gastric ulceration in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arginase; Cytokines; Indomethac | 2009 |
Regulation of arginase/nitric oxide synthesis axis via cytokine balance contributes to the healing action of malabaricone B against indomethacin-induced gastric ulceration in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arginase; Cytokines; Indomethac | 2009 |
The anti-ulcer activities of bisabolangelone from Angelica polymorpha.
Topics: Angelica; Animals; Anti-Ulcer Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gast | 2009 |
The anti-ulcer activities of bisabolangelone from Angelica polymorpha.
Topics: Angelica; Animals; Anti-Ulcer Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gast | 2009 |
Effect of gastric ulceration on physiologic responses to exercise in horses.
Topics: Animals; Anti-Ulcer Agents; Female; Food Deprivation; Gastric Mucosa; Horse Diseases; Horses; Male; | 2009 |
Effect of gastric ulceration on physiologic responses to exercise in horses.
Topics: Animals; Anti-Ulcer Agents; Female; Food Deprivation; Gastric Mucosa; Horse Diseases; Horses; Male; | 2009 |
It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
Topics: Antiviral Agents; Endoscopy, Gastrointestinal; Hemostatic Techniques; Humans; Injections, Intravenou | 2009 |
It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
Topics: Antiviral Agents; Endoscopy, Gastrointestinal; Hemostatic Techniques; Humans; Injections, Intravenou | 2009 |
Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Asian People; Drug Administration Sch | 2009 |
Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Asian People; Drug Administration Sch | 2009 |
Phytochemical analyses and gastroprotective effects of Eugenia umbelliflora (Myrtaceae) on experimental gastric ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Central Nervous System Depressa | 2009 |
Phytochemical analyses and gastroprotective effects of Eugenia umbelliflora (Myrtaceae) on experimental gastric ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Central Nervous System Depressa | 2009 |
Inappropriate use of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Cross-Sectional Studies; Dyspepsia | 2010 |
Inappropriate use of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Cross-Sectional Studies; Dyspepsia | 2010 |
[An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Humans; Hypocalcemia; Hypokalemia; Hypoparathyro | 2009 |
[An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Humans; Hypocalcemia; Hypokalemia; Hypoparathyro | 2009 |
[Delayed hypersensitivity to sodium lauryl sulphate in omeprazole].
Topics: Anti-Ulcer Agents; Drug Hypersensitivity; Excipients; Female; Humans; Hypersensitivity, Delayed; Mid | 2009 |
[Delayed hypersensitivity to sodium lauryl sulphate in omeprazole].
Topics: Anti-Ulcer Agents; Drug Hypersensitivity; Excipients; Female; Humans; Hypersensitivity, Delayed; Mid | 2009 |
Controversial warning on Plavix and stomach-protecting medications.
Topics: Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Drug Labeling; Health Knowledge, Attitudes, Pract | 2010 |
Controversial warning on Plavix and stomach-protecting medications.
Topics: Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Drug Labeling; Health Knowledge, Attitudes, Pract | 2010 |
Interactive medical case. Bitter pills.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Creatini | 2010 |
Interactive medical case. Bitter pills.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Creatini | 2010 |
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Synergi | 2012 |
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Synergi | 2012 |
Clinical problem-solving. Bitter pills.
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Diagnosis, Di | 2010 |
Clinical problem-solving. Bitter pills.
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Diagnosis, Di | 2010 |
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bombesin; Drug | 2011 |
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bombesin; Drug | 2011 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resis | 2010 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resis | 2010 |
Anti-ulcer constituents of Annona squamosa twigs.
Topics: Animals; Annona; Anti-Ulcer Agents; Aporphines; Aspirin; Benzylisoquinolines; Berberine Alkaloids; C | 2011 |
Anti-ulcer constituents of Annona squamosa twigs.
Topics: Animals; Annona; Anti-Ulcer Agents; Aporphines; Aspirin; Benzylisoquinolines; Berberine Alkaloids; C | 2011 |
What is the evidence? Portosystemic shunt in a dog.
Topics: Animals; Anti-Ulcer Agents; Diet; Dog Diseases; Dogs; Evidence-Based Medicine; Gastrointestinal Hemo | 2011 |
What is the evidence? Portosystemic shunt in a dog.
Topics: Animals; Anti-Ulcer Agents; Diet; Dog Diseases; Dogs; Evidence-Based Medicine; Gastrointestinal Hemo | 2011 |
Black tea and theaflavins suppress various inflammatory modulators and i-NOS mediated nitric oxide synthesis during gastric ulcer healing.
Topics: Animals; Biflavonoids; Catechin; Cell Adhesion Molecules; Immunoblotting; Indomethacin; Mice; Nitric | 2011 |
Black tea and theaflavins suppress various inflammatory modulators and i-NOS mediated nitric oxide synthesis during gastric ulcer healing.
Topics: Animals; Biflavonoids; Catechin; Cell Adhesion Molecules; Immunoblotting; Indomethacin; Mice; Nitric | 2011 |
Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Catechin; Disease | 2011 |
Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Catechin; Disease | 2011 |
Comparative healing property of kombucha tea and black tea against indomethacin-induced gastric ulceration in mice: possible mechanism of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Models, Animal; Ferment | 2010 |
Comparative healing property of kombucha tea and black tea against indomethacin-induced gastric ulceration in mice: possible mechanism of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Models, Animal; Ferment | 2010 |
Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate.
Topics: Animals; Anti-Ulcer Agents; Catechin; Gene Expression Regulation; Intercellular Adhesion Molecule-1; | 2011 |
Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate.
Topics: Animals; Anti-Ulcer Agents; Catechin; Gene Expression Regulation; Intercellular Adhesion Molecule-1; | 2011 |
Gastroprotective effect of Senecio candicans DC on experimental ulcer models.
Topics: Adenosine Triphosphatases; Alkaloids; Animals; Anti-Ulcer Agents; Antioxidants; Biphenyl Compounds; | 2012 |
Gastroprotective effect of Senecio candicans DC on experimental ulcer models.
Topics: Adenosine Triphosphatases; Alkaloids; Animals; Anti-Ulcer Agents; Antioxidants; Biphenyl Compounds; | 2012 |
Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Arbutin; Aspirin; Cell Line; Cytoprotection; Disease Model | 2012 |
Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Arbutin; Aspirin; Cell Line; Cytoprotection; Disease Model | 2012 |
Effects of Pithecellobium jiringa ethanol extract against ethanol-induced gastric mucosal injuries in Sprague-Dawley rats.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Female; Gastric Mucosa; Kidney; Lipid Peroxidation; Lipid-Linke | 2012 |
Effects of Pithecellobium jiringa ethanol extract against ethanol-induced gastric mucosal injuries in Sprague-Dawley rats.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Female; Gastric Mucosa; Kidney; Lipid Peroxidation; Lipid-Linke | 2012 |
Methanol extract of Bauhinia purpurea leaf possesses anti-ulcer activity.
Topics: Animals; Bauhinia; Dose-Response Relationship, Drug; Gastrointestinal Agents; Indomethacin; Male; Me | 2012 |
Methanol extract of Bauhinia purpurea leaf possesses anti-ulcer activity.
Topics: Animals; Bauhinia; Dose-Response Relationship, Drug; Gastrointestinal Agents; Indomethacin; Male; Me | 2012 |
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Interactions; Famotidine; Gastric Acid; Gastr | 2012 |
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Interactions; Famotidine; Gastric Acid; Gastr | 2012 |
Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Carbohydrate Metabolism; Cell Proliferation; Cold Temperature; | 2012 |
Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Carbohydrate Metabolism; Cell Proliferation; Cold Temperature; | 2012 |
Cytoprotective effect of benzyl N'-(5-chloro-indol-3-yl-methylidene)-hydrazinecarbodithioate against ethanol-induced gastric mucosal injury in rats.
Topics: Animals; Anti-Ulcer Agents; Benzyl Compounds; Cytoprotection; Drug Evaluation, Preclinical; Ethanol; | 2012 |
Cytoprotective effect of benzyl N'-(5-chloro-indol-3-yl-methylidene)-hydrazinecarbodithioate against ethanol-induced gastric mucosal injury in rats.
Topics: Animals; Anti-Ulcer Agents; Benzyl Compounds; Cytoprotection; Drug Evaluation, Preclinical; Ethanol; | 2012 |
Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Indoles; Male; Omeprazole; Rats; Stomach; Sto | 2014 |
Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Indoles; Male; Omeprazole; Rats; Stomach; Sto | 2014 |
Gastroprotective effects of extracts and guttiferone A isolated from Garcinia achachairu Rusby (Clusiaceae) against experimentally induced gastric lesions in mice.
Topics: Animals; Anti-Ulcer Agents; Benzophenones; Disease Models, Animal; Dose-Response Relationship, Drug; | 2012 |
Gastroprotective effects of extracts and guttiferone A isolated from Garcinia achachairu Rusby (Clusiaceae) against experimentally induced gastric lesions in mice.
Topics: Animals; Anti-Ulcer Agents; Benzophenones; Disease Models, Animal; Dose-Response Relationship, Drug; | 2012 |
Antiulcer activity of the chloroform extract of Bauhinia purpurea leaf.
Topics: Animals; Anti-Ulcer Agents; Bauhinia; Chloroform; Chromatography, High Pressure Liquid; Cytoprotecti | 2012 |
Antiulcer activity of the chloroform extract of Bauhinia purpurea leaf.
Topics: Animals; Anti-Ulcer Agents; Bauhinia; Chloroform; Chromatography, High Pressure Liquid; Cytoprotecti | 2012 |
Refractory ulcer of reconstructed gastric tube after esophagectomy: a case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Carcinoma, Squamous Cell; Cy | 2013 |
Refractory ulcer of reconstructed gastric tube after esophagectomy: a case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Carcinoma, Squamous Cell; Cy | 2013 |
Thymoquinone: Novel gastroprotective mechanisms.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Benzoquinones; Cytoprotection; Disease Models, Animal; Gas | 2012 |
Thymoquinone: Novel gastroprotective mechanisms.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Benzoquinones; Cytoprotection; Disease Models, Animal; Gas | 2012 |
Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cytoprotection; Dinoprostone; Disease Models, Anim | 2012 |
Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cytoprotection; Dinoprostone; Disease Models, Anim | 2012 |
Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Carbenoxolone; Ch | 2013 |
Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Carbenoxolone; Ch | 2013 |
[Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Epithelium; Famotidine; Gastric | 2002 |
[Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Epithelium; Famotidine; Gastric | 2002 |
Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats.
Topics: Animals; Ethanol; Gastric Mucosa; Hydrochloric Acid; Lipid Peroxidation; Omeprazole; Phytotherapy; P | 2002 |
Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats.
Topics: Animals; Ethanol; Gastric Mucosa; Hydrochloric Acid; Lipid Peroxidation; Omeprazole; Phytotherapy; P | 2002 |
[Changes of rat gastric mucosal barrier under stress conditions].
Topics: Animals; Anti-Ulcer Agents; Bicarbonates; Gastric Acid; Gastric Mucosa; Male; Mucus; Omeprazole; Pro | 2002 |
[Changes of rat gastric mucosal barrier under stress conditions].
Topics: Animals; Anti-Ulcer Agents; Bicarbonates; Gastric Acid; Gastric Mucosa; Male; Mucus; Omeprazole; Pro | 2002 |
Nonhealing gastric ulcer caused by chronic alendronate administration.
Topics: Abdominal Pain; Aged; Alendronate; Anti-Ulcer Agents; Bone Resorption; Drug Administration Schedule; | 2002 |
Nonhealing gastric ulcer caused by chronic alendronate administration.
Topics: Abdominal Pain; Aged; Alendronate; Anti-Ulcer Agents; Bone Resorption; Drug Administration Schedule; | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clari | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clari | 2002 |
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2002 |
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2002 |
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cohort Studies; Duodenal Ul | 2002 |
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cohort Studies; Duodenal Ul | 2002 |
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Susceptibility; Duo | 2002 |
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Susceptibility; Duo | 2002 |
[Effect of pantoprazole on non-variceal bleeding].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; F | 2000 |
[Effect of pantoprazole on non-variceal bleeding].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; F | 2000 |
Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Topics: Animals; Cell Degranulation; Gastric Mucosa; Male; Mast Cells; Omeprazole; p-Methoxy-N-methylpheneth | 2002 |
Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Topics: Animals; Cell Degranulation; Gastric Mucosa; Male; Mast Cells; Omeprazole; p-Methoxy-N-methylpheneth | 2002 |
[Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Ad | 2002 |
[Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Ad | 2002 |
[Pariet in eradication therapy plans].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; D | 2002 |
[Pariet in eradication therapy plans].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; D | 2002 |
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biological Availability; Humans | 2002 |
Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biological Availability; Humans | 2002 |
[Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Gastr | 2002 |
[Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Gastr | 2002 |
[Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France].
Topics: Anti-Ulcer Agents; Drug Monitoring; Drug Prescriptions; Drug Utilization; Duodenal Ulcer; France; Hu | 2002 |
[Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France].
Topics: Anti-Ulcer Agents; Drug Monitoring; Drug Prescriptions; Drug Utilization; Duodenal Ulcer; France; Hu | 2002 |
Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2002 |
Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2002 |
A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antioxidants; Apoptosis; DNA Damage; Free Radical | 2003 |
A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antioxidants; Apoptosis; DNA Damage; Free Radical | 2003 |
[Patient with increased stomach cancer risk. Helicobacter can cause damage here].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, | 2002 |
[Patient with increased stomach cancer risk. Helicobacter can cause damage here].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, | 2002 |
Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Colony Count, Microbial; Drug Therapy, Combination; Gastric | 2003 |
Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Colony Count, Microbial; Drug Therapy, Combination; Gastric | 2003 |
Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Follow-Up Studies; Gastric Mucosa; Gastr | 2002 |
Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Follow-Up Studies; Gastric Mucosa; Gastr | 2002 |
[Is gastric and duodenal ulcer drug-treatable or surgical disease?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Humans; Lansoprazole; Om | 1997 |
[Is gastric and duodenal ulcer drug-treatable or surgical disease?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Humans; Lansoprazole; Om | 1997 |
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, | 2003 |
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, | 2003 |
Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role?
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; H | 2003 |
Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role?
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; H | 2003 |
Acute hyperkalemia associated with intravenous omeprazole therapy.
Topics: Acute Disease; Anti-Ulcer Agents; Gastroscopy; Humans; Hyperkalemia; Injections, Intravenous; Male; | 2003 |
Acute hyperkalemia associated with intravenous omeprazole therapy.
Topics: Acute Disease; Anti-Ulcer Agents; Gastroscopy; Humans; Hyperkalemia; Injections, Intravenous; Male; | 2003 |
Gastric myoelectrical activity in patients with recurrent gastric or duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Endoscopy, Digest | 2003 |
Gastric myoelectrical activity in patients with recurrent gastric or duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Endoscopy, Digest | 2003 |
Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastrosc | 2003 |
Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastrosc | 2003 |
Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.
Topics: Age Factors; Animals; Anti-Ulcer Agents; Breeding; Case-Control Studies; Female; Gastroscopy; Horse | 2003 |
Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.
Topics: Age Factors; Animals; Anti-Ulcer Agents; Breeding; Case-Control Studies; Female; Gastroscopy; Horse | 2003 |
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Com | 2003 |
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Com | 2003 |
A new furoxan NO-donor rabeprazole derivative and related compounds.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Drug Design; He | 2003 |
A new furoxan NO-donor rabeprazole derivative and related compounds.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Drug Design; He | 2003 |
Treatment of patients at high risk for recurrent bleeding from a peptic ulcer.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrha | 2003 |
Treatment of patients at high risk for recurrent bleeding from a peptic ulcer.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrha | 2003 |
Summaries for patients. Combination treatment for peptic ulcers at high risk for recurrent bleeding.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Female; Gastrointestinal | 2003 |
Summaries for patients. Combination treatment for peptic ulcers at high risk for recurrent bleeding.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Female; Gastrointestinal | 2003 |
Study of Mimusops elengi bark in experimental gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimida | 2003 |
Study of Mimusops elengi bark in experimental gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimida | 2003 |
Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Drug Compounding; Female; Gastric Acid; Gastric Mu | 2003 |
Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Drug Compounding; Female; Gastric Acid; Gastric Mu | 2003 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2003 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2003 |
Evaluation of urine sucrose concentration for detection of gastric ulcers in horses.
Topics: Animals; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Endoscopy; Horse Diseases; Horses; | 2004 |
Evaluation of urine sucrose concentration for detection of gastric ulcers in horses.
Topics: Animals; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Endoscopy; Horse Diseases; Horses; | 2004 |
The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Dose-Response Rel | 2003 |
The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Dose-Response Rel | 2003 |
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cyclooxygenase 1; Cyclooxygenas | 2004 |
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cyclooxygenase 1; Cyclooxygenas | 2004 |
Parietal cell density during gastric ulcer healing in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cell Count; Female; Helicobacte | 2004 |
Parietal cell density during gastric ulcer healing in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cell Count; Female; Helicobacte | 2004 |
Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol; Cimetidine; Diseas | 2004 |
Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol; Cimetidine; Diseas | 2004 |
Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Female; Fibroblast Growth Factor | 2004 |
Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Female; Fibroblast Growth Factor | 2004 |
Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
Topics: Animals; Atropine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinopro | 2004 |
Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
Topics: Animals; Atropine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinopro | 2004 |
Management options for patients with ulcer hemorrhage.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrha | 2004 |
Management options for patients with ulcer hemorrhage.
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrha | 2004 |
Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulce | 2004 |
Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulce | 2004 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U | 2004 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U | 2004 |
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-U | 2004 |
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-U | 2004 |
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydroge | 2004 |
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydroge | 2004 |
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Mic | 2004 |
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Mic | 2004 |
[Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase Inhibitors; Dyspepsia; Hi | 2004 |
[Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase Inhibitors; Dyspepsia; Hi | 2004 |
Crohn's disease with isolated esophagus and gastric involvement.
Topics: Adult; Anti-Ulcer Agents; Azathioprine; Biopsy; Crohn Disease; Endoscopy, Gastrointestinal; Esophage | 2004 |
Crohn's disease with isolated esophagus and gastric involvement.
Topics: Adult; Anti-Ulcer Agents; Azathioprine; Biopsy; Crohn Disease; Endoscopy, Gastrointestinal; Esophage | 2004 |
Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
Topics: Animals; Anti-Ulcer Agents; Atropine; Brain; Gastric Mucosa; Hydrochloric Acid; Injections, Intraven | 2005 |
Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
Topics: Animals; Anti-Ulcer Agents; Atropine; Brain; Gastric Mucosa; Hydrochloric Acid; Injections, Intraven | 2005 |
Less acid + less bleeding = better outcomes and more money!
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic | 2004 |
Less acid + less bleeding = better outcomes and more money!
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic | 2004 |
Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Cell Line | 2005 |
Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Cell Line | 2005 |
Allophylus serratus: a plant with potential anti-ulcerogenic activity.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Disease Models, Animal; | 2005 |
Allophylus serratus: a plant with potential anti-ulcerogenic activity.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Disease Models, Animal; | 2005 |
Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Pe | 2005 |
Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Pe | 2005 |
Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl | 2005 |
Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl | 2005 |
Desmodium gangeticum: a potent anti-ulcer agent.
Topics: Alcohols; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Duodenal Ulcer; Ethanol; Fabaceae; | 2005 |
Desmodium gangeticum: a potent anti-ulcer agent.
Topics: Alcohols; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Duodenal Ulcer; Ethanol; Fabaceae; | 2005 |
Mechanisms of action of leptin in preventing gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Lansoprazole; Leptin; Nitric Ox | 2005 |
Mechanisms of action of leptin in preventing gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Lansoprazole; Leptin; Nitric Ox | 2005 |
Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Base Sequence; Benzimidazoles; Biopsy, Needle; Case- | 2005 |
Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Base Sequence; Benzimidazoles; Biopsy, Needle; Case- | 2005 |
Gastric ulcer despite no acid in a renal allograft recipient: what is the link?
Topics: Adult; Anti-Ulcer Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Gastric Acid; Gastroi | 2005 |
Gastric ulcer despite no acid in a renal allograft recipient: what is the link?
Topics: Adult; Anti-Ulcer Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Gastric Acid; Gastroi | 2005 |
Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.
Topics: Animals; Anti-Ulcer Agents; Blotting, Western; Celecoxib; Chronic Disease; Cyclooxygenase 2; Dinopro | 2005 |
Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.
Topics: Animals; Anti-Ulcer Agents; Blotting, Western; Celecoxib; Chronic Disease; Cyclooxygenase 2; Dinopro | 2005 |
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Diagnosis, Differential; Female; Humans; Lansoprazole | 2005 |
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Diagnosis, Differential; Female; Humans; Lansoprazole | 2005 |
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ul | 2005 |
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ul | 2005 |
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; A | 2005 |
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; A | 2005 |
[Application of the proton pump inhibitors in treatment of an acute gastro-intestinal bleeding of the ulcer etiology].
Topics: Acute Disease; Adult; Aged; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Ma | 2005 |
[Application of the proton pump inhibitors in treatment of an acute gastro-intestinal bleeding of the ulcer etiology].
Topics: Acute Disease; Adult; Aged; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Ma | 2005 |
[What does the H. pylori eradication bring?].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Double-Blind Method; Drug | 2005 |
[What does the H. pylori eradication bring?].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Double-Blind Method; Drug | 2005 |
[Gastric protection and treatment with low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; | 2006 |
[Gastric protection and treatment with low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; | 2006 |
Is omeprazole or misoprostol superior for improving indomethacin-induced delayed maturation of granulation tissue in rat gastric ulcers?
Topics: Analysis of Variance; Animals; Collagen; Granulation Tissue; Hydroxyproline; Immunohistochemistry; I | 2006 |
Is omeprazole or misoprostol superior for improving indomethacin-induced delayed maturation of granulation tissue in rat gastric ulcers?
Topics: Analysis of Variance; Animals; Collagen; Granulation Tissue; Hydroxyproline; Immunohistochemistry; I | 2006 |
Chronic diarrhea and weight loss in three horses.
Topics: Animals; Anti-Ulcer Agents; Desulfovibrionaceae Infections; Diarrhea; Endoscopy, Gastrointestinal; E | 2006 |
Chronic diarrhea and weight loss in three horses.
Topics: Animals; Anti-Ulcer Agents; Desulfovibrionaceae Infections; Diarrhea; Endoscopy, Gastrointestinal; E | 2006 |
Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Line; Cell Proliferation; | 2006 |
Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Line; Cell Proliferation; | 2006 |
Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Apoptosis; Caspase 12; Caspases; Disease Models, A | 2006 |
Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Apoptosis; Caspase 12; Caspases; Disease Models, A | 2006 |
Endothelin-1, inducible nitric oxide synthase and macrophage inflammatory protein-1alpha in the pathogenesis of stress ulcer in neurotraumatic patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Brain Injuries; Chemokine CCL3; Chemokine CCL4; Endothelin-1; Female | 2006 |
Endothelin-1, inducible nitric oxide synthase and macrophage inflammatory protein-1alpha in the pathogenesis of stress ulcer in neurotraumatic patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Brain Injuries; Chemokine CCL3; Chemokine CCL4; Endothelin-1; Female | 2006 |
Anti-ulcer effect of tea catechin in rats.
Topics: Acetic Acid; Administration, Oral; Animals; Anti-Ulcer Agents; Camellia sinensis; Catechin; Dose-Res | 2006 |
Anti-ulcer effect of tea catechin in rats.
Topics: Acetic Acid; Administration, Oral; Animals; Anti-Ulcer Agents; Camellia sinensis; Catechin; Dose-Res | 2006 |
Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood).
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Ethanol; Female; Ligation; Male; Medici | 2007 |
Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood).
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Ethanol; Female; Ligation; Male; Medici | 2007 |
[Effect of mucosal protective on the quality of gastric ulcer healing].
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; ErbB Receptors; Gast | 2007 |
[Effect of mucosal protective on the quality of gastric ulcer healing].
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; ErbB Receptors; Gast | 2007 |
Post-tonsillectomy bleeding.
Topics: Anti-Ulcer Agents; Child, Preschool; Female; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Postoperat | 2007 |
Post-tonsillectomy bleeding.
Topics: Anti-Ulcer Agents; Child, Preschool; Female; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Postoperat | 2007 |
Baccharis dracunculifolia, the main botanical source of Brazilian green propolis, displays antiulcer activity.
Topics: Animals; Anti-Ulcer Agents; Baccharis; Brazil; Chromatography, High Pressure Liquid; Cimetidine; Cin | 2007 |
Baccharis dracunculifolia, the main botanical source of Brazilian green propolis, displays antiulcer activity.
Topics: Animals; Anti-Ulcer Agents; Baccharis; Brazil; Chromatography, High Pressure Liquid; Cimetidine; Cin | 2007 |
Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Brazil; Cimetidine; Disease Mod | 2007 |
Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Brazil; Cimetidine; Disease Mod | 2007 |
The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dinoprostone; Femal | 2007 |
The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dinoprostone; Femal | 2007 |
Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; | 2007 |
Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; | 2007 |
Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease | 2008 |
Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease | 2008 |
The role of sildenafil citrate in the protection of gastric mucosa from nonsteroidal anti-inflammatory drug-induced damage.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease M | 2007 |
The role of sildenafil citrate in the protection of gastric mucosa from nonsteroidal anti-inflammatory drug-induced damage.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease M | 2007 |
Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cell P | 2008 |
Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cell P | 2008 |
The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Ac | 2008 |
The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Ac | 2008 |
Antiulcerogenic activity of fractions and 3,15-dioxo-21alpha-hydroxy friedelane isolated from Maytenus robusta (Celastraceae).
Topics: Acetates; Animals; Anti-Ulcer Agents; Chloroform; Ethanol; Gastric Mucosa; Hexanes; Indicators and R | 2008 |
Antiulcerogenic activity of fractions and 3,15-dioxo-21alpha-hydroxy friedelane isolated from Maytenus robusta (Celastraceae).
Topics: Acetates; Animals; Anti-Ulcer Agents; Chloroform; Ethanol; Gastric Mucosa; Hexanes; Indicators and R | 2008 |
[Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2008 |
[Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2008 |
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Humans; Ma | 2008 |
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Humans; Ma | 2008 |
Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.
Topics: Activities of Daily Living; Adult; Aged; Anti-Ulcer Agents; Data Interpretation, Statistical; Esopha | 2008 |
Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.
Topics: Activities of Daily Living; Adult; Aged; Anti-Ulcer Agents; Data Interpretation, Statistical; Esopha | 2008 |
Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Catechols; Cyclooxygenase 1; Cyclooxygenase 2; Dinoproston | 2008 |
Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Catechols; Cyclooxygenase 1; Cyclooxygenase 2; Dinoproston | 2008 |
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithrom | 2008 |
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithrom | 2008 |
[Stress ulcer prophylaxis in septic patients. Evidence-based overview].
Topics: Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Evidence-Based Medicine; Gastric Acid; Gastrointestin | 2008 |
[Stress ulcer prophylaxis in septic patients. Evidence-based overview].
Topics: Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Evidence-Based Medicine; Gastric Acid; Gastrointestin | 2008 |
Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats.
Topics: Animals; Aspirin; Benzimidazoles; Dose-Response Relationship, Drug; Epoprostenol; Ethanol; Female; G | 1983 |
Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats.
Topics: Animals; Aspirin; Benzimidazoles; Dose-Response Relationship, Drug; Epoprostenol; Ethanol; Female; G | 1983 |
Omeprazole provides protection against experimentally induced gastric mucosal lesions.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Ethanol; Female; Injections, Intravenous; Omepr | 1983 |
Omeprazole provides protection against experimentally induced gastric mucosal lesions.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Ethanol; Female; Injections, Intravenous; Omepr | 1983 |
Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
Topics: Animals; Aspirin; Benzimidazoles; Chemical Phenomena; Chemistry; Duodenal Ulcer; Epirizole; Gastric | 1984 |
Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
Topics: Animals; Aspirin; Benzimidazoles; Chemical Phenomena; Chemistry; Duodenal Ulcer; Epirizole; Gastric | 1984 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats.
Topics: Animals; Famotidine; Gastric Mucosa; Immersion; Leukotrienes; Male; Omeprazole; Peroxidase; Polyethy | 1994 |
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats.
Topics: Animals; Famotidine; Gastric Mucosa; Immersion; Leukotrienes; Male; Omeprazole; Peroxidase; Polyethy | 1994 |
Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin.
Topics: Animals; Bromodeoxyuridine; Drug Combinations; Female; Fibroblast Growth Factor 2; Gastric Acid; Gas | 1995 |
Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin.
Topics: Animals; Bromodeoxyuridine; Drug Combinations; Female; Fibroblast Growth Factor 2; Gastric Acid; Gas | 1995 |
Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Dru | 1995 |
Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Dru | 1995 |
Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anesthesia; Animals; Anti-Ulcer Agents; Cats; Female; Gastr | 1995 |
Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anesthesia; Animals; Anti-Ulcer Agents; Cats; Female; Gastr | 1995 |
Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats.
Topics: Acetamides; Animals; Anti-Ulcer Agents; Drug Interactions; Gastric Mucosa; Gastrointestinal Motility | 1995 |
Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats.
Topics: Acetamides; Animals; Anti-Ulcer Agents; Drug Interactions; Gastric Mucosa; Gastrointestinal Motility | 1995 |
Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory | 1995 |
Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory | 1995 |
Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Resistance; Duodenal Ulcer; Gastric | 1995 |
Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Resistance; Duodenal Ulcer; Gastric | 1995 |
Factors affecting quality of ulcer healing after lansoprazole treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Alcohol Drinking; Anti-Ulcer Agents; Duodenal | 1995 |
Factors affecting quality of ulcer healing after lansoprazole treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Alcohol Drinking; Anti-Ulcer Agents; Duodenal | 1995 |
Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
Topics: Adolescent; Adult; Age Distribution; Aged; Antacids; Child; Child, Preschool; Drug Prescriptions; Dr | 1995 |
Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
Topics: Adolescent; Adult; Age Distribution; Aged; Antacids; Child; Child, Preschool; Drug Prescriptions; Dr | 1995 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy | 1995 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy | 1995 |
Mucosal regeneration of gastric ulcer confirmed by electronic endoscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Electronics, Medical; Famot | 1995 |
Mucosal regeneration of gastric ulcer confirmed by electronic endoscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Electronics, Medical; Famot | 1995 |
Omeprazole and the metabolism of caffeine.
Topics: Caffeine; Duodenal Ulcer; Humans; Omeprazole; Research Design; Statistics as Topic; Stomach Ulcer | 1995 |
Omeprazole and the metabolism of caffeine.
Topics: Caffeine; Duodenal Ulcer; Humans; Omeprazole; Research Design; Statistics as Topic; Stomach Ulcer | 1995 |
Quality of gastric ulcer healing. Is it influenced by antiulcer drugs?
Topics: Animals; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sucralfate | 1995 |
Quality of gastric ulcer healing. Is it influenced by antiulcer drugs?
Topics: Animals; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sucralfate | 1995 |
Omeprazole-associated agranulocytosis.
Topics: Adult; Agranulocytosis; Female; Humans; Omeprazole; Stomach Ulcer | 1995 |
Omeprazole-associated agranulocytosis.
Topics: Adult; Agranulocytosis; Female; Humans; Omeprazole; Stomach Ulcer | 1995 |
Antibacterial treatment of gastric ulcers.
Topics: Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometal | 1995 |
Antibacterial treatment of gastric ulcers.
Topics: Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometal | 1995 |
Acid-suppression did not enhance healing of gastric ulcer associated with paraesophageal hernia after hernial reduction.
Topics: Esophageal Diseases; Gastric Acid; Hernia; Herniorrhaphy; Humans; Male; Middle Aged; Omeprazole; Ran | 1995 |
Acid-suppression did not enhance healing of gastric ulcer associated with paraesophageal hernia after hernial reduction.
Topics: Esophageal Diseases; Gastric Acid; Hernia; Herniorrhaphy; Humans; Male; Middle Aged; Omeprazole; Ran | 1995 |
Effect of cimetidine and omeprazole on gastric ulcer healing of rats with limited food intake time.
Topics: Acetates; Acetic Acid; Administration, Oral; Analysis of Variance; Animals; Atropine; Cimetidine; Di | 1994 |
Effect of cimetidine and omeprazole on gastric ulcer healing of rats with limited food intake time.
Topics: Acetates; Acetic Acid; Administration, Oral; Analysis of Variance; Animals; Atropine; Cimetidine; Di | 1994 |
Cimetidine and omeprazole accelerate gastric ulcer healing by an increase in gastrin secretion.
Topics: Analysis of Variance; Animals; Cimetidine; Disease Models, Animal; Drug Interactions; Drug Synergism | 1994 |
Cimetidine and omeprazole accelerate gastric ulcer healing by an increase in gastrin secretion.
Topics: Analysis of Variance; Animals; Cimetidine; Disease Models, Animal; Drug Interactions; Drug Synergism | 1994 |
Association between medically induced achlorhydria of the stomach and a severe postoperative infection? A report of two cases.
Topics: Achlorhydria; Adult; Aged; Bacteria, Anaerobic; Bacterial Infections; Duodenal Ulcer; Gastrectomy; H | 1994 |
Association between medically induced achlorhydria of the stomach and a severe postoperative infection? A report of two cases.
Topics: Achlorhydria; Adult; Aged; Bacteria, Anaerobic; Bacterial Infections; Duodenal Ulcer; Gastrectomy; H | 1994 |
Validity of kissing gastric ulcers induced in rats for screening of antiulcer drugs.
Topics: Acetates; Acetic Acid; Aluminum Hydroxide; Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; D | 1994 |
Validity of kissing gastric ulcers induced in rats for screening of antiulcer drugs.
Topics: Acetates; Acetic Acid; Aluminum Hydroxide; Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; D | 1994 |
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastros | 1994 |
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastros | 1994 |
Hyperplastic polyps following treatment of acute gastric ulcers.
Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Po | 1994 |
Hyperplastic polyps following treatment of acute gastric ulcers.
Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Po | 1994 |
Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastric Aci | 1994 |
Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastric Aci | 1994 |
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Benzodiazepines; Duodenal Ulcer; Epirizole; Ethanol; Famotidine; Gastric | 1994 |
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Benzodiazepines; Duodenal Ulcer; Epirizole; Ethanol; Famotidine; Gastric | 1994 |
Antiulcerogenicity of the flavonoid fraction from Bidens aurea: comparison with ranitidine and omeprazole.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cold Temperature; Disease Models, Animal; Female; Flavono | 1994 |
Antiulcerogenicity of the flavonoid fraction from Bidens aurea: comparison with ranitidine and omeprazole.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cold Temperature; Disease Models, Animal; Female; Flavono | 1994 |
Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Cell Survival; | 1994 |
Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Cell Survival; | 1994 |
[Generalized convulsive crisis during the intravenous administration of omeprazole at high doses].
Topics: Aged; Aged, 80 and over; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Omepr | 1994 |
[Generalized convulsive crisis during the intravenous administration of omeprazole at high doses].
Topics: Aged; Aged, 80 and over; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Omepr | 1994 |
The effects of omeprazole on the ultrastructure of gastric parietal cells.
Topics: Child; Child, Preschool; Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Infant, Ne | 1994 |
The effects of omeprazole on the ultrastructure of gastric parietal cells.
Topics: Child; Child, Preschool; Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Infant, Ne | 1994 |
[Reversible thrombocytopenia due to digitoxin overdose].
Topics: Aged; Digitoxin; Drug Overdose; Female; Gastritis; Gastroscopy; Heart Failure; Humans; Nausea; Omepr | 1994 |
[Reversible thrombocytopenia due to digitoxin overdose].
Topics: Aged; Digitoxin; Drug Overdose; Female; Gastritis; Gastroscopy; Heart Failure; Humans; Nausea; Omepr | 1994 |
Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole.
Topics: Aluminum Hydroxide; Animals; Antacids; Cell Division; Drug Therapy, Combination; Female; Gastric Muc | 1994 |
Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole.
Topics: Aluminum Hydroxide; Animals; Antacids; Cell Division; Drug Therapy, Combination; Female; Gastric Muc | 1994 |
Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Capill | 1994 |
Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Capill | 1994 |
The role of thyrotropin-releasing hormone (TRH) in the pathogenesis of water-immersion stress in rats--inhibition of TRH release from the stomach by atropine, ranitidine or omeprazole.
Topics: Animals; Atropine; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Juice; Gastric Mucosa; | 1993 |
The role of thyrotropin-releasing hormone (TRH) in the pathogenesis of water-immersion stress in rats--inhibition of TRH release from the stomach by atropine, ranitidine or omeprazole.
Topics: Animals; Atropine; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Juice; Gastric Mucosa; | 1993 |
Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Biomarkers; Body Weight; Bone Resorption; Calcium; Ch | 1993 |
Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Biomarkers; Body Weight; Bone Resorption; Calcium; Ch | 1993 |
Endoscopic ultrasonographic (EUS) evaluation of the quality of gastric ulcer healing.
Topics: Gastroscopy; Histamine H2 Antagonists; Humans; Omeprazole; Recurrence; Stomach; Stomach Ulcer; Time | 1993 |
Endoscopic ultrasonographic (EUS) evaluation of the quality of gastric ulcer healing.
Topics: Gastroscopy; Histamine H2 Antagonists; Humans; Omeprazole; Recurrence; Stomach; Stomach Ulcer; Time | 1993 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1994 |
Gastric ulcer induced by submucosal injection of ET-1: role of potent vasoconstriction and intraluminal acid.
Topics: Acids; Animals; Drug Synergism; Endothelins; Gastric Mucosa; Injections; Male; Nicardipine; Omeprazo | 1993 |
Gastric ulcer induced by submucosal injection of ET-1: role of potent vasoconstriction and intraluminal acid.
Topics: Acids; Animals; Drug Synergism; Endothelins; Gastric Mucosa; Injections; Male; Nicardipine; Omeprazo | 1993 |
Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Topics: Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Epirizole; Ethano | 1993 |
Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Topics: Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Epirizole; Ethano | 1993 |
[New development on the study of etiological pathology of gastritis, peptic ulcer and stomach cancers in relationship to Helicobacter pylori infection].
Topics: Antibodies, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1993 |
[New development on the study of etiological pathology of gastritis, peptic ulcer and stomach cancers in relationship to Helicobacter pylori infection].
Topics: Antibodies, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1993 |
[Esophageal mycosis during treatment with omeprazole].
Topics: Esophageal Diseases; Fluconazole; Humans; Male; Middle Aged; Mycoses; Omeprazole; Stomach Ulcer | 1993 |
[Esophageal mycosis during treatment with omeprazole].
Topics: Esophageal Diseases; Fluconazole; Humans; Male; Middle Aged; Mycoses; Omeprazole; Stomach Ulcer | 1993 |
[Nonsteroidal antiinflammatory drugs and duodenal ulceration].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Stomach Ul | 1993 |
[Nonsteroidal antiinflammatory drugs and duodenal ulceration].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Stomach Ul | 1993 |
The relationship between endoscopic findings of gastric ulcer scar and ulcer relapse.
Topics: Adult; Aged; Aged, 80 and over; Famotidine; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middl | 1993 |
The relationship between endoscopic findings of gastric ulcer scar and ulcer relapse.
Topics: Adult; Aged; Aged, 80 and over; Famotidine; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middl | 1993 |
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, C | 1994 |
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, C | 1994 |
Proton-pump inhibitor-refractory gastric ulcer and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Helicobacter Infections; He | 1993 |
Proton-pump inhibitor-refractory gastric ulcer and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Helicobacter Infections; He | 1993 |
Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimid | 1993 |
Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimid | 1993 |
[Helicobacter pylori infection and ulcer disease].
Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Stomach Ulcer | 1993 |
[Helicobacter pylori infection and ulcer disease].
Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Stomach Ulcer | 1993 |
Prospect of the treatment of human gastric ulcers with orally administered epidermal growth factor.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cellulose; Drug Therapy, Combination; Epidermal Gr | 1993 |
Prospect of the treatment of human gastric ulcers with orally administered epidermal growth factor.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cellulose; Drug Therapy, Combination; Epidermal Gr | 1993 |
NC-1300, a proton-pump inhibitor, requires gastric acid to exert cytoprotection in rat gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Cell Survival; | 1993 |
NC-1300, a proton-pump inhibitor, requires gastric acid to exert cytoprotection in rat gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Cell Survival; | 1993 |
Omeprazole: is it the answer of peptic ulcer disease?
Topics: Adenosine Triphosphatases; Drug Administration Schedule; Duodenal Ulcer; Humans; Omeprazole; Peptic | 1993 |
Omeprazole: is it the answer of peptic ulcer disease?
Topics: Adenosine Triphosphatases; Drug Administration Schedule; Duodenal Ulcer; Humans; Omeprazole; Peptic | 1993 |
[Peptic ulcer and Helicobacter pylori. Comments on the authors' cases].
Topics: Adult; Aged; Anti-Ulcer Agents; Colloids; Drug Evaluation; Duodenal Ulcer; Female; Helicobacter Infe | 1993 |
[Peptic ulcer and Helicobacter pylori. Comments on the authors' cases].
Topics: Adult; Aged; Anti-Ulcer Agents; Colloids; Drug Evaluation; Duodenal Ulcer; Female; Helicobacter Infe | 1993 |
Effects of 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid, an inhibitor of Cl(-)-HCO3- exchanger, on stress-induced gastric lesions in rats.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfo | 1993 |
Effects of 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid, an inhibitor of Cl(-)-HCO3- exchanger, on stress-induced gastric lesions in rats.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfo | 1993 |
Efficacy of famotidine for omeprazole-refractory gastric ulcer.
Topics: Adult; Famotidine; Humans; Male; Omeprazole; Stomach Ulcer | 1993 |
Efficacy of famotidine for omeprazole-refractory gastric ulcer.
Topics: Adult; Famotidine; Humans; Male; Omeprazole; Stomach Ulcer | 1993 |
[Severe hyponatremia induced by meprazole].
Topics: Aged; Aged, 80 and over; Female; Humans; Hyponatremia; Omeprazole; Stomach Ulcer | 1993 |
[Severe hyponatremia induced by meprazole].
Topics: Aged; Aged, 80 and over; Female; Humans; Hyponatremia; Omeprazole; Stomach Ulcer | 1993 |
[Esophageal candidiasis during omeprazole treatment].
Topics: Aged; Aged, 80 and over; Candidiasis; Esophageal Diseases; Humans; Male; Omeprazole; Peptic Ulcer He | 1993 |
[Esophageal candidiasis during omeprazole treatment].
Topics: Aged; Aged, 80 and over; Candidiasis; Esophageal Diseases; Humans; Male; Omeprazole; Peptic Ulcer He | 1993 |
Hypergastrinemia increases proliferation of gastroduodenal epithelium during gastric ulcer healing in rats.
Topics: Animals; Anti-Ulcer Agents; Apoptosis; Autoradiography; Cell Count; Cell Division; Duodenum; Epithel | 1996 |
Hypergastrinemia increases proliferation of gastroduodenal epithelium during gastric ulcer healing in rats.
Topics: Animals; Anti-Ulcer Agents; Apoptosis; Autoradiography; Cell Count; Cell Division; Duodenum; Epithel | 1996 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm | 1995 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm | 1995 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1996 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1996 |
Prozac or prilosec for gastric ulcer?
Topics: Drug Labeling; Fluoxetine; Humans; Male; Medication Errors; Omeprazole; Stomach Ulcer; Terminology a | 1996 |
Prozac or prilosec for gastric ulcer?
Topics: Drug Labeling; Fluoxetine; Humans; Male; Medication Errors; Omeprazole; Stomach Ulcer; Terminology a | 1996 |
Effects of leminoprazole, omeprazole and sucralfate on indomethacin-induced delayed healing of kissing gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Indomethacin; Male; Omeprazole; Peroxidase; Rats; Rats, | 1996 |
Effects of leminoprazole, omeprazole and sucralfate on indomethacin-induced delayed healing of kissing gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Indomethacin; Male; Omeprazole; Peroxidase; Rats; Rats, | 1996 |
Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Epirizole; Gastric Acid; Gastric Mucos | 1996 |
Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Epirizole; Gastric Acid; Gastric Mucos | 1996 |
[Dynamic imaging of gastric ulcer healing using the most modern Morph-Software].
Topics: Amoxicillin; Anti-Ulcer Agents; Computer Systems; Drug Therapy, Combination; Gastroscopes; Helicobac | 1996 |
[Dynamic imaging of gastric ulcer healing using the most modern Morph-Software].
Topics: Amoxicillin; Anti-Ulcer Agents; Computer Systems; Drug Therapy, Combination; Gastroscopes; Helicobac | 1996 |
Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Topics: Anti-Ulcer Agents; Case-Control Studies; Child; Dose-Response Relationship, Drug; Duodenal Ulcer; En | 1996 |
Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Topics: Anti-Ulcer Agents; Case-Control Studies; Child; Dose-Response Relationship, Drug; Duodenal Ulcer; En | 1996 |
Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats.
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Atropine; Chronic Disease; Cimetidine; Duodenal Ulcer; Hist | 1996 |
Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats.
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Atropine; Chronic Disease; Cimetidine; Duodenal Ulcer; Hist | 1996 |
Omeprazole prevents indomethacin-induced gastric ulcers in rabbits.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Enzyme Inhibitors; Gastric Acid; Gas | 1996 |
Omeprazole prevents indomethacin-induced gastric ulcers in rabbits.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Enzyme Inhibitors; Gastric Acid; Gas | 1996 |
A new gastric ulcer model induced by ischemia-reperfusion in the rat: role of leukocytes on ulceration in rat stomach.
Topics: Animals; Anti-Ulcer Agents; Antibodies, Monoclonal; CD18 Antigens; Disease Models, Animal; Gastric A | 1996 |
A new gastric ulcer model induced by ischemia-reperfusion in the rat: role of leukocytes on ulceration in rat stomach.
Topics: Animals; Anti-Ulcer Agents; Antibodies, Monoclonal; CD18 Antigens; Disease Models, Animal; Gastric A | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; | 1996 |
Proton-pump inhibition and gastric giardiasis: a causal or casual association?
Topics: Aged; Amoxicillin; Animals; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mu | 1995 |
Proton-pump inhibition and gastric giardiasis: a causal or casual association?
Topics: Aged; Amoxicillin; Animals; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mu | 1995 |
Helicobacter pylori, gastric ulcer, and duodenal ulcer.
Topics: Age of Onset; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omepr | 1996 |
Helicobacter pylori, gastric ulcer, and duodenal ulcer.
Topics: Age of Onset; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omepr | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-U | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-U | 1996 |
Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Costs and Cost Analysis; Critical Care; Critical Illness; Female; Ga | 1997 |
Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Costs and Cost Analysis; Critical Care; Critical Illness; Female; Ga | 1997 |
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Duodenal Ulcer; | 1997 |
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Duodenal Ulcer; | 1997 |
[A case of hemolysis induced by lansoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anemia, Hemolytic; Anti-Ulcer Agents; Humans; Lansoprazole; | 1996 |
[A case of hemolysis induced by lansoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anemia, Hemolytic; Anti-Ulcer Agents; Humans; Lansoprazole; | 1996 |
Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Inflammatory Agents, Non-Ste | 1997 |
Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Inflammatory Agents, Non-Ste | 1997 |
Endoscopic hydrostatic balloon dilation of ulcer-induced pyloric stenosis in rheumatoid arthritis and secondary amyloidosis.
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Biop | 1997 |
Endoscopic hydrostatic balloon dilation of ulcer-induced pyloric stenosis in rheumatoid arthritis and secondary amyloidosis.
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Biop | 1997 |
[Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1997 |
[Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1997 |
Effects of cisapride on ulcer formation and gastric secretion in rats: comparison with ranitidine and omeprazol.
Topics: Animals; Anti-Ulcer Agents; Cisapride; Gastric Juice; Gastric Mucosa; Histamine Release; Ligation; M | 1996 |
Effects of cisapride on ulcer formation and gastric secretion in rats: comparison with ranitidine and omeprazol.
Topics: Animals; Anti-Ulcer Agents; Cisapride; Gastric Juice; Gastric Mucosa; Histamine Release; Ligation; M | 1996 |
Increase in pH and prevention of gastropathy induced by nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Hydrogen-Ion Concentration; Ind | 1997 |
Increase in pH and prevention of gastropathy induced by nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Hydrogen-Ion Concentration; Ind | 1997 |
Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Emptying; Gastrins; Helic | 1997 |
Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Emptying; Gastrins; Helic | 1997 |
The role of endogenous acid in the development of acute gastric ulcer induced by ischemia-reperfusion in the rat.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cimetidine; Gastric Acid; Gastric Mucosa; Ischemia; Male; | 1998 |
The role of endogenous acid in the development of acute gastric ulcer induced by ischemia-reperfusion in the rat.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cimetidine; Gastric Acid; Gastric Mucosa; Ischemia; Male; | 1998 |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinati | 1997 |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinati | 1997 |
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biop | 1997 |
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biop | 1997 |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 1997 |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 1997 |
Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; DNA Primers; Drug Therapy, Combination; | 1998 |
Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; DNA Primers; Drug Therapy, Combination; | 1998 |
Omeprazole induces altered bile acid metabolism.
Topics: Adult; Aged; Anti-Ulcer Agents; Bile Acids and Salts; Breath Tests; Dietary Fats; Gastric Mucosa; Hu | 1998 |
Omeprazole induces altered bile acid metabolism.
Topics: Adult; Aged; Anti-Ulcer Agents; Bile Acids and Salts; Breath Tests; Dietary Fats; Gastric Mucosa; Hu | 1998 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 1998 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 1998 |
Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Campylobacter Infections; Clarithromycin; Drug Resistan | 1998 |
Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Campylobacter Infections; Clarithromycin; Drug Resistan | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
Treating ulcers caused by NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Omeprazole; Stomach Ulcer | 1998 |
Treating ulcers caused by NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Omeprazole; Stomach Ulcer | 1998 |
Effect of Helicobacter pylori infection on gastric juice pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Ulcer Agents; Case-Control Studi | 1998 |
Effect of Helicobacter pylori infection on gastric juice pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Ulcer Agents; Case-Control Studi | 1998 |
Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Dithiothreitol; Duodenal Ulcer; Female; Gastric Acid; Ga | 1998 |
Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Dithiothreitol; Duodenal Ulcer; Female; Gastric Acid; Ga | 1998 |
Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chem | 1998 |
Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chem | 1998 |
Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Ethanol; Female; Gastric Acid; Gastric | 1998 |
Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Ethanol; Female; Gastric Acid; Gastric | 1998 |
The response of early gastric cancer to proton-pump inhibitors.
Topics: Adenocarcinoma; Adult; Aged; Diagnostic Errors; Female; Humans; Omeprazole; Proton Pump Inhibitors; | 1998 |
The response of early gastric cancer to proton-pump inhibitors.
Topics: Adenocarcinoma; Adult; Aged; Diagnostic Errors; Female; Humans; Omeprazole; Proton Pump Inhibitors; | 1998 |
Omeprazole, nitrendipine, famotidine and stress-induced ulcers.
Topics: Animals; Anti-Ulcer Agents; Calcium Channel Blockers; Famotidine; Gastric Mucosa; Histamine H2 Antag | 1997 |
Omeprazole, nitrendipine, famotidine and stress-induced ulcers.
Topics: Animals; Anti-Ulcer Agents; Calcium Channel Blockers; Famotidine; Gastric Mucosa; Histamine H2 Antag | 1997 |
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Anti | 1998 |
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Anti | 1998 |
An overview of selected diseases and drug needs in the llama and alpaca industries.
Topics: Animal Husbandry; Animals; Anthelmintics; Anti-Ulcer Agents; Antinematodal Agents; Bacterial Infecti | 1998 |
An overview of selected diseases and drug needs in the llama and alpaca industries.
Topics: Animal Husbandry; Animals; Anthelmintics; Anti-Ulcer Agents; Antinematodal Agents; Bacterial Infecti | 1998 |
Anti-ulcer effects of antioxidants: effect of probucol.
Topics: Acetic Acid; Acute Disease; Animals; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Cimetidine; D | 1998 |
Anti-ulcer effects of antioxidants: effect of probucol.
Topics: Acetic Acid; Acute Disease; Animals; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Cimetidine; D | 1998 |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combinat | 1998 |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combinat | 1998 |
[Proton-pump inhibitor Rabeprazole: faster acid- and symptom-control].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastroes | 1998 |
[Proton-pump inhibitor Rabeprazole: faster acid- and symptom-control].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastroes | 1998 |
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastric Acid; Gastric | 1998 |
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastric Acid; Gastric | 1998 |
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1998 |
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1998 |
Effect of combined administration of lansoprazole and sofalcone on microvascular and connective tissue regeneration after ethanol-induced gastric mucosal damage.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; CD36 Antigens; Chalcone; Chalco | 1998 |
Effect of combined administration of lansoprazole and sofalcone on microvascular and connective tissue regeneration after ethanol-induced gastric mucosal damage.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; CD36 Antigens; Chalcone; Chalco | 1998 |
Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; | 1998 |
Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; | 1998 |
Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Critical Care; DNA; Histamine H2 Antagon | 1999 |
Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Critical Care; DNA; Histamine H2 Antagon | 1999 |
Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Dru | 1999 |
Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Dru | 1999 |
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helic | 1999 |
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helic | 1999 |
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Calcium; Cats; | 1999 |
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Calcium; Cats; | 1999 |
Helicobacter heilmannii associated erosive gastritis.
Topics: Abietanes; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Endoscopy, D | 1999 |
Helicobacter heilmannii associated erosive gastritis.
Topics: Abietanes; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Endoscopy, D | 1999 |
Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimida | 1999 |
Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimida | 1999 |
[Images in medicine. Giant gastric ulcer revealed by anemia].
Topics: Aged; Anemia; Female; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Omeprazole; Radiography; Sto | 1999 |
[Images in medicine. Giant gastric ulcer revealed by anemia].
Topics: Aged; Anemia; Female; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Omeprazole; Radiography; Sto | 1999 |
The treatment and prophylaxis of nonsteroidal anti-inflammatory drug (NSAID)-associated ulcers and erosions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Controlled Clinical Trials as Topic; Gas | 1999 |
The treatment and prophylaxis of nonsteroidal anti-inflammatory drug (NSAID)-associated ulcers and erosions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Controlled Clinical Trials as Topic; Gas | 1999 |
Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Dermatitis, Exfoliative; Drug Erup | 1999 |
Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Dermatitis, Exfoliative; Drug Erup | 1999 |
A case of prurigo and lichenified plaques successfully treated with proton pump inhibitor.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Helicobacter Infections; Heli | 1999 |
A case of prurigo and lichenified plaques successfully treated with proton pump inhibitor.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Helicobacter Infections; Heli | 1999 |
Treatment of Helicobacter pylori: where are we now? What are the key questions?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter | 1999 |
Treatment of Helicobacter pylori: where are we now? What are the key questions?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter | 1999 |
Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Blood Transfusion; Confidence Intervals; Duodenal | 1999 |
Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Blood Transfusion; Confidence Intervals; Duodenal | 1999 |
Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 1999 |
Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 1999 |
[Congress of the American College of Surgeons (ACS). San Francisco, 10-15 October 1999].
Topics: Anti-Ulcer Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholang | 1999 |
[Congress of the American College of Surgeons (ACS). San Francisco, 10-15 October 1999].
Topics: Anti-Ulcer Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholang | 1999 |
[Award winning drug].
Topics: Antacids; Anti-Ulcer Agents; Esophageal Neoplasms; Gastric Acidity Determination; Gastroesophageal R | 1999 |
[Award winning drug].
Topics: Antacids; Anti-Ulcer Agents; Esophageal Neoplasms; Gastric Acidity Determination; Gastroesophageal R | 1999 |
Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
Topics: Animals; Anti-Ulcer Agents; Benzenesulfonates; Disease Models, Animal; Gastric Juice; Histamine H2 A | 2000 |
Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
Topics: Animals; Anti-Ulcer Agents; Benzenesulfonates; Disease Models, Animal; Gastric Juice; Histamine H2 A | 2000 |
Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461.
Topics: Animals; Anti-Ulcer Agents; Enzyme Inhibitors; Gastric Acid; Omeprazole; Proton Pump Inhibitors; Rab | 2000 |
Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461.
Topics: Animals; Anti-Ulcer Agents; Enzyme Inhibitors; Gastric Acid; Omeprazole; Proton Pump Inhibitors; Rab | 2000 |
H2-blocker modulates heart rate variability.
Topics: Aged; Analysis of Variance; Anti-Ulcer Agents; Arrhythmias, Cardiac; Circadian Rhythm; Diterpenes; E | 1999 |
H2-blocker modulates heart rate variability.
Topics: Aged; Analysis of Variance; Anti-Ulcer Agents; Arrhythmias, Cardiac; Circadian Rhythm; Diterpenes; E | 1999 |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug | 2000 |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug | 2000 |
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cel | 2000 |
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cel | 2000 |
Optimal acid suppression therapy in critically ill patients.
Topics: Anti-Ulcer Agents; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Omeprazole; Raniti | 2000 |
Optimal acid suppression therapy in critically ill patients.
Topics: Anti-Ulcer Agents; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Omeprazole; Raniti | 2000 |
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Blood Flow Velocity; Disease Progression; Gastric Acid; G | 2000 |
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Blood Flow Velocity; Disease Progression; Gastric Acid; G | 2000 |
Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulce | 2000 |
Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulce | 2000 |
Pantoprazole (Protonix).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Dose-Response Rel | 2000 |
Pantoprazole (Protonix).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Dose-Response Rel | 2000 |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Co | 2000 |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Co | 2000 |
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Age | 2000 |
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Age | 2000 |
Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Diabetes Mellitus, Experimental; Gastric Acid; Gastric Mucosa; | 2000 |
Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Diabetes Mellitus, Experimental; Gastric Acid; Gastric Mucosa; | 2000 |
[Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Da | 2000 |
[Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Da | 2000 |
Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa.
Topics: Animals; Benzodiazepinones; Female; Freezing; Gastric Mucosa; Gastrins; Omeprazole; Parietal Cells, | 2000 |
Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa.
Topics: Animals; Benzodiazepinones; Female; Freezing; Gastric Mucosa; Gastrins; Omeprazole; Parietal Cells, | 2000 |
Suppressive effect of antiulcer agents on granulocytes--a role for granulocytes in gastric ulcer formation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Animals; Anti-Ulcer Agents; Depression, Chemical; Gr | 2000 |
Suppressive effect of antiulcer agents on granulocytes--a role for granulocytes in gastric ulcer formation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Animals; Anti-Ulcer Agents; Depression, Chemical; Gr | 2000 |
Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cysteamine; Disease Models, Animal; Dose-Response Relationship, | 2001 |
Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cysteamine; Disease Models, Animal; Dose-Response Relationship, | 2001 |
Evaluation of the gastroprotective activity of cordatin, a diterpene isolated from Aparisthmium cordatum (Euphorbiaceae).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Disease Models, Animal; Diterpe | 2000 |
Evaluation of the gastroprotective activity of cordatin, a diterpene isolated from Aparisthmium cordatum (Euphorbiaceae).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Disease Models, Animal; Diterpe | 2000 |
Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Aspirin; Disease | 2001 |
Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Aspirin; Disease | 2001 |
The association between antiulcer medication and initiation of cobalamin replacement in older persons.
Topics: Aged; Anti-Ulcer Agents; Canada; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Stomach | 2001 |
The association between antiulcer medication and initiation of cobalamin replacement in older persons.
Topics: Aged; Anti-Ulcer Agents; Canada; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Stomach | 2001 |
Delayed healing of gastric ulcers in adjuvant arthritis rats: role of acid secretion and basic fibroblast growth factor.
Topics: Animals; Arthritis, Rheumatoid; Blotting, Western; Disease Models, Animal; Fibroblast Growth Factors | 2001 |
Delayed healing of gastric ulcers in adjuvant arthritis rats: role of acid secretion and basic fibroblast growth factor.
Topics: Animals; Arthritis, Rheumatoid; Blotting, Western; Disease Models, Animal; Fibroblast Growth Factors | 2001 |
Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Enzyme-Linked Immunosorbent Assay; Gastric Acid; H | 2001 |
Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Enzyme-Linked Immunosorbent Assay; Gastric Acid; H | 2001 |
[Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Humans; Male; Middle Aged; Misop | 2001 |
[Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Humans; Male; Middle Aged; Misop | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2001 |
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Topics: Adult; Aged; Chi-Square Distribution; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Fe | 2001 |
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Topics: Adult; Aged; Chi-Square Distribution; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Fe | 2001 |
Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats.
Topics: Animals; Heat-Shock Proteins; HSC70 Heat-Shock Proteins; HSP47 Heat-Shock Proteins; HSP70 Heat-Shock | 2001 |
Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats.
Topics: Animals; Heat-Shock Proteins; HSC70 Heat-Shock Proteins; HSP47 Heat-Shock Proteins; HSP70 Heat-Shock | 2001 |
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2001 |
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
Antiulcerogenic effect of Hippophae rhamnoides L.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Famotidine; Fruit; Indomethacin; Male; Misoprost | 2001 |
Antiulcerogenic effect of Hippophae rhamnoides L.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Famotidine; Fruit; Indomethacin; Male; Misoprost | 2001 |
Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
Topics: Anti-Ulcer Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Fema | 2002 |
Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
Topics: Anti-Ulcer Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Fema | 2002 |
[Pharma-clinics medication of the month. Rabeprazole (Pariet)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulcer; E | 2002 |
[Pharma-clinics medication of the month. Rabeprazole (Pariet)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulcer; E | 2002 |
Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Furans; Male; Naphthalenes; O | 2002 |
Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Furans; Male; Naphthalenes; O | 2002 |
A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Central N | 2002 |
A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Central N | 2002 |
Lansoprazole-induced thrombocytopenia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Gastrointestina | 2002 |
Lansoprazole-induced thrombocytopenia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Gastrointestina | 2002 |
[Treatment of NSAIDs induced ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
[Treatment of NSAIDs induced ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase Inh | 2002 |
Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase Inh | 2002 |
Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice.
Topics: Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice.
Topics: Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relation | 2002 |
Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relation | 2002 |
Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; | 2002 |
Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; | 2002 |
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Det | 2002 |
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Det | 2002 |
Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole.
Topics: Aging; Animals; Cimetidine; Gastrins; Male; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer | 2002 |
Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole.
Topics: Aging; Animals; Cimetidine; Gastrins; Male; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer | 2002 |
A drug usage review of omeprazole.
Topics: Dose-Response Relationship, Drug; Drug Therapy; Drug Utilization; Duodenal Ulcer; England; Esophagit | 1992 |
A drug usage review of omeprazole.
Topics: Dose-Response Relationship, Drug; Drug Therapy; Drug Utilization; Duodenal Ulcer; England; Esophagit | 1992 |
[Treatment of gastric ulcers with proton pump inhibitors--long-term treatment].
Topics: Adenosine Triphosphatases; Animals; Depression, Chemical; Gastric Acid; Gastrins; H(+)-K(+)-Exchangi | 1992 |
[Treatment of gastric ulcers with proton pump inhibitors--long-term treatment].
Topics: Adenosine Triphosphatases; Animals; Depression, Chemical; Gastric Acid; Gastrins; H(+)-K(+)-Exchangi | 1992 |
[Effect of proton pump inhibitor, in combination with epidermal growth factor, on the healing of chronic gastric ulcer in submandibular gland removed rats].
Topics: Acetates; Acetic Acid; Adenosine Triphosphatases; Animals; Chronic Disease; Drug Therapy, Combinatio | 1992 |
[Effect of proton pump inhibitor, in combination with epidermal growth factor, on the healing of chronic gastric ulcer in submandibular gland removed rats].
Topics: Acetates; Acetic Acid; Adenosine Triphosphatases; Animals; Chronic Disease; Drug Therapy, Combinatio | 1992 |
[Magnifying endoscopic observation on the effect of a proton pump inhibitor on the healing process of gastric ulcer].
Topics: Adenosine Triphosphatases; Aged; Female; Gastric Mucosa; Gastroscopy; H(+)-K(+)-Exchanging ATPase; H | 1992 |
[Magnifying endoscopic observation on the effect of a proton pump inhibitor on the healing process of gastric ulcer].
Topics: Adenosine Triphosphatases; Aged; Female; Gastric Mucosa; Gastroscopy; H(+)-K(+)-Exchanging ATPase; H | 1992 |
[Evaluation of chromo-endoscopy for diagnosis of histological repair of gastric ulcer].
Topics: Adenosine Triphosphatases; Gastric Mucosa; Gastroscopy; H(+)-K(+)-Exchanging ATPase; Humans; Male; M | 1992 |
[Evaluation of chromo-endoscopy for diagnosis of histological repair of gastric ulcer].
Topics: Adenosine Triphosphatases; Gastric Mucosa; Gastroscopy; H(+)-K(+)-Exchanging ATPase; Humans; Male; M | 1992 |
[Endoscopic studies on refractory gastric ulcers, especially, linear ulcers, treated with proton pump inhibitor].
Topics: Adenosine Triphosphatases; Adult; Drug Resistance; Gastric Mucosa; Gastroscopy; H(+)-K(+)-Exchanging | 1992 |
[Endoscopic studies on refractory gastric ulcers, especially, linear ulcers, treated with proton pump inhibitor].
Topics: Adenosine Triphosphatases; Adult; Drug Resistance; Gastric Mucosa; Gastroscopy; H(+)-K(+)-Exchanging | 1992 |
[H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Depression, Chemical; D | 1992 |
[H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Depression, Chemical; D | 1992 |
[Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
Topics: Adenosine Triphosphatases; Duodenal Ulcer; Duodenoscopy; Gastroscopy; H(+)-K(+)-Exchanging ATPase; H | 1992 |
[Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
Topics: Adenosine Triphosphatases; Duodenal Ulcer; Duodenoscopy; Gastroscopy; H(+)-K(+)-Exchanging ATPase; H | 1992 |
[Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
Topics: Adenosine Triphosphatases; Adult; Aged; Female; Gastroscopy; H(+)-K(+)-Exchanging ATPase; Histamine | 1992 |
[Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
Topics: Adenosine Triphosphatases; Adult; Aged; Female; Gastroscopy; H(+)-K(+)-Exchanging ATPase; Histamine | 1992 |
Effects of histamine H2-receptor antagonists and a proton pump inhibitor on the mucosal hydroxyproline content of ethanol-HCl-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benz | 1992 |
Effects of histamine H2-receptor antagonists and a proton pump inhibitor on the mucosal hydroxyproline content of ethanol-HCl-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benz | 1992 |
Omeprazole heals mucosal ulcers associated with endoscopic injection sclerotherapy.
Topics: Adult; Aged; Endoscopy; Esophageal and Gastric Varices; Esophageal Diseases; Female; Humans; Male; M | 1992 |
Omeprazole heals mucosal ulcers associated with endoscopic injection sclerotherapy.
Topics: Adult; Aged; Endoscopy; Esophageal and Gastric Varices; Esophageal Diseases; Female; Humans; Male; M | 1992 |
Criteria for use of omeprazole in adult inpatients and outpatients.
Topics: Adult; Barrett Esophagus; Duodenal Ulcer; Education, Pharmacy, Continuing; Esophagitis, Peptic; Huma | 1992 |
Criteria for use of omeprazole in adult inpatients and outpatients.
Topics: Adult; Barrett Esophagus; Duodenal Ulcer; Education, Pharmacy, Continuing; Esophagitis, Peptic; Huma | 1992 |
Oesophageal candidiasis after omeprazole therapy.
Topics: Aged; Candidiasis; Esophageal Diseases; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Stomach | 1992 |
Oesophageal candidiasis after omeprazole therapy.
Topics: Aged; Candidiasis; Esophageal Diseases; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Stomach | 1992 |
Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Gastric | 1991 |
Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Gastric | 1991 |
[Peptic ulcer and drug therapy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Ga | 1991 |
[Peptic ulcer and drug therapy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Ga | 1991 |
Effects of cimetidine and omeprazole on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats.
Topics: Acetates; Acetic Acid; Animals; Cimetidine; Dose-Response Relationship, Drug; Granulation Tissue; Ma | 1990 |
Effects of cimetidine and omeprazole on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats.
Topics: Acetates; Acetic Acid; Animals; Cimetidine; Dose-Response Relationship, Drug; Granulation Tissue; Ma | 1990 |
Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration.
Topics: Adult; Eosinophilia; Female; Gastritis; Gastroscopy; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ra | 1991 |
Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration.
Topics: Adult; Eosinophilia; Female; Gastritis; Gastroscopy; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ra | 1991 |
Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids.
Topics: Acute Disease; Aluminum Hydroxide; Animals; Antacids; Chronic Disease; Drug Combinations; Ethanol; F | 1991 |
Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids.
Topics: Acute Disease; Aluminum Hydroxide; Animals; Antacids; Chronic Disease; Drug Combinations; Ethanol; F | 1991 |
Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benz | 1991 |
Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benz | 1991 |
Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Dog Diseases; Dogs; Double-Blind Method; Gastrit | 1991 |
Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Dog Diseases; Dogs; Double-Blind Method; Gastrit | 1991 |
A new method for evaluating gastric ulcer healing by endoscopic ultrasonography.
Topics: Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Female; Gastroscopy; Gefarnate; Humans; Ma | 1991 |
A new method for evaluating gastric ulcer healing by endoscopic ultrasonography.
Topics: Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Female; Gastroscopy; Gefarnate; Humans; Ma | 1991 |
Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Cimetidi | 1991 |
Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Cimetidi | 1991 |
Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Esoph | 1991 |
Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Esoph | 1991 |
Role of gastric mucosal blood flow in cytoprotection.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Cimetidine; Ethanol; Gastric Mucosa; Lasers; Male; Misopros | 1991 |
Role of gastric mucosal blood flow in cytoprotection.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Cimetidine; Ethanol; Gastric Mucosa; Lasers; Male; Misopros | 1991 |
Omeprazole.
Topics: Duodenal Ulcer; Esophagitis; Gastroesophageal Reflux; Humans; Omeprazole; Stomach Ulcer | 1991 |
Omeprazole.
Topics: Duodenal Ulcer; Esophagitis; Gastroesophageal Reflux; Humans; Omeprazole; Stomach Ulcer | 1991 |
Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Topics: Animals; Anti-Ulcer Agents; Cold Temperature; Cysteamine; Duodenal Ulcer; Gastric Acid; Histamine; H | 1990 |
Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Topics: Animals; Anti-Ulcer Agents; Cold Temperature; Cysteamine; Duodenal Ulcer; Gastric Acid; Histamine; H | 1990 |
Controlling gastric pH: the impact of newer agents on the critically ill patient.
Topics: Alprostadil; Anti-Ulcer Agents; Critical Care; Gastric Acid; Histamine H2 Antagonists; Humans; Hydro | 1990 |
Controlling gastric pH: the impact of newer agents on the critically ill patient.
Topics: Alprostadil; Anti-Ulcer Agents; Critical Care; Gastric Acid; Histamine H2 Antagonists; Humans; Hydro | 1990 |
Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benz | 1990 |
Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benz | 1990 |
Omeprazole and acid peptic disease.
Topics: Animals; Drug Administration Schedule; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Humans; Om | 1991 |
Omeprazole and acid peptic disease.
Topics: Animals; Drug Administration Schedule; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Humans; Om | 1991 |
Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats.
Topics: Acetates; Acetic Acid; Animals; Dinoprostone; Gastric Mucosa; Indomethacin; Male; Omeprazole; Rats; | 1991 |
Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats.
Topics: Acetates; Acetic Acid; Animals; Dinoprostone; Gastric Mucosa; Indomethacin; Male; Omeprazole; Rats; | 1991 |
Omeprazole in gastric and duodenal ulcers.
Topics: Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Prognosis; Stomach Ulcer | 1991 |
Omeprazole in gastric and duodenal ulcers.
Topics: Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Prognosis; Stomach Ulcer | 1991 |
Synthesis of 2-[[(4-fluoroalkoxy-2-pyridyl)methyl]sulfinyl]-1H- benzimidazoles as antiulcer agents.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Survival; Gastric Mucosa; | 1990 |
Synthesis of 2-[[(4-fluoroalkoxy-2-pyridyl)methyl]sulfinyl]-1H- benzimidazoles as antiulcer agents.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Survival; Gastric Mucosa; | 1990 |
Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alprostadil; Animals; Atropine; Duodenal Ulcer; Female | 1990 |
Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alprostadil; Animals; Atropine; Duodenal Ulcer; Female | 1990 |
Effect of epidermal growth factor in combination with sucralfate or omeprazole on the healing of chronic gastric ulcers in the rat.
Topics: Acetates; Acetic Acid; Animals; Drug Therapy, Combination; Epidermal Growth Factor; Male; Omeprazole | 1990 |
Effect of epidermal growth factor in combination with sucralfate or omeprazole on the healing of chronic gastric ulcers in the rat.
Topics: Acetates; Acetic Acid; Animals; Drug Therapy, Combination; Epidermal Growth Factor; Male; Omeprazole | 1990 |
Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats.
Topics: Acetates; Acetic Acid; Animals; Drug Therapy, Combination; Gastric Acid; Histamine; Indomethacin; Ma | 1990 |
Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats.
Topics: Acetates; Acetic Acid; Animals; Drug Therapy, Combination; Gastric Acid; Histamine; Indomethacin; Ma | 1990 |
[Progress of gastrin research--from gene to big gastrin N-terminal fragment].
Topics: Amino Acid Sequence; Chromatography; Gastric Mucosa; Gastrins; Glicentin; Glucagon; Glucagon-Like Pe | 1990 |
[Progress of gastrin research--from gene to big gastrin N-terminal fragment].
Topics: Amino Acid Sequence; Chromatography; Gastric Mucosa; Gastrins; Glicentin; Glucagon; Glucagon-Like Pe | 1990 |
Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats.
Topics: Animals; Bicarbonates; Brain; Cold Temperature; Corticotropin-Releasing Hormone; Gastric Juice; Gast | 1990 |
Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats.
Topics: Animals; Bicarbonates; Brain; Cold Temperature; Corticotropin-Releasing Hormone; Gastric Juice; Gast | 1990 |
Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
Topics: Biopsy; Cell Count; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Gastrins; Gastroscopy; Humans | 1989 |
Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
Topics: Biopsy; Cell Count; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Gastrins; Gastroscopy; Humans | 1989 |
The role of prostaglandin D2 in the genesis of indomethacin-induced gastric lesions in rats.
Topics: Animals; Biomechanical Phenomena; Gastric Mucosa; Indomethacin; Male; Omeprazole; Prostaglandin D2; | 1989 |
The role of prostaglandin D2 in the genesis of indomethacin-induced gastric lesions in rats.
Topics: Animals; Biomechanical Phenomena; Gastric Mucosa; Indomethacin; Male; Omeprazole; Prostaglandin D2; | 1989 |
[Omeprazole in peptic ulceration: acid inhibition and endoscopic healing].
Topics: Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Humans; Omeprazole; Stomach Ulcer | 1989 |
[Omeprazole in peptic ulceration: acid inhibition and endoscopic healing].
Topics: Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Humans; Omeprazole; Stomach Ulcer | 1989 |
Effects of NC-1300, a gastric proton pump inhibitor, on healing of acetic acid-induced gastric ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Administration, Oral; Animals; Anti-Ulcer Agents; | 1989 |
Effects of NC-1300, a gastric proton pump inhibitor, on healing of acetic acid-induced gastric ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Administration, Oral; Animals; Anti-Ulcer Agents; | 1989 |
Omeprazole versus ranitidine for gastric ulcer.
Topics: Humans; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
Omeprazole versus ranitidine for gastric ulcer.
Topics: Humans; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Critical Care; Gastri | 1985 |
Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Critical Care; Gastri | 1985 |
Omeprazole.
Topics: Adenocarcinoma; Adult; Aged; Animals; Esophagitis, Peptic; Humans; Omeprazole; Rats; Stomach Neoplas | 1987 |
Omeprazole.
Topics: Adenocarcinoma; Adult; Aged; Animals; Esophagitis, Peptic; Humans; Omeprazole; Rats; Stomach Neoplas | 1987 |
Effects of antimuscarinic agents, H2-blockers and omeprazole on rat chronic gastric ulcer after long- and short-term administration.
Topics: Administration, Oral; Animals; Female; Gastric Acid; Gastrointestinal Motility; Histamine H2 Antagon | 1988 |
Effects of antimuscarinic agents, H2-blockers and omeprazole on rat chronic gastric ulcer after long- and short-term administration.
Topics: Administration, Oral; Animals; Female; Gastric Acid; Gastrointestinal Motility; Histamine H2 Antagon | 1988 |
[Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
Topics: Animals; Dogs; Duodenitis; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Male; Omepraz | 1988 |
[Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
Topics: Animals; Dogs; Duodenitis; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Male; Omepraz | 1988 |
Does early antisecretory treatment limit ulcer development?
Topics: Animals; Cimetidine; Omeprazole; Rats; Stomach Ulcer; Time Factors | 1989 |
Does early antisecretory treatment limit ulcer development?
Topics: Animals; Cimetidine; Omeprazole; Rats; Stomach Ulcer; Time Factors | 1989 |
Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
Topics: Adenosine Triphosphatases; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Gastric Acid; | 1986 |
Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
Topics: Adenosine Triphosphatases; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Gastric Acid; | 1986 |
Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors.
Topics: Adenosine Triphosphatases; Digestive System Diseases; Duodenal Ulcer; Esophagitis, Peptic; Gastric A | 1986 |
Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors.
Topics: Adenosine Triphosphatases; Digestive System Diseases; Duodenal Ulcer; Esophagitis, Peptic; Gastric A | 1986 |
Indomethacin-induced gastric antral ulcers in hamsters.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Cricetinae; Dinoprostone; Disease Models, Animal | 1988 |
Indomethacin-induced gastric antral ulcers in hamsters.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Cricetinae; Dinoprostone; Disease Models, Animal | 1988 |
[Inhibitory effects of omeprazole and cimetidine on the formation of gastric ulcer in rats with obstructive jaundice and acute renal failure].
Topics: Acute Kidney Injury; Animals; Cholestasis; Cimetidine; Gastric Mucosa; Male; Omeprazole; Rats; Rats, | 1988 |
[Inhibitory effects of omeprazole and cimetidine on the formation of gastric ulcer in rats with obstructive jaundice and acute renal failure].
Topics: Acute Kidney Injury; Animals; Cholestasis; Cimetidine; Gastric Mucosa; Male; Omeprazole; Rats; Rats, | 1988 |
Effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion in rats.
Topics: Animals; Cimetidine; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Pentagastrin; Rats; Rats, Inbre | 1988 |
Effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion in rats.
Topics: Animals; Cimetidine; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Pentagastrin; Rats; Rats, Inbre | 1988 |
[Synthesis and anti-ulcer activity of some new compounds with arylthiomethyl-pyridine structure].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Indomethacin; M | 1988 |
[Synthesis and anti-ulcer activity of some new compounds with arylthiomethyl-pyridine structure].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Indomethacin; M | 1988 |
Insulin-induced gastric ulcers in the rat.
Topics: Animals; Gastric Mucosa; Insulin; Male; Omeprazole; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred S | 1987 |
Insulin-induced gastric ulcers in the rat.
Topics: Animals; Gastric Mucosa; Insulin; Male; Omeprazole; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred S | 1987 |
Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Autoradiography; Body Weight; Gastric Mucosa; Gastrins; Ind | 1988 |
Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Autoradiography; Body Weight; Gastric Mucosa; Gastrins; Ind | 1988 |
Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.
Topics: Female; Gastric Mucosa; Gastrins; Humans; Male; Omeprazole; Parietal Cells, Gastric; Peptic Ulcer; R | 1988 |
Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.
Topics: Female; Gastric Mucosa; Gastrins; Humans; Male; Omeprazole; Parietal Cells, Gastric; Peptic Ulcer; R | 1988 |
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
Topics: Adult; Aged; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastrins; Humans; Male; Middle Aged; Omepr | 1988 |
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
Topics: Adult; Aged; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastrins; Humans; Male; Middle Aged; Omepr | 1988 |
Effects of NC-1300 and its degradation products on gastric secretion and HCl.ethanol-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Drug Stability; Ethanol; Gastric A | 1987 |
Effects of NC-1300 and its degradation products on gastric secretion and HCl.ethanol-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Drug Stability; Ethanol; Gastric A | 1987 |
The influence of omeprazole on the protective effects of secretagogues against ethanol-induced gastric ulceration in rats.
Topics: Animals; Ethanol; Gastric Mucosa; Histamine; Male; Methacholine Compounds; Omeprazole; Pentagastrin; | 1987 |
The influence of omeprazole on the protective effects of secretagogues against ethanol-induced gastric ulceration in rats.
Topics: Animals; Ethanol; Gastric Mucosa; Histamine; Male; Methacholine Compounds; Omeprazole; Pentagastrin; | 1987 |
[Effects of omeprazole, a benzimidazole derivative, on the gastric mucosal blood flow in chronic gastric ulcer in humans].
Topics: Aged; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; Gastric Mucosa; Humans; Omeprazole; Region | 1986 |
[Effects of omeprazole, a benzimidazole derivative, on the gastric mucosal blood flow in chronic gastric ulcer in humans].
Topics: Aged; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; Gastric Mucosa; Humans; Omeprazole; Region | 1986 |
Cytoprotective effects of NC-1300 and omeprazole on Hcl . ethanol-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Ethanol; Ethylm | 1986 |
Cytoprotective effects of NC-1300 and omeprazole on Hcl . ethanol-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Ethanol; Ethylm | 1986 |
Effect of omeprazole on acute gastric stress ulceration in cervical cord transected rats.
Topics: Achlorhydria; Animals; Body Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; F | 1987 |
Effect of omeprazole on acute gastric stress ulceration in cervical cord transected rats.
Topics: Achlorhydria; Animals; Body Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; F | 1987 |